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Verocytotoxin-producing Escherichia coli (VTEC) are important human pathogens 
that may cause diarrhoea, haemorrhagic colitis and haemolytic uremic syndrome 
(HUS).  Worldwide, non-sorbitol-fermenting (NSF) VTEC O157:H7 is the most 
common serogroup associated with HUS but several non-O157:H7 serogroups have 
emerged as causes of this disease.  This research investigated the pathogenic 
potential of two non-O157:H7 serogroups: O26 and sorbitol-fermenting (SF) 
O157:NM.  While VTEC O26 have emerged as a significant cause of HUS in 
continental Europe, human infections associated with this pathogen are uncommon in 
Scotland and generally only result in simple diarrhoea.  The study characterised E. 
coli O26 isolates recovered from human infections in Europe and Scotland and 
isolates collected from Scottish cattle with the objectives to identify factors which 
may allow strains to cause more serious clinical disease and to investigate the 
potential of bovine VTEC O26 in Scotland to cause human infection.  MLST 
analysis of housekeeping genes found little genetic variation in the genomic 
‘backbone’ among the vast majority of E. coli O26 isolates.  The gene for 
verocytotoxin 2 (vtx2) alone was carried by VTEC O26 isolates recovered from 
patients in continental Europe but was found in no Scottish human isolate, where the 
majority of isolates did not harbour a vtx gene.  It was demonstrated that among the 
European VTEC O26 human isolates, 67% carried a specific allele within the 
promoter region for LEE1 and 87% harboured the tccP2 gene.  In contrast, no 
Scottish VTEC O26 human isolate carried this allele or the tccP2 gene.  The impact 
these genotypic characteristics have on the pathogenic potential of a strain remains 
uncertain.  There were no clear differences in verocytotoxin titres, levels of LEE-
encoded protein secretion or levels of adherence to Caco-2 cells between VTEC O26 
isolates recovered from human infections of varying severity.  However, levels of 
LEE-encoded protein secretion from cattle isolates were generally higher than those 
from many of the human isolates.  The differences in pathogenic potential between 
isolates are likely to be due to horizontally acquired DNA, including vtx2 carriage 
and the O-island-phage-associated effector protein repertoire.  Further work is 
required to determine if the differences identified may also impact on shedding levels 
 xix
from cattle and therefore the likelihood of transmission to humans.  Since 1988, SF 
VTEC O157:NM strains have emerged and have been associated with a higher 
incidence of progression to HUS than NSF VTEC O157:H7.  This study investigated 
bacterial factors that may account for the increased pathogenic potential of SF VTEC 
O157:NM.  While no evidence of toxin or toxin expression differences between the 
two VTEC O157 groups was found, the SF VTEC O157:NM strains adhered at 
significantly higher levels to a human colonic cell line.  Under the conditions tested, 
curli were shown to be the main factor responsible for the increased adherence to 
Caco-2 cells.  The capacity of SF VTEC O157:NM strains to express curli at 37C 
may have relevance to the epidemiology of human infections as curliated strains 
could promote higher levels of colonization and inflammation in the human intestine.  
In turn this could lead to increased toxin exposure and an increased likelihood of 















1.1 Bacterial evolution and pathogenesis 
In examining the mechanisms that bacteria use to cause infections, it is worth 
pointing out that animals, including humans, and bacteria have evolved together.   
The majority of bacteria exist in a state of equilibrium with the host where 
commensal colonisation represents a beneficial circumstance for both.  Additionally, 
animals may encounter pathogenic bacteria (that is disease-causing bacteria) many 
times a day, yet infection after such exposure is generally the exception rather than 
the rule.  Of those who become infected some individuals will develop asymptomatic 
carriage and not all will progress to clinical disease.  Bacterial disease is thus likely 
to occur in only a small proportion of the initially exposed population. 
 
It is now accepted that many bacterial diseases are a consequence of a complex set of 
interactions between the bacteria and their host.  Mammals have evolved many ways 
of protecting themselves from bacterial pathogens and the relatively high replication 
rate of most bacteria has meant they have evolved various mechanisms to overcome 
these innate and adaptive immune responses.  Genome sequencing has revealed that 
strains within many bacterial species share a common genetic backbone which can 
be interspersed with ‘islands’ of DNA.  This variable content is often associated with 
virulence capacity, either directly or by modulating an existing activity.  Many of 
these islands show evidence of having been horizontally acquired from other bacteria 
via direct DNA uptake, conjugation or phage transduction, indicating many groups of 
bacteria have the capacity to share or exchange this information.   
 
The Enterobacteriaceae family of Gram negative bacteria contain a number of genera 
of important pathogens that can produce infections in a wide range of hosts and elicit 
different types of pathologies.  Even focusing down to one genus and one species 
such as Escherichia coli (E. coli) still provides a diverse group of bacteria that range 
from harmless commensals of the gastrointestinal tract to highly virulent pathogens.  
While the work described in this thesis is aimed at understanding differences in the 
pathogenic potential between related E. coli strains, it should be borne in mind that 
the mechanisms and evolutionary forces by which E. coli have evolved to survive in 
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its host either by causing disease, manipulating host defences or evading the immune 
response are relevant to many other pathogens, bacterial or otherwise. 
  
1.2 Introduction to E. coli 
E. coli is a Gram negative bacillus and is a normal constituent of the human colonic 
flora, typically colonising the infant gastrointestinal tract shortly after birth (Nataro 
& Kaper, 1998; Sussman, 1997).  E. coli usually exist innocuously in the intestinal 
lumen and can be beneficial to the host.  However, human disease can arise as: (i) 
normal, non-pathogenic strains, can cause infection in immunocompromised hosts 
and (ii) certain E. coli species are highly adapted and have evolved the ability to 
cause a wide spectrum of human diseases (Nataro & Kaper, 1998).  E. coli is an 
important etiological agent in urinary tract infections, septicaemia, meningitis and 
diarrhoeal disease. 
 
1.3 Diarrheagenic E. coli  
E. coli strains associated with diarrhoeal disease can be categorised into five 
principal pathogenicity groups based on their virulence properties and mechanisms 
of pathogenicity (Wasteson, 2001): 
 (i) Enterotoxigenic E. coli (ETEC) 
 (ii) Enteroaggregative E. coli (EAEC) 
(iii) Enteroinvasive E. coli (EIEC) 
(iv) Enteropathogenic E. coli (EPEC) 
(iv) Enterohaemorrhagic E. coli (EHEC)/Verocytotoxin-producing E. coli 
(VTEC)/Shiga toxin-producing E. coli (STEC) 
 
1.3.1 Enterotoxigenic E. coli (ETEC) 
ETEC strains colonise the surface of the small bowel mucosa and produce 
enterotoxins – namely, heat-labile toxins and heat-stable toxins – which result in 
watery diarrhoea.  ETEC are associated with diarrhoea in travellers and infants in 




1.3.2 Enteroaggregative E. coli (EAEC) 
EAEC are associated with persistent diarrhoea in developing populations and are 
defined by the fact that they have a characteristic adherence phenotype on HEp-2 
cells, where the bacteria aggregate to each other in a stacked-brick configuration 
(Nataro & Kaper, 1998).  While EAEC pathogenesis is not well understood, a three-
stage model involving initial aggregative adherence followed by enhanced mucus 
production and then the production of an EAEC cytotoxin, which results in intestinal 
cell damage, has been suggested (Nataro & Kaper, 1998). 
 
1.3.3 Enteroinvasive E. coli (EIEC) 
EIEC produce disease in humans almost identical to the disease caused by Shigella 
spp. (Nataro & Kaper, 1998; Wasteson, 2001).  Infection with EIEC results in watery 
diarrhoea and occasionally the patient experiences the dysentery syndrome, with 
blood, mucus and leukocytes in the stool, tenesmus and fever (Nataro & Kaper, 
1998).  EIEC invade and multiply within colonic epithelial cells (Wasteson, 2001) 
and have directional movement through the cytoplasm, extending into adjacent 
epithelial cells (Nataro & Kaper, 1998). 
 
1.3.4 Enteropathogenic E. coli (EPEC) 
EPEC is a major cause of infantile diarrhoea in developing countries (Nataro & 
Kaper, 1998; Wasteson, 2001).  The central mechanism of EPEC pathogenesis is the 
attaching and effacing (A/E) lesion (Nataro & Kaper, 1998; Wasteson, 2001).  This 
lesion is characterised by the effacement of microvilli, intimate adherence between 
the bacteria and the intestinal epithelium, accumulation of polymerised actin beneath 
the adherent bacteria and pedestal formation (Nataro & Kaper, 1998).  Multiple 
mechanisms have been suggested for how diarrhoea results from infection with 
EPEC.  The rapid onset of severe watery diarrhoea could be accounted for by the 
ability of EPEC to rapidly inactivate the sodium-D-glucose cotransporter, which is 
responsible for the daily uptake of approximately 6 litres of fluid from the normal 
intestine (Dean et al., 2006).  Additional mechanisms which may contribute to 
diarrhoea include disruption of barrier function and immune response-triggered 
secretory responses (Dean et al., 2006; Nataro & Kaper, 1998). 
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Typical EPEC are characterised by the presence of the EPEC adherence factor (EAF) 
plasmid (Trabulsi et al., 2002).  This plasmid carries the cluster of genes that encode 
bundle-forming pili (BFP), which interconnect bacteria within compact 
microcolonies and mediate localised adherence on cultured epithelial cells.  EPEC 
lacking the EAF plasmid are referred to as atypical EPEC (aEPEC) (Trabulsi et al., 
2002).   
 
1.3.5 Enterohaemorrhagic E. coli (EHEC)/Verocytotoxin-producing E. coli 
(VTEC)/Shiga toxin-producing E. coli (STEC)  
1.3.5.1  Nomenclature 
The term verocytotoxin-producing E. coli (VTEC) originates from the observation by 
Konowalchuk et al. (1977) that these strains produced a toxin which was cytotoxic to 
Vero cells.  VTEC is synonymous with Shiga toxin-producing E. coli (STEC), a term 
which reflects the fact that one of the cytotoxins produced by these organisms is very 
similar in biological properties, physical properties and antigenicity to the Shiga 
toxin produced by Shigella dysenteriae (Nataro & Kaper, 1998).  The term 
enterohaemorrhagic E. coli (EHEC) was originally devised to denote strains that 
cause haemorrhagic colitis and haemolytic uraemic syndrome (HUS), produce 
verocytotoxin, evoke A/E lesions on epithelial cells and possess a large plasmid (of ~ 
60 MDa) (Nataro & Kaper, 1998; O'Brien & Kaper, 1998).  Thus, EHEC represents a 
subset of VTEC and incorporates a clinical connotation that is not inferred with 
VTEC.  Although not all VTEC are considered to be pathogenic, all EHEC strains 
are believed to be pathogens (Nataro & Kaper, 1998; Tarr et al., 2005). 
 
1.3.5.2  Human infection 
Infection by VTEC can cause a spectrum of human diseases, ranging from 
asymptomatic carriage and mild diarrhoea to severe bloody diarrhoea and 
haemorrhagic colitis.  Haemorrhagic colitis is characterised by severe abdominal 
cramps, watery diarrhoea followed by grossly bloody diarrhoea, and little or no fever 
(Nataro & Kaper, 1998; O'Brien & Kaper, 1998; Riley et al., 1983).  Human 
infection with VTEC strains is potentially fatal and may be associated with serious 
complications such as HUS (World Health Organisation, 1998).  HUS is defined by a 
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triad of clinical features that include acute renal failure, thrombocytopaenia and 
microangiopathic haemolytic anaemia (Nataro & Kaper, 1998; O'Brien & Kaper, 
1998).  HUS is the principal cause of acute renal failure in children (O'Brien & 
Kaper, 1998; Tarr et al., 2005).  VTEC infections are most frequently observed in 
infants, children and elderly patients (World Health Organisation, 1998). 
 
1.4 Typing methods for E. coli 
1.4.1 Serotyping 
The current scheme for the serological classification of E. coli is a modified version 
of that originally proposed by Kauffman in 1944.  In accordance with the modified 
Kauffman scheme, E. coli are serotyped with respect to a number of antigens – 
namely, their somatic lipopolysaccharide O-antigen, flagellar H-antigen and capsular 
K-antigen (Nataro & Kaper, 1998; Sussman, 1997). 
 
1.4.2 Biochemical typing 
E. coli strains can be typed on the basis of their biochemical capabilities (Nataro & 
Kaper, 1998).  Commercially available test strips (API 20E strips) are routinely used 
to characterise E. coli strains via the following biochemical reactions: production of 
β-galactosidase, arginine dehydrolase, lysine decarboxylase, ornithine decarboxylase, 
hydrogen sulphide, urease and indole; utilisation of citrate; deamination of 
tryptophan; conversion of pyruvate to acetoin; hydrolysis of gelatin; and 
fermentation of glucose, mannitol, inositol, sorbitol, rhamnose, saccharose, 
melibiose, amygdalin and arabinose.  However, the introduction of the Biolog 
Phenotype MicroArray system makes it possible to characterise strains with respect 
to a greater number of biochemical properties.    
 
1.4.3 Pulsed-field gel electrophoresis (PFGE) 
Pulsed-field gel electrophoresis (PFGE) is the current method of choice for the 
epidemiological subtyping of E. coli strains and is favoured because of its high level 
of discrimination (Noller et al., 2003). 
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The digestion of genomic DNA with restriction enzymes that cut infrequently 
generates DNA fragments that are usually too large to separate by conventional 
agarose gel electrophoresis.  However, these fragments can be effectively resolved 
by PFGE, which promotes the differential migration of large DNA fragments 
through agarose gels by periodically changing the direction of the electrical field 
(Sambrook et al., 1989). 
 
PFGE is designed to show maximal variation within a population.  PFGE identifies 
the microvariation that is required to distinguish strains within a geographic area and 
is therefore useful for studying local epidemiology, such as investigations of 
localised outbreaks of disease (Maiden et al., 1998).  However, PFGE is too 
discriminatory for long term and global epidemiology (Maiden et al., 1998). 
 
1.4.4 Multilocus sequence typing (MLST) 
Multilocus sequence typing (MLST) was first developed by Maiden et al. (1998) for 
the pathogen Neisseria meningitidis but has since been employed to study many 
other bacterial species (Cooper & Feil, 2004).  MLST is a nucleotide sequence-based 
typing system that was established for analysing pathogenic bacteria from a global 
epidemiology perspective (Maiden et al., 1998; Urwin & Maiden, 2003).  MLST is 
based on the principles of multilocus enzyme electrophoresis (MLEE) (Selander et 
al., 1986) but differs in that it characterises the alleles present at multiple house-
keeping loci directly by nucleotide sequencing rather than indirectly via the 
electrophoretic mobility of the enzymes they encode (Maiden et al., 1998).  Like 
MLEE, MLST considers variation that accumulates slowly, and which is expected to 
be selectively neutral, and achieves high resolution by analysing multiple loci 
(Enright & Spratt, 1998; Maiden et al., 1998).  A major advantage of MLST over 
other molecular typing methods is that sequence data are unambiguous and can be 
accurately compared between different laboratories (Maiden et al., 1998). 
 
MLST uses the sequences of internal fragments of several (usually seven) 
housekeeping genes.  Unique sequences for each gene are given arbitrary allele 
numbers as identifiers and, for each isolate, the combination of allele numbers at all 
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loci defines the allelic profile.  Each unique allelic profile is assigned a sequence type 
(ST) number and related STs are assigned to the same ST complex (Maiden et al., 
1998; Wirth et al., 2006). 
 
1.5 E. coli serogroup O157 
1.5.1 E. coli O157:H7 
E. coli O157:H7 was first recognised as a human pathogen in 1982 following its 
association with two major disease outbreaks in the United States (Riley et al., 
1983).  Since its identification as a pathogen, E. coli O157:H7 has been found to be 
the predominant VTEC serotype and the cause of a series of outbreaks in the United 
States, Canada, the United Kingdom and Japan (O'Brien & Kaper, 1998).  
Worldwide, the majority of the reported human illness outbreaks have been 
attributed to serotype O157:H7 (Bettelheim, 2003; Caprioli et al., 1997; Tarr et al., 
2005) and this serotype has the strongest and most enduring aetiological association 
with HUS (Tarr et al., 2005).   
 
The recognition of E. coli O157:H7 as a pathogen has been facilitated by the 
availability of microbiological detection procedures based on the characteristic 
phenotypic feature of this organism, namely, its inability to ferment sorbitol (Mead 
& Griffin, 1998). 
 
1.5.1.1  Sources of E. coli O157:H7 infection 
Cattle and sheep are major reservoirs of EHEC, including E. coli O157:H7.  These 
ruminants carry E. coli O157:H7 asymptomatically in their intestines and shed it in 
their faeces.  Traditionally, many reported outbreaks of E. coli O157:H7 were food-
borne and were associated with the consumption of foods, including beef and dairy 
products and salads (Centers for Disease Control and Prevention, 2000 & 2008; Tarr 
et al., 2005; Upton & Coia, 1994; Willshaw et al., 1994).  These foods may have 
been contaminated directly with faeces or indirectly, through contaminated irrigation 
or via contamination during packaging and/or food preparation.  Recent outbreaks 
have increasingly recognised environmental exposure as an important source of 
human infection.  This includes contamination of water supplies from faeces of 
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animals (Licence et al., 2001) and direct contact with farm animals and their faeces 
following visits to farms and recreational use of animal pasture (Strachan et al., 
2001).  In addition, person to person transmission is also reported to be an infection 
route (Al-Jader et al., 1999).  
 
1.5.2 Sorbitol-fermenting (SF) E. coli O157:NM 
In addition to E. coli O157:H7, strains of serotype O157:NM (nonmotile) which 
ferment sorbitol have emerged as important human pathogens in continental Europe 
(Karch & Bielaszewska, 2001). 
 
1.5.2.1  SF VTEC O157:NM strains as human pathogens  
SF VTEC O157:NM strains were first recognised during an outbreak of HUS in 
children in Bavaria, Germany, in 1988 (Karch & Bielaszewska, 2001).  Since then, 
these strains have been isolated from patients throughout Germany (Gunzer et al., 
1992; Karch et al., 1993), including a further outbreak in Bavaria that resulted in 
twenty-eight cases of HUS, three of them fatal (Ammon et al., 1999).  The first 
isolation of SF VTEC O157:NM strains outside Germany occurred in the Czech 
Republic in 1995 (Bielaszewska et al., 1998).  There have since been reports of this 
pathogen causing diarrhoea or HUS in Hungary (Karch & Bielaszewska, 2001), 
Finland (Keskimaki et al., 1998), another region of the Czech Republic 
(Bielaszewska et al., 2000), Austria (Orth et al., 2006) and Sweden (S. Löfdahl, 
personal communication).  Infection with SF VTEC O157:NM was not reported 
outside continental Europe until 2002 when it was isolated in Australia (Bettelheim 
et al., 2002) and Scotland (Allison, 2002).  It was subsequently isolated from patients 
in England (HPA, 2006) and Ireland (Garvey et al., 2006). 
 
1.5.2.2  Sources of SF VTEC O157:NM infection 
The reservoirs and transmission routes of SF VTEC O157:NM remain largely 
unknown.  While cattle are well established as a major reservoir of VTEC O157:H7, 
there are only two reports of the isolation of SF VTEC O157:NM strains from cattle 
(Bielaszewska et al., 2000; Orth et al., 2006).  Although more than 1,300 bovine 
faecal samples have been examined for SF VTEC O157:NM in Germany and the 
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Czech Republic (Karch & Bielaszewska, 2001), only one was found to be positive 
for this pathogen (Bielaszewska et al., 2000).  In addition, except for a single 
isolation of a SF VTEC O157:NM strain from a pony, this pathogen has not been 
isolated from any other domestic or wild animal, including sheep, goats and deer, in 
continental Europe (Karch & Bielaszewska, 2001).  However, SF VTEC O157:NM 
has been isolated from cat faeces in Scotland (Locking et al., 2004).  Since SF VTEC 
O157:NM have only rarely been isolated from animals, it has been suggested that 
these pathogens might be adapted to the human intestine and that humans may be 
their principal reservoir (Karch & Bielaszewska, 2001). 
 
The routes of transmission of SF VTEC O157:NM infection are unknown in most 
cases.  However, the main transmission routes of VTEC O157:H7 infection have also 
been identified for SF VTEC O157:NM.  A large outbreak of HUS caused by SF 
VTEC O157:NM in Germany probably had a food-borne origin (Ammon et al., 
1999).  Case-control studies identified two sausages, namely mortadella and 
teewurst, the latter of which contains raw beef, as likely sources of infection 
(Ammon et al., 1999).  In addition, a report from Austria described the isolation of 
SF VTEC O157:NM from a child with HUS who had consumed unpasteurised cow’s 
milk (Allerberger et al., 2001).  Direct contact with animals, including a cow 
(Bielaszewska et al., 2000) and a pony (Karch & Bielaszewska, 2001) that shed SF 
VTEC O157:NM in their faeces, was the most probable route of transmission of 
infection to patients in two instances (Bielaszewska et al., 2000; Karch & 
Bielaszewska, 2001).  Moreover, SF VTEC O157:NM was isolated from cat faeces 
at a farm where a bloody diarrhoeal infection had occurred and the cat isolate shared 
an indistinguishable PFGE profile with the clinical isolate (Locking et al., 2004).  
Finally, person to person transmission was suggested to be the route of SF VTEC 
O157:NM infection of a 10 month old child in Austria (Orth et al., 2006). 
 
1.5.3 Evolutionary model of E. coli O157      
In the evolutionary model proposed by Feng et al. (1998; 2007), both VTEC 
O157:H7 and SF VTEC O157:NM evolved from a common EPEC-like O55:H7 
ancestor that was able to ferment sorbitol (SOR+) and express β-glucuronidase 
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(GUD+) and that carried the LEE (locus of enterocyte effacement) pathogenicity 
island.  This E. coli O55:H7 ancestor is proposed to have acquired the gene for 
verocytotoxin 2 (vtx2), a large plasmid and the rfb region encoding O157 antigen, 
resulting in a hypothetical intermediate O157:H7 Vtx2-producing strain that retained 
the SOR+ GUD+ phenotype (Feng et al., 1998).  From this E. coli O157:H7 ancestor, 
the model proposes that two distinct lineages evolved.  In one path, the loss of the 
ability to ferment sorbitol and express β-glucuronidase and the acquisition of the vtx1 
gene led to the emergence of the prototypic non-sorbitol-fermenting (NSF) VTEC 
O157:H7 clone (Feng et al., 1998).  Along the other path, the loss of motility yielded 
the SF VTEC O157:NM clone, which retained the ancestral ability to ferment 
sorbitol, express β-glucuronidase and produce Vtx2 (Feng et al., 1998).   
 
1.6 Non-O157 VTEC 
1.6.1 Non-O157 VTEC in human disease 
More than 200 non-O157 VTEC serotypes have been reported and over 100 of them 
have been associated with human illness (World Health Organisation, 1998).  It has 
only lately been appreciated that non-O157 VTEC are important pathogens, capable 
of causing a spectrum of disease in humans comparable to that produced by serotype 
O157:H7 (World Health Organisation, 1998).  However, the prevalence of infections 
with non-O157 VTEC strains is probably underestimated due to the failure of 
routinely used diagnostic procedures, such as sorbitol MacConkey agar, to detect 
non-O157 VTEC serotypes (Bettelheim, 2003; Karch et al., 1999; World Health 
Organisation, 1998).  
 
In the United States, Canada, the United Kingdom and Japan, the prevalence of non-
O157 VTEC is low, much lower than that of VTEC O157:H7.  However, in parts of 
the Southern hemisphere and continental Europe, non-O157 VTEC are significant 
causes of human disease, being responsible for a series of outbreaks and sporadic 
cases (Blanco et al., 2004; Caprioli et al., 1994; Caprioli et al., 1997; Elliott et al., 




Among European countries, the proportions of VTEC infections due to VTEC O157 
and VTEC non-O157 reported through Enter-net (an international surveillance 
network for human gastrointestinal infections) for 2005 are shown in Table 1.1.  
These data show considerable differences in the ratio between cases of VTEC O157 
and non-O157 VTEC infections in different countries.  For example, the vast 
majority of infections detected in Scotland, England and Wales were attributed to 
VTEC O157.  In contrast, in continental Europe, many of the infections were due to 
non-O157 serotypes, although there were marked national differences.  VTEC O157 
is the most prevalent serotype detected in Belgium, France, the Netherlands and 
Spain whereas in Denmark, Germany, Italy, Luxembourg and Norway other 
serotypes are more commonly detected.  While some of these differences are likely 
to reflect the diagnostic and surveillance strategies in these countries, they may also 
reflect natural differences in the occurrence of these pathogens. 
 
 
Table 1.1. Numbers of reported VTEC cases, proportions due to VTEC O157 
and VTEC non-O157 and numbers of cases of HUS for 2005 (Enter-net, 2005)a. 
 
Country % of cases due to 
 
Number of 
cases O157 Non-O157 
Number of 
HUS casesb 
Belgium 52 60% 40% 20 
Denmark 156 17% 72%c 4 
England and Wales 954 100%  NKd 
France 108 68% 19%c 20 
Germany 759 10% 64%c 8 
Ireland 125 86% 14% 17 
Italy 22 14% 82%c 19 
Luxemburg 11 18% 82% NKd 
Netherlands 54 100%  4 
Norway 18 39% 50%c 1 
Scotland 176 94% 6% NKd 
Spain 15 100%  1 
a Table adapted from Panel on Biological Hazards (2007). 
b HUS is a clinical diagnosis, hence cases are also reported in the absence of the 
isolation or confirmation of VTEC infection. 
c Isolates from some cases not serotyped. 





Among the numerous non-O157 VTEC serotypes, strains belonging to serogroups 
O26, O103, O111 and O145 are more commonly associated with serious disease, 
such as haemorrhagic colitis and HUS, and are thus clearly recognised as human 
pathogens (Brooks et al., 2005; Nataro & Kaper, 1998; World Health Organisation, 
1998). 
 
1.6.2 Prevalence of non-O157 VTEC in cattle 
A recent study investigated the prevalence of E. coli serogroups O26, O103, O111 
and O145 in faeces of cattle in Scotland (Pearce et al., 2006).  It was reported that no 
E. coli O111 were detected and, while E. coli O103 and O145 were isolated from the 
faeces of Scottish cattle, the carriage of verocytotoxin genes in these strains was rare 
(Pearce et al., 2006).  In contrast, VTEC O26 strains were common and widely 
dispersed in Scottish cattle (Pearce et al., 2006). 
 
1.6.3 E. coli serogroup O26 
E. coli serogroup O26 comprises two major groups of strains.  One group consists of 
strains that possess the verocytotoxin genes and are classified as VTEC.  The other 
group comprises E. coli O26 strains that lack the verocytotoxin genes and are 
classified as aEPEC as they have the ability to form A/E lesions on the intestinal 
epithelium but lack the EAF plasmid (Nataro & Kaper, 1998). 
 
Although the prevalence of VTEC O26 remains low in relation to VTEC O157:H7 in 
the United Kingdom, VTEC O26 has emerged as an important cause of human 
disease in other countries (Caprioli et al., 1997; Tozzi et al., 2003; Werber et al., 
2002; Zhang et al., 2000).  
 
1.6.3.1  Sources of E. coli O26 infection 
The source of VTEC O26 infections are rarely found (Jenkins et al., 2008; Zhang et 
al., 2000).  However, there is evidence to suggest that food-borne transmission was 
the most likely route for a number of VTEC O26 infections (Allerberger et al., 2003; 
Werber et al., 2002).  In addition, since VTEC O26 have been isolated from the 
faeces of cattle, pigs, sheep, goats and chickens (Jenkins et al., 2008; Leomil et al., 
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2005; Pearce et al., 2006), their transmission to humans directly or indirectly from 
animals and their faeces is also a possible route of infection (Jenkins et al., 2008). 
 
1.6.3.2  E. coli O26 in animals 
E. coli O26 are also of veterinary importance.  While they have been isolated from a 
variety of healthy animals, including cattle and pigs (Jenkins et al., 2008; Pearce et 
al., 2004, 2006), they are commonly associated with diarrhoea in calves (Pearson et 
al., 1999; Wieler et al., 1996).  E. coli O26 are often recovered from diarrhoeic 
calves which are simultaneously infected with Cryptosporidium or are otherwise 
immunocompromised (R. La Ragione, personal communication). 
 
1.7 VTEC virulence factors 
1.7.1 Verocytotoxins  
The ability to produce verocytotoxin (Vtx) is a major virulence trait of all VTEC.  
The structural genes for Vtx are encoded on lysogenic bacteriophages which have 
inserted into the chromosome.  Two major toxin types, Vtx1 and Vtx2, have been 
described.  The structural genes of Vtx1 and Vtx2 only share 56% amino acid 
sequence homology and the two toxins are antigenically distinct (Nataro & Kaper, 
1998).  A single VTEC isolate may produce Vtx1 alone, Vtx2 alone or both of these 
toxins in combination (Melton-Celsa & O'Brien, 1998).   
 
1.7.1.1  Structure and mode of action 
Both Vtx1 and Vtx2 have a conserved A1B5 subunit structure, in which one A 
subunit is noncovalently associated with a pentamer of B subunits (O'Brien & 
Holmes, 1987).  The ~32 kDa A subunit is proteolytically cleaved to yield a ~28 kDa 
peptide (A1) and a ~4 kDa peptide (A2), which remain linked by a disulphide bond.  
The A1 peptide contains the enzymatic activity, while the A2 peptide binds the A 
subunit to a pentamer of identical ~7.7 kDa B subunits (Nataro & Kaper, 1998).  The 
B pentamer binds the toxin to a specific glycolipid receptor, typically 
globotriaosylceramide (Gb3), present on the surface of eukaryotic cells.  The toxin is 
subsequently endocytosed through coated pits and transported to the Golgi apparatus 
and then to the endoplasmic reticulum (Nataro & Kaper, 1998).  The A subunit is 
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translocated to the cytoplasm where it acts on the 60S ribosomal subunit – the A1 
peptide is an N-glycosidase that removes a single adenine residue from the 28S 
rRNA of eukaryotic ribosomes, thereby preventing protein synthesis (Nataro & 
Kaper, 1998).  The disruption of protein synthesis causes cell death (Melton-Celsa & 
O'Brien, 1998; Nataro & Kaper, 1998). 
 
1.7.1.2  Vtx1 
Vtx1 originally appeared to be highly conserved.  The nucleotide sequences for vtx1 
from three different bacteriophages, H19B (De Grandis et al., 1987), H30 (Kozlov 
Yu et al., 1988) and 933J (Jackson et al., 1987), are identical and are very similar to 
the nucleotide sequence of stx from Shigella dysenteriae type 1 (Strockbine et al., 
1988).  However, several variants of Vtx1 have since been described.  Paton et al. 
(1993, 1995) identified three minor vtx1 variants which shared more than 99% 
nucleotide sequence identity with vtx1 from phage 933J and encoded Vtx1 proteins 
which differed from Vtx1 encoded by phage 933J by only two amino acid residues in 
their A subunits.  In contrast, the vtx1 variants, vtx1c and vtx1d, differ considerably 
from the classical vtx1.  vtx1c, present in VTEC strains of human and ovine origin, 
differs from vtx1 of phage 933J by 43 nucleotides, resulting in changes of nine amino 
acids in the A subunit and three amino acids in the B subunit (Paton et al., 1995; 
Zhang et al., 2002).  vtx1d, identified in a VTEC strain isolated from cattle, has only 
91% nucleotide sequence homology with vtx1 from phage 933J, resulting in changes 
of twenty and seven amino acid residues in the A and B subunits, respectively (Burk 
et al., 2003).  
 
1.7.1.3  Vtx2 
The Vtx2 group is highly heterogeneous, containing Vtx2 and several Vtx2 variants 
including Vtx2c (Schmitt et al., 1991), Vtx2d (Pierard et al., 1998), Vtx2e 
(Weinstein et al., 1988), Vtx2f (Schmidt et al., 2000) and Vtx2g (Leung et al., 2003).  
While Vtx2, Vtx2c, Vtx2d and Vtx2e can all be produced by VTEC strains isolated 
from humans (Friedrich et al., 2002; Pierard et al., 1998; Schmitt et al., 1991), 
VTEC strains possessing different vtx2 variants appear to differ in their pathogenic 
potential (Friedrich et al., 2002).  VTEC containing vtx2 or vtx2c are associated with 
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HUS whereas strains possessing vtx2d or vtx2e are less virulent (Friedrich et al., 
2002).  VTEC isolates harbouring vtx2 variants vtx2d, vtx2e and vtx2f are typically 
recovered from sheep (Pierard et al., 1998; Ramachandran et al., 2001), pigs 
(Weinstein et al., 1988) and pigeons (Schmidt et al., 2000), respectively. 
 
1.7.1.4  Role of Vtx in human disease 
Vtx is thought to be the principal factor responsible for the intestinal manifestations 
(bloody diarrhoea and haemorrhagic colitis) and systemic complications (HUS) 
following VTEC infection (World Health Organisation, 1998).  There is evidence 
that VTEC producing Vtx2 are more likely to cause HUS than VTEC producing only 
Vtx1 (Boerlin et al., 1999; Brooks et al., 2005; Ethelberg et al., 2004; Jenkins et al., 
2003; Ostroff et al., 1989; Scotland et al., 1987).  These observations have been 
supported in both a mouse model (Tesh et al., 1993) and primate animal model 
(Siegler et al., 2003).  Tesh et al. (1993) found that Vtx2 was more toxic to mice than 
Vtx1 and Siegler et al. (2003) reported that the administration of purified Vtx2, but 
not of Vtx1, caused HUS in experimentally treated baboons.  
 
A number of observations indicate that the amount of Vtx produced by infecting 
VTEC strains may correlate with the clinical outcome of infection (Eklund et al., 
2002; Muniesa et al., 2003).  However, others did not see this phenomenon (Cornick 
et al., 2002; Zhang et al., 2005). 
 
1.7.1.4.1 Vtx in intestinal disease 
It has been suggested that diarrhoea results from the local action of Vtx on the 
intestinal mucosa, with Vtx selectively killing the absorptive villus tip intestinal 
epithelial cells (Karmali, 1989; Nataro & Kaper, 1998).  In rabbit ileum, the Gb3 
receptor is present in much higher concentrations in villus cells than in secretory 
crypt cells and so the death of absorptive cells and proliferation of secretory crypt 
cells could result in intestinal secretion instead of intestinal absorption which 
normally occurs (Nataro & Kaper, 1998).  However, it has also been proposed that 
bloody diarrhoea, and possibly even diarrhoea, is caused by mesenteric ischaemia 
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initiated by circulating toxin, rather than by direct VTEC injury of the intestinal 
epithelium (Tarr et al., 2005).  
 
1.7.1.4.2 Vtx in HUS 
The most important target of Vtx in the development of HUS is the renal 
microvascular endothelium.  However, how Vtx is transported from the intestine to 
its extraintestinal target organ is uncertain.  It has been suggested that Vtx might be 
transported on the surface of circulating neutrophils (Brigotti et al., 2006; Griener et 
al., 2007; te Loo et al., 2000).  However, others have been unable to reproduce this 
finding (Flagler et al., 2007; Geelen et al., 2007). 
 
Following transport to its target organ, Vtx binds to Gb3 receptors, which occur on 
renal glomerular endothelial, mesangial and tubular epithelial cells (Tarr et al., 
2005).  Vtx is believed to damage the glomerular endothelial cells, and this injury 
generates thrombin, and fibrin is deposited in the microvasculature.  The resultant 
decrease in the rate of glomerular filtration is assumed to be responsible for the acute 
renal failure which is typical of HUS (Nataro & Kaper, 1998).   
 
There are many potential outcomes of HUS, the most severe being death.  However, 
fortunately, most patients do recover from HUS, but there are concerns about their 
long-term renal function and it is possible that some patients will require dialysis 
(Tarr et al., 2005).  
 
1.7.2 Attaching and effacing (A/E) lesion formation 
Central to the pathogenesis of VTEC is their ability to colonise the intestinal mucosa 
via the formation of A/E lesions.  The A/E lesion is characterised by effacement of 
epithelial cell microvilli, intimate adherence of the bacterium to the epithelial cell 
membrane and the formation of an actin-rich pedestal-like structure in the host cell 
underneath the membrane at the site of attachment (Kaper et al., 1998; Nataro & 
Kaper, 1998) (Figure 1.1).  The genes required for the formation of A/E lesions are 
carried on a 36 kb pathogenicity island termed the locus of enterocyte effacement 
(LEE) (McDaniel et al., 1995). 
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Figure 1.1.  Electron micrograph showing a characteristic attaching and effacing (A/E) 
lesion.  There is intimate attachment of the bacterium to the epithelial cell membrane 
following effacement of epithelial cell microvilli.  The bacterium appears to be sitting on a 
pedestal-like structure on the host cell.  Magnification bar, 0.4 µm.  Image reproduced from 
Knutton et al. (1987).   
 
 
1.7.2.1  Locus of enterocyte effacement (LEE) 
The LEE has a considerably lower G and C content in comparison to the average E. 
coli genome, indicating that the LEE was likely acquired from another species by 
horizontal gene transfer (Frankel et al., 1998).  Three tRNA genes (selC, pheU and 
pheV) are known as integration sites of the LEE (Jores et al., 2004).  In EPEC 
O127:H6 strain E2348/69 and EHEC O157:H7 the LEE is inserted into the 
chromosome at the selC tRNA locus (McDaniel et al., 1995; Wieler et al., 1997) and 
in E. coli O26 strains the LEE is inserted into the pheU gene (Jores et al., 2004).  The 
LEE is not only necessary but also sufficient for the formation of A/E lesions by 
EPEC.  McDaniel and Kaper (1997) reported that cloning the entire LEE of EPEC 
E2348/69 into E. coli K-12 was sufficient to enable them to form A/E lesions.  In 
contrast, the LEE of EHEC O157:H7 failed to produce A/E lesions when cloned into 
the same K-12 strain (Elliott et al., 1999).  It has since been demonstrated that non-
LEE encoded TccP is also required for actin polymerisation by EHEC O157:H7 
(Campellone et al., 2004; Garmendia et al., 2004) (discussed in more detail in 
section 1.7.2.2.1). 
 
The LEE contains 41 open reading frames (ORFs) organised in five operons, LEE1 




secretion system (T3SS), a number of secreted (Esp) proteins and the translocated 
intimin receptor, Tir (Nataro & Kaper, 1998).  The outer membrane protein intimin, 
encoded by the eae gene, is responsible for the intimate adherence of bacteria to 
epithelial cells.  The secreted proteins, EspA, EspB and EspD, are involved in the 
formation of a translocon, through which effector proteins can transfer into the host 
cell (Frankel et al., 1998).  Tir, which is one of the translocated proteins, is inserted 




Figure 1.2.  The genetic organisation of the locus of enterocyte effacement (LEE).  The 
diagram details the LEE of Citrobacter rodentium, which is very similar to that of EHEC 
O157:H7 and EPEC.  Image reproduced from Deng et al. (2004).  
 
 
1.7.2.2  Model of A/E lesion formation 
Initial contact between the bacterium and the epithelial cell stimulates the expression 
of LEE-encoded proteins and the formation of a translocon apparatus.  The 
translocon consists of a hollow EspA filament which connects an EscC-generated 
pore in the bacterial envelope and an EspB/EspD-generated pore in the host cell 
membrane, thus providing a continuous but gated channel from the bacterial 
cytoplasm to the host cell (Figure 1.3).  Tir is translocated into the host cell, where it 
becomes inserted into the plasma membrane in a hairpin loop topology (Hartland et 
al., 1999).  The extracellular Tir loop serves as a receptor for the bacterial outer 
membrane protein intimin [reviewed in Frankel et al. (2001)] while the intracellular 
amino and carboxy termini interact with several focal adhesion and cytoskeletal 
proteins, linking the extracellular bacterium to the host-cell cytoskeleton 
(Campellone & Leong, 2003; Goosney et al., 2001).  The clustering of Tir in the host 
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cell membrane following intimin binding triggers a signalling cascade leading to the 
formation of actin-rich pedestals underneath adherent bacteria. 
 
 
Figure 1.3.  Translocon apparatus of the type III secretion system.  The translocon 
consists of a hollow EspA filament which connects an EscC-generated pore in the bacterial 
outer membrane and an EspB/EspD-generated pore in the host cell membrane, thus 
providing a continuous but gated channel from the bacterial cytoplasm to the host cell.  
Image reproduced from Gauthier et al. (2003).     
 
 
1.7.2.2.1 Actin polymerisation by EHEC and EPEC 
Until recently, it was considered that localised actin polymerisation by EHEC and 
EPEC is achieved by distinct signal-transduction pathways.  Actin assembly by 
EPEC O127:H6 strain E2348/69 requires phosphorylation of tyrosine Y474 of the 
intracellular carboxy-terminal domain of Tir (Kenny, 1999), which is present in the 
context of the consensus binding site (YpDEP/D/V) for the mammalian adaptor 
protein Nck.  Tyrosine phosphorylated Tir recruits Nck (Campellone et al., 2002; 
Gruenheid et al., 2001), which in turn binds and activates the neuronal Wiskott-
Aldrich syndrome protein (N-WASP).  N-WASP activates the actin-related protein 
2/3 (Arp2/3) complex, triggering actin polymerisation and pedestal formation 
[reviewed in Garmendia et al. (2005a)].  In addition, Tir EPEC O127:H6 can also 
initiate actin polymerisation by an Nck-independent mechanism through 
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phosphorylation of a second carboxy-terminal tyrosine residue, Y454 (Campellone & 
Leong, 2005).  This pathway generates actin pedestals at a much reduced efficiency 
compared with the Nck pathway and the putative adaptor for the recruitment of N-
WASP and Arp2/3 in this minor pathway is currently unknown.   
 
In contrast to the above, Tir EHEC O157:H7 lacks a Y474 equivalent and is not 
tyrosine phosphorylated.  Instead of Nck, EHEC O157:H7 utilises a second bacterial 
T3SS effector protein, TccP (Tir-cytoskeleton coupling protein) (also termed EspFU) 
(Campellone et al., 2004; Garmendia et al., 2004).  TccP mimics Nck in terms of 
recruitment and activation of N-WASP to trigger localised actin polymerisation.  A 
12-residue peptide within the carboxy-terminal of Tir EHEC O157:H7 has been 
shown to be necessary and sufficient to recruit TccP and initiate actin polymerisation 
(Campellone et al., 2006).  This peptide includes Y458, which is the equivalent of 
Y454 in Tir EPEC O127:H6 that has been implicated in the inefficient Nck-
independent actin polymerisation pathway (Brady et al., 2007; Campellone et al., 
2006).  Importantly, TccP does not appear to bind Tir directly (Campellone et al., 
2004; Garmendia et al., 2004), but the identity of the putative linker protein remains 
unknown.  TccP is only the second effector protein after Tir that plays a direct role in 
actin polymerisation by EHEC O157:H7 (Frankel & Phillips, 2008).  
 
It has become apparent that the distinction between the EPEC and EHEC actin 
polymerisation pathways is not absolute.  Analysis of a large number of clinical and 
environmental isolates revealed that tccP is not confined to EHEC O157:H7; tccP is 
also present in some non-O157 EHEC and EPEC strains (Garmendia et al., 2005b). 
Further investigation of a representative tccP-positive EPEC O119:H6 strain 
(ICC199) revealed that Tir is tyrosine (Y473) phosphorylated and can 
simultaneously utilise both the Nck and TccP pathways (Whale et al., 2006). 
 
1.7.2.2.2 TccP 
The gene tccP (Z3072/ECs2715) is carried on prophage CP-933U/Sp14, forming an 
operon with the upstream gene espJ (Garmendia & Frankel, 2005), which encodes 
another effector protein.  TccP consists of a unique 80 amino acid amino-terminal 
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region, that is involved in protein translocation (Garmendia et al., 2006), and several 
almost identical 47 amino acid proline-rich repeats (PRRs) (Campellone et al., 2004; 
Garmendia et al., 2006).  The two sequenced EHEC O157:H7 strains, EDL933 and 
Sakai (Hayashi et al., 2001; Perna et al., 2001), contain a tccP gene that encodes a 
unique amino-terminus and five PRRs and the beginning of a sixth repeat.  
Examination of numerous E. coli O157:H7 isolates revealed that the number of PRRs 
can vary between two and five (Garmendia et al., 2005b).  It has been shown that a 
TccP variant containing the unique amino-terminus and the first two PRRs is the 
smallest derivative of TccP capable of triggering host cell actin polymerisation 
(Garmendia et al., 2006). 
 
1.7.2.2.3 TccP2 
In addition to tccP, the sequenced EHEC O157:H7 strains also contain a pseudogene, 
tccP2 (Z1385/ECs1126), which is carried on prophage CP-933M/Sp4.  A single base 
pair deletion at position 28 introduces a translation frame shift and a premature stop 
codon.  Indeed, deletion of tccP2 in EHEC O157:H7 EDL933 has no effect on actin 
polymerisation activity (Garmendia et al., 2004).  It has recently been found that SF 
EHEC O157:NM and the majority of non-O157 EHEC (serogroups O26, O103, 
O111, O121 and O145) harbour an intact functional tccP2 gene (Ogura et al., 2007).  
A study of the prevalence of tccP2 in typical EPEC isolates found that while all 
EPEC lineage 1 strains (characterised by the expression of flagellar antigen H6 and 
intimin α) analysed were tccP2 negative, all but one of the EPEC lineage 2 strains 
(characterised by the expression of flagellar antigen H2 and intimin β) tested 
contained intact tccP2 (Whale et al., 2007).   
 
TccP2 consists of a unique 80 amino acid amino terminus, which shares 42.7% 
sequence identity and 69.5% sequence similarity with the amino terminus of TccP 
(Frankel & Phillips, 2008), and several PRRs that are almost identical to those of 
TccP (Ogura et al., 2007).  Similarly to TccP, variation in the number of TccP2 
PRRs between strains has been noted (Ogura et al., 2007).  Functional studies have 
revealed that TccP2 is translocated by the LEE-encoded T3SS, and that TccP2 is 
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functionally equivalent to TccP as TccP2 restored actin polymerisation ability to 
EDL933ΔtccP (Ogura et al., 2007; Whale et al., 2007). 
 
1.7.3 Fimbriae  
Adherence is a necessary prerequisite for bacterial colonisation and pathogenesis.  
Fimbrial adhesins are important virulence factors that mediate adherence of the 
bacteria to cells of the gastrointestinal tract.  At least 16 putative fimbrial operons 
have been identified in E. coli O157:H7 (Hayashi et al., 2001; Low et al., 2006; 
Perna et al., 2001), including the well-characterised type 1 fimbriae and curli 
adhesins. 
 
1.7.3.1  Type 1 fimbriae 
Type 1 fimbriae are the most common adhesin produced by E. coli (Leathart & 
Gally, 1998) (Figure 1.4) and mediate adherence to mannose-containing 
glycoproteins found on the surfaces of many eukaryotic cells.  Type 1 fimbriae are a 
proven virulence factor for uropathogenic E. coli, playing an important role in their 









Figure 1.4.  Electron micrograph of a bacterium expressing type 1 fimbriae.  
Magnification bar, 0.4 µm.  Image courtesy of Prof D. Gally. 
 
 
The expression of type 1 fimbriae is phase variable and depends on an invertible 
DNA element (fim switch) (Abraham et al., 1985) that contains the promoter for 
fimA, the gene which encodes the main fimbrial subunit.  When the fim switch is in 
the off orientation, type 1 fimbriae cannot be produced.  Inversion of the fim switch 
type 1 fimbriae 
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requires two recombinases, FimB and FimE, as well as numerous co-factors (Gally et 
al., 1996).  E. coli O157:H7 are unable to produce type 1 fimbriae because they 
contain a 16 bp deletion in the fim switch (Li et al., 1997; Roe et al., 2001), which 
prevents inversion of the fim switch to the on orientation.   
 
1.7.3.2  Curli 
Many strains of E. coli express thin aggregative fimbriae called curli (Barnhart & 
Chapman, 2006) (Figure 1.5).  Curli expression is optimal at temperatures below 
30°C and under conditions of low nutrients, low osmolarity and stationary growth 









Figure 1.5.  Electron micrograph of bacteria expressing curli.  Magnification bar, 0.4 
µm.  Image reproduced from Barnhart & Chapman (2006). 
 
 
There are several lines of evidence which suggest that curli are important during 
human infection.  Firstly, curli bind to the extracellular matrix proteins fibronectin 
and laminin (Barnhart & Chapman, 2006; Olsen et al., 1989) and have been shown to 
contribute to the attachment and invasion of host cells (Kikuchi et al., 2005; Kim & 
Kim, 2004; Uhlich et al., 2002).  Thus, curli are likely to play an important role in 
the initial stages of the infection process (Barnhart & Chapman, 2006).  Secondly, 
curli interact with numerous host proteins, many of which may facilitate the spread 
of the bacteria through the host (Barnhart & Chapman, 2006).  Curliated bacteria 
bind plasminogen and tissue type plasminogen activator simultaneously, which 
results in the activation of plasminogen to plasmin, a serine protease that degrades 
soft tissue (Barnhart & Chapman, 2006; Sjobring et al., 1994).  In addition, curli can 
curli 
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bind to human contact-phase proteins, including fibrinogen, and thus slow clotting 
(Barnhart & Chapman, 2006).  Thirdly, curli can activate the innate immune system.  
Curli have been shown to be a pathogen-associated molecular pattern (PAMP) that is 
recognized by Toll-like receptor 2 (TLR2) and results in the activation of interleukin-
8 (IL-8) (Tukel et al., 2005).  This is consistent with an earlier study which 
demonstrated that curli induce the proinflammatory cytokines tumour necrosis factor 
alpha (TNF-α), IL-6 and IL-8 (Bian et al., 2000). 
 
The genes responsible for curli formation are organised into two divergently 
transcribed operons, csgBAC and csgDEFG, which are under complex regulation 
involving numerous regulators, including CsgD, Crl, RpoS, CpxA/R and Rcs 
(Barnhart & Chapman, 2006).  The csgBAC operon encodes the main curli structural 
subunit protein, CsgA, and the nucleator protein, CsgB (Barnhart & Chapman, 
2006).  CsgA is secreted outside of the cell where CsgB nucleates it into a fibre 
(Barnhart & Chapman, 2006).  CsgC, also encoded on the csgBAC operon, has no 
reported role in curli formation (Barnhart & Chapman, 2006).  The csgDEFG operon 
encodes four accessory proteins necessary for curli assembly (Barnhart & Chapman, 
2006).  CsgD is a positive transcriptional regulator of the csgBAC operon.  CsgG is 
an outer membrane lipoprotein which is required for the stability and secretion of 
CsgA and CsgB, and CsgE and CsgF are putative curli assembly factors, both of 
which interact with CsgG at the outer membrane (Barnhart & Chapman, 2006). 
 
1.7.3.3  Sfp fimbriae   
SF E. coli O157:NM strains harbour a cluster of six genes, sfpA, sfpH, sfpC, sfpD, 
sfpJ and sfpG, on their large plasmid (Brunder et al., 2001, 2006), which encode Sfp 
fimbriae (sorbitol-fermenting EHEC O157 fimbriae, plasmid encoded) mediating 
mannose-resistant haemagglutination (Brunder et al., 2001).  The possession of sfp is 
a unique characteristic of SF E. coli O157:NM strains, that is not present in E. coli 
O157:H7, other E. coli or other Enterobacteriaceae (Brunder et al., 2001; Friedrich et 
al., 2004).  It has been shown that Sfp fimbriae are expressed by SF E. coli 
O157:NM strains cultured under anaerobic conditions on solid media simulating the 
colonic environment, and that the induction of Sfp fimbriae on wild-type SF E. coli 
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O157:NM strains correlated with increased adherence to Caco-2 and HCT-8 cells 
(Musken et al., 2008). 
 
1.7.4 Plasmid-mediated factors 
The majority of VTEC strains of different serotypes are known to contain large 
plasmids.  All strains of E. coli O157:H7 possess a highly conserved ~90 kb plasmid, 
designated pO157, which carries the genes for several putative virulence factors 
(Nataro & Kaper, 1998).  These include the EHEC hly operon encoding 
enterohaemolysin, espP which encodes an extracellular serine protease, katP 
encoding a periplasmic catalase-peroxidase, the etp gene cluster encoding a complex 
type II secretion system, and toxB which has been linked to type III secretion.  
However, the role of pO157 in the pathogenesis of E. coli O157:H7 is uncertain due 
to conflicting results from animal experiments (Nataro & Kaper, 1998). 
 
The virulence plasmid of SF E. coli O157:NM strains, termed pSFO157, is 
approximately 32% larger than pO157 at ~120 kb (Brunder et al., 2006).  The 
majority of SF E. coli O157:NM strains possess a plasmid which differs from pO157 
by the absence of espP, katP and toxB, and the presence of the sfp fimbriae gene 
cluster instead (Bielaszewska et al., 2000; Brunder et al., 1999, 2006; Karch & 
Bielaszewska, 2001).  However, the large plasmids carried by certain SF E. coli 
O157:NM strains isolated in the Czech Republic did not contain any of the putative 
virulence genes possessed by pO157 (Bielaszewska et al., 2000), suggesting the 
presence of two different large plasmids in SF E. coli O157:NM strains.  In contrast 
to the uniformity of pO157, the plasmids of non-O157 VTEC serotypes are highly 
variable in both gene composition and arrangement (Brunder et al., 1999).     
 
1.7.4.1  Enterohaemolysin 
The hly operon encoding enterohaemolysin is found in nearly all E. coli O157:H7 
strains and is widely distributed among non-O157 VTEC strains (Nataro & Kaper, 
1998).  Enterohaemolysin belongs to the family of RTX (repeats in toxin) toxins.  
Enterohaemolysin acts as a pore-forming cytolysin (Schmidt et al., 1995), although 
its role in pathogenesis is still uncertain.  The lysis of erythrocytes in vivo would 
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release haem and haemoglobin, which enhance the growth of E. coli O157:H7 and 
could serve as a source of iron (Nataro & Kaper, 1998).  Bonnet et al. (1998) 
suggested that enterohaemolysin may act by lysing eukaryotic cells or by modulating 
the immune response, thus enhancing virulence, and Aldick et al. (2007) 
demonstrated that enterohaemolysin was cytotoxic to human microvascular 
endothelial cells, which are the major targets affected during HUS.  The possible 
involvement of enterohaemolysin in the development of HUS is supported by a study 
which demonstrated that patients infected with hly-positive VTEC were at a higher 
risk of developing HUS than patients infected with hly-negative strains (Schmidt & 
Karch, 1996), and by the fact that patients with HUS had an immune response 
against enterohaemolysin (Schmidt et al., 1995).   
 
1.7.4.2  EspP 
The amino acid sequence of the extracellular serine protease EspP shows homology 
to several secreted or surface proteins of pathogenic bacteria.  These include: PssA, a 
serine protease encoded on the large plasmid present in bovine VTEC O26:H- strain 
413/89-1 (Djafari et al., 1997); EspC, a 110 kDa protein secreted by EPEC; SepA, 
the major extracellular protein of Shigella flexneri; Tsh, a haemagglutinin from an 
avian-pathogenic E. coli strain; and IgA1 proteases from Neisseria spp. and 
Haemophilus influenzae (Brunder et al., 1997; Karch et al., 1998). 
  
EspP is capable of cleaving pepsin A and human coagulation factor V (Brunder et 
al., 1997).  Secretion of EspP by VTEC attached to the gastrointestinal mucosa could 
result in local degradation of coagulation factor V, and increased haemorrhage into 
the gastrointestinal tract.  Thus, EspP could contribute to the bloody diarrhoea seen 
in many patients suffering from a VTEC infection (Brunder et al., 1997).  The 
importance of EspP in VTEC pathogenesis is supported by the fact that patients 
suffering from VTEC infections show an antibody response to EspP, whereas healthy 
control persons do not (Brunder et al., 1997).  Similarly, antibodies to PssA were 
detected in serum from an HUS patient but were absent in serum from a healthy 
individual (Djafari et al., 1997). 
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1.7.4.3  KatP 
The katP gene encodes the bifunctional periplasmic catalase-peroxidase, KatP 
(Brunder et al., 1996).  This enzyme can protect the bacterium against oxidative 
stress, which is a potential hazard of infecting mammalian cells (Burland et al., 
1998).   
 
1.7.4.4  EHEC type II secretion system 
A cluster of 13 ORFs, designated etpC to etpO (EHEC type II pathway), are located 
on pO157 upstream of the enterohaemolysin operon (Schmidt et al., 1997).  This 
gene cluster has sequence similarities to operons encoding type II secretion systems 
of Gram negative bacteria, including the pullulanase operons of Klebsiella 
pneumoniae and K. oxytoca (Schmidt et al., 1997). 
 
The etp gene cluster was detected in 100% of EHEC O157 isolates and in 60% of 
non-O157 EHEC isolates (serogroups O103, O26 and O111) tested, which had been 
recovered from clinical cases of infection (Schmidt et al., 1997).  In addition, the etp 
genes were only found in 10% of VTEC isolates recovered from bovine faeces and 
were not detected in EPEC, ETEC, EAEC and EIEC strains (Schmidt et al., 1997).  
 
An example of a protein secreted by the etp type II secretion pathway is the 
metalloprotease, StcE (secreted protease of C1 esterase inhibitor from EHEC). 
 
1.7.4.5  StcE 
StcE is encoded by the stcE gene located on pO157 and is secreted by the etp type II 
secretion pathway (Lathem et al., 2002).  The extracellular levels of StcE are 
positively regulated by Ler, the LEE-encoded regulator, suggesting that “stcE is part 
of a global virulence regulon central to the pathogenicity of E. coli O157:H7” 
(Lathem et al., 2002).  StcE cleaves C1 esterase inhibitor (C1-INH), an essential 
regulator of the complement system (Lathem et al., 2002), and it has been 
demonstrated that StcE interaction with C1-INH potentiates rather than destroys the 
ability of C1-INH to down regulate the classical complement cascade (Lathem et al., 
2004).  StcE binds to and localises active C1-INH to cell membranes, enhancing the 
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ability of C1-INH to regulate complement effectors at sites of potential lytic complex 
formation.  The consequence of this is reduced inflammation and complement-
mediated lysis at the site of infection (Lathem et al., 2004).  In addition, Grys et al. 
(2005) identified glycoprotein 340 and mucin 7 as additional substrates for StcE 
activity, and reported that StcE reduces the viscosity of human saliva.  Furthermore, 
StcE was shown to contribute to intimate adherence of E. coli O157:H7 to HEp-2 
cells (Grys et al., 2005).  By degrading the protective layer of mucins and 
glycoproteins on host cells, StcE may impede host clearance of E. coli O157 and 
contribute to the intimate adherence of this pathogen to host cells (Grys et al., 2005).  
The expression of StcE during human infection has been demonstrated by the 
presence of StcE antigen in the faeces of a child infected with E. coli O157:H7 
(Lathem et al., 2002). 
 
1.7.4.6  ToxB 
The toxB gene is a large ORF, encoding 3169 amino acids, which shows N-terminal 
homology to large clostridial toxins, including ToxA and ToxB from Clostridium 
difficile (Burland et al., 1998).  It has been reported that the deletion of pO157 from 
an E. coli O157:H7 strain reduced adherence to Caco-2 cells, and that introducing the 
region of pO157 containing toxB restored adherence (Tatsuno et al., 2001).  
However, it was suggested that the contribution of ToxB on the adherence of EHEC 
to epithelial cells is indirect through the promotion of production and secretion of 
LEE-encoded type III secreted proteins (Tatsuno et al., 2001).  
 
A ToxB homologue is present in non-O157 EHEC strains, designated Efa1 (EHEC 
factor for adherence), which is encoded by the chromosomal gene efa1.  E. coli 
O157:H7 strains lack full-length efa1 but carry a truncated version of the gene 
(efa1’) on the chromosome (Stevens et al., 2002b), whereas SF E. coli O157:NM 
strains contain a complete efa1 gene (Janka et al., 2002).  Efa1 has been shown to 
contribute to the adherence of E. coli O111:H- to Chinese Hamster Ovary cells 
(Nicholls et al., 2000).  In addition, Efa1 has been identified as an important factor in 
experimental colonisation of the bovine intestine by EHEC serotypes O5 and O111 
(Stevens et al., 2002b), although this may be an indirect consequence of influencing 
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the expression and secretion of LEE-encoded proteins or other membrane-associated 
proteins that influence colonisation (Stevens et al., 2002a).  However, it has been 
shown that mutation of toxB and efa1’ did not significantly affect intestinal 
colonisation by E. coli O157:H7 following experimental inoculation in calves or 
sheep, despite affecting the expression and secretion of LEE-encoded proteins 
(Stevens et al., 2004). 
 
The efa1 gene is almost identical in nucleotide sequence to lifA, a gene present in 
EPEC O127:H6 strain E2348/69 that encodes a toxin termed lymphostatin 
(Klapproth et al., 2000).  Lymphostatin inhibits lymphocyte proliferation and IL-2, 
IL-4 and γ-interferon production (Klapproth et al., 2000), indicating that this toxin, 
and possibly Efa1, may influence intestinal colonisation by modulating mucosal 
immunity in the gut (Stevens et al., 2002a).  
 
1.8 Additional factors that contribute to the occurrence of human disease 
In addition to the bacterial virulence factors described in section 1.7 it must be 
remembered that many other factors, including those of host and environment, will 
influence the outcome of human disease.  An illustration of the complexity of 
interactions is presented in Figure 1.6. 
 
Other pathogen-related characteristics that may contribute to the potential to cause 
human disease include: the capacity of strains to survive the harsh conditions in the 
gastrointestinal tract, to resist the immune system and to compete with other 
organisms in the colonic flora.  A further issue that contributes to the human disease 
outcome is the environmental exposure dose, with greater human exposure possibly 
resulting in an increased risk of infection.  Elements which contribute to exposure 
dose are: the carriage rate in cattle or other reservoir hosts, shedding levels by cattle, 
the ability to survive in the environment and undefined differences in animal 
management, husbandry or human lifestyle that may influence exposure (Chase-
Topping et al., 2008; Innocent et al., 2005).  Finally, host factors are highly likely to 
play an important role in the clinical outcome of infection.  These include age, 
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clinical history, or treatment issues such as the administration of antibiotics and/or 










1.9 Research hypothesis and aims 
The purpose of this research at the outset was to examine the pathogenic potential of 
E. coli O26.  VTEC O26 strains have emerged as significant human pathogens in 
continental Europe, often causing severe diarrhoea that can progress to HUS.  In 
contrast, human infections associated with E. coli O26 are uncommon in Scotland 
and are generally associated with simple diarrhoea.  This is despite the fact that 
VTEC O26 strains are common and widely dispersed in Scottish cattle.  The 
hypothesis underlying this research is that there are bacterial characteristics that 
account for the observed differences in human disease.  Therefore, the principal aims 
of this research were to compare E. coli O26 isolates from human infections of 
varying severity to identify bacterial factors which allow these strains to cause more 
serious disease, and to compare E. coli O26 isolates from Scottish cattle to those 
recovered from human infections, to determine whether strains from the Scottish 
food-chain represent a threat to human health. 
 
During this research, an outbreak of SF VTEC O157:NM occurred in Scotland, and it 
appeared that this pathogen was more frequently associated with HUS than the NSF 
VTEC O157:H7 strains most commonly recognised.  This observation posed the 
question of whether SF VTEC O157:NM strains are more virulent than NSF VTEC 
O157:H7 strains.  Since this question was related to my research interests, it was 
agreed that my research could be expanded to include SF VTEC O157:NM, with the 
hypothesis that these pathogens possess virulence traits which contribute to their 
increased association with HUS.     
 
The common hypothesis underlying this research is that there are fundamental 
bacterial traits that lead to the observed differences in human disease.  The research 
on these pathogens was to utilise the opportunity of comparing and contrasting 
characteristics of isolates recovered from different hosts or populations to develop a 
better understanding of human infection.  The thesis is structured in two separate 
sections with the background information and specific objectives for each pathogen 

















2.1 Bacterial strains 
All bacterial strains used in this research are detailed in Table 2.1. 
 
2.1.1 Reference E. coli strains 
All reference E. coli strains used in this research are listed in Table 2.1(A).  The 
majority of the reference E. coli strains were used as controls in this research.  E. coli 
O26 isolate 413/89-1 was recovered from a case of bovine diarrhoea and its LEE 
pathogenicity island was sequenced during a PhD study by P. Benkel at Justus-
Liebig University, Giessen, Germany (GenBank accession no. AJ277443).  ZAP078 
and ZAP194 are E. coli O26 isolates from our laboratory collection of strains.  Four 
well-studied E. coli O157:H7 strains were also included as reference strains in this 
research.  NCTC 12900 and Walla-3 are verocytotoxin negative strains of E. coli 
O157:H7.  EDL933 is a verocytotoxin positive E. coli O157:H7 strain and its 
genome has been sequenced (Perna et al., 2001).  TUV93-0 is a verocytotoxin 
negative derivative of EDL933.  MG1655 is a non-pathogenic E. coli K-12 strain and 
its genome has also been sequenced (Blattner et al., 1997).  E. coli O127:H6 strain 
E2348/69 is the prototype typical EPEC strain which has been studied extensively 
and its genome was recently sequenced (Iguchi et al., 2009). 
 
SF E. coli O157:NM strain H8824ΔcsgBA was created by Ms T. Dransfield (ZAP 
Laboratory, University of Edinburgh) by deleting the csgA and csgB genes from SF 
E. coli O157:NM isolate H8824 by allelic exchange.  E. coli DH5α was used during 
genetic cloning.  DH5α transforms with high efficiency and recA1 and endA1 
mutations in this strain increase insert stability and improve plasmid DNA yield and 
quality from minipreps. 
 
2.1.2 E. coli O26 isolates 
The E. coli O26 isolates from different backgrounds that were used in this study are 





2.1.2.1 Bovine E. coli O26 isolates 
Thirty three E. coli O26 isolates recovered from Scottish cattle were obtained from a 
study conducted to determine the prevalence of non-O157 E. coli strains in faeces of 
Scottish cattle (Pearce et al., 2006).  The study by Pearce et al. (2006) screened all 
isolates for the presence of certain virulence determinants and the isolates included in 
this research were deliberately chosen because they possessed different combinations 
of virulence genes.  Among those selected, the majority carried the gene(s) for 
verocytotoxin as these are considered to be more pathogenic. 
 
2.1.2.2 Human E. coli O26 isolates 
Thirty five E. coli O26 isolates from cases of human infection with different forms of 
clinical disease were obtained for this research.  Thirteen isolates were recovered 
from patients in Scotland and were kindly provided by Dr L. Allison (Scottish E. coli 
O157 Reference Laboratory, Scotland).  This collection of 13 isolates contains the 
vast majority of E. coli O26 isolates recovered from human infections in Scotland, 
and most of them were associated with simple diarrhoea. 
     
To investigate E. coli O26 isolates associated with more serious clinical disease, it 
was necessary to obtain isolates from continental Europe.  A total of 22 isolates were 
collected.  Sixteen were isolated from patients in Germany and were kindly provided 
by Prof. H. Karch (Műnster University, Germany), while the remaining six were 
recovered in Italy and were kindly supplied by Prof. A. Caprioli (Istituto Superiore di 
Sanità, Rome, Italy).  The isolates obtained from continental Europe had been 
previously screened for the presence of verocytotoxin genes and were specifically 
selected for this study because they possessed various combinations of verocytotoxin 
gene carriage and were associated with different clinical forms of disease, including 
life-threatening HUS.  
 
2.1.3 E. coli O157 isolates 
The E. coli O157 isolates used in this study are detailed in Table 2.1(C).  Wild-type 
sorbitol-fermenting (SF) VTEC O157:NM isolates H8824, H8432, H8489, H8757 
and H8478 were recovered during the 2006 Scottish outbreak cluster and shared an 
36 
 
indistinguishable PFGE profile.  A single SF VTEC O157:NM isolate (H2687) was 
obtained from an isolated case in Scotland (Locking et al., 2004) and was associated 
with bloody diarrhoea.  Four SF VTEC O157:NM isolates collected in Germany 
(340/97, 080/01, E02/879 and E06/486) were also included in this study and were 
kindly provided by Prof. H. Karch.  Four non-sorbitol-fermenting (NSF) VTEC 
O157:H7 strains were included for comparison in this research.  Three (H77, H511 
and 1477/AI) were isolated from separate Scottish outbreaks (Cowden, 1997; 
Outbreak Control Team, 2001; SCIEH, 2001) and the remaining NSF VTEC 
O157:H7 isolate was the sequenced strain EDL933 (Perna et al., 2001).  The VTEC 
O157 isolates recovered in Scotland were kindly provided by Dr L. Allison. 
 





Serotype Description Source or reference 
413/89-1 O26:H- Isolated from a case of bovine diarrhoea T. Chakrabortya 
ZAP078 O26:Huntyped Isolated from a case of human disease Reference Laboratory, Aberdeen
b 
ZAP194  O26:K60:Huntyped Produces A/E lesions in cattle Pearson et al. (1999) 
NCTC 12900 O157:H7 Verocytotoxin negative strain of E. coli O157:H7 NCTC, HPAc 
Walla-3 O157:H7 Verocytotoxin negative strain of E. coli O157:H7 Ostroff et al. (1990) 
EDL933 O157:H7 Sequenced E. coli O157:H7 Perna et al. (2001) 
TUV93-0 O157:H7 Verocytotoxin negative derivative of EDL933 Campellone et al. (2002) 
MG1655 K-12 Sequenced E. coli K-12 Blattner et al. (1997) 
E2348/69 O127:H6 Sequenced EPEC strain Iguchi et al. (2009) 
H8824ΔcsgBA  SF O157:NM SF VTEC O157:NM isolate H8824 with csgBA deleted ZAP laboratory strain  
DH5α K-12 Used in genetic cloning Laboratory stock 
a T. Chakraborty, Justus-Liebig University, Giessen, Germany. 
b Scottish National Reference Laboratory for Campylobacter and E. coli O157, Aberdeen, Scotland. 




Table 2.1. Bacterial strains continued 
 
(B) 




Source or reference 
Bovine (Scotland) ZAP1077_B1 (WX007861S01K) O26:H11  12/06/2002 Pearce et al. (2006) 
 ZAP1078_B2 (WX007869S01K) O26:H11  12/06/2002  
 ZAP1079_B3 (WX008325S01K) O26:H11  22/07/2002  
 ZAP1080_B4 (WX008326S01K) O26:H11  22/07/2002  
 ZAP1081_B5 (WX008349S01K) O26:H11  22/07/2002  
 ZAP1082_B6 (WX008576S01K) O26:H11  29/07/2002  
 ZAP1083_B7 (WX008650S01K) O26:H11  12/08/2002  
 ZAP1084_B8 (WX008796S01K) O26:H11  19/08/2002  
 ZAP1085_B9 (WX008809S01K) O26:H11  19/08/2002  
 ZAP1086_B10 (WX008821S01K) O26:H11  19/08/2002  
 ZAP1087_B11 (WX008859S01K) O26:H11  19/08/2002  
 ZAP1088_B12 (WX009926S01K) O26:H11  16/09/2002  
 ZAP1089_B13 (WX009931S01K) O26:H11  16/09/2002  
 ZAP1090_B14 (WX010765S01K) O26:H11  07/10/2002  
 ZAP1091_B15 (WX011378S01K) O26:H11  11/11/2002  
 ZAP1092_B16 (WX011379S01K) O26:H11  11/11/2002  
 ZAP1093_B17 (WX012116S01K) O26:H11  09/12/2002  
 ZAP1094_B18 (WX014441S01K) O26:H11  28/04/2003  
 ZAP1095_B19 (WX014851S01K) O26:H11  13/05/2003  
 ZAP1096_B20 (WX016290S01K) O26:H11  30/06/2003  
 ZAP1097_B21 (WX016693S01K) O26:H11  28/07/2003  
 ZAP1098_B22 (WX016732S01K) O26:H11  28/07/2003  
 ZAP1099_B23 (WX017042S01K) O26:H11  04/08/2003  
 ZAP1100_B24 (WX017873S01K) O26:Huntyped  25/08/2003  
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Table 2.1(B) continued     




Source or reference 
Bovine (Scotland) ZAP1101_B25 (WX017876S01K) O26:Huntyped  25/08/2003 Pearce et al. (2006) 
 ZAP1102_B26 (WX018178S01K) O26:H11  08/09/2003  
 ZAP1103_B27 (WX019091S01K) O26:H11  20/10/2003  
 ZAP1104_B28 (WX019199S01K) O26:H11  27/10/2003  
 ZAP1105_B29 (WX019482S01K) O26:H11  10/11/2003  
 ZAP1106_B30 (WX019909S01K) O26:Huntyped  10/12/2003  
 ZAP1107_B31 (WX020495S01K) O26:H11  12/01/2004  
 ZAP1108_B32 (WX020561S01K) O26:H11  19/01/2004  
 ZAP1109_B33 (WX020761S01K) O26:H11  26/01/2004  
      
Human (Scotland) ZAP1110_S1 (972) O26:Huntyped Diarrhoea  
 ZAP1111_S2 (1003) O26:Huntyped No info  
 ZAP1112_S3 (1122) O26:Huntyped Diarrhoea  
 ZAP1113_S4 (1768) O26:Huntyped Diarrhoea  
L. Allison,  
Scottish E. coli O157 
Reference Laboratory, 
Scotland 
 ZAP1114_S6 (2261) O26:Huntyped Diarrhoea   
 ZAP1115_S7 (2410) O26:Huntyped Diarrhoea   
 ZAP1116_S8 (2444) O26:Huntyped BD   
 ZAP1117_S9 (2820) O26:Huntyped Diarrhoea   
 ZAP1118_S10 (2848) O26:Huntyped Diarrhoea   
 ZAP1119_S11 (4396) O26:Huntyped Diarrhoea   
 ZAP1120_S12 (5606) O26:Huntyped Diarrhoea   
 ZAP1152_S35 (H7788) O26:Huntyped Diarrhoea   
 ZAP1153_S36 (H7291) O26:Huntyped BD   
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Table 2.1(B) continued     




Source or reference 
Human (Germany) ZAP1121_G13 (1616/96) O26:H- Diarrhoea 1996 
 ZAP1122_G14 (2150/98) O26:H- HUS 1998 
 ZAP1123_G15 (2185/99) O26:H11 HUS 1999 
H. Karch,  
Műnster University, 
Germany 
 ZAP1124_G16 (2245/98) O26:H- HUS 1998  
 ZAP1125_G17 (2514/99) O26:H- Diarrhoea 1999  
 ZAP1126_G18 (2640/99) O26:H11 HUS 1999  
 ZAP1127_G19 (2959/99) O26:H- Diarrhoea 1999  
 ZAP1128_G20 (2983/00) O26:H11 HUS 2000  
 ZAP1129_G21 (3073/00) O26:H11 HUS 2000  
 ZAP1130_G22 (3901/97) O26:H- HUS 1997  
 ZAP1131_G23 (4166/94) O26:H- Diarrhoea 1994  
 ZAP1132_G24 (4497/00) O26:H- HUS 2000  
 ZAP1133_G25 (4602/97) O26:H- Diarrhoea 1997  
 ZAP1134_G26 (5720/96) O26:H- HUS 1996  
 ZAP1135_G27 (6932/94) O26:H11 Diarrhoea 1994  
 ZAP1136_G28 (8574/96) O26:H11 Diarrhoea 1996  
      
Human (Italy) ZAP1146_I29 (ED 17) O26:Huntyped HUS  
 ZAP1147_I30 (ED 147) O26:Huntyped HC  
 ZAP1148_I31 (ED 166) O26:Huntyped HUS  
A. Caprioli,  
Istituto Superiore di 
Sanità, Rome, Italy 
 ZAP1149_I32 (ED 180) O26:Huntyped HUS   
 ZAP1150_I33 (ED 551) O26:Huntyped HUS   
 ZAP1151_I34 (ED 567) O26:Huntyped HUS   
a The suffix indicates the origin of the isolate: B, bovine; S, human (Scotland); G, human (Germany); I, human (Italy). 
b Information provided by the supplier of the isolate. 
c BD, bloody diarrhoea; HC, haemorrhagic colitis; HUS, haemolytic uraemic syndrome. 
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Table 2.1. Bacterial strains continued 
 
(C) 
Serotypea Isolate(s) Country of origin Source or reference 
NSF VTEC O157:H7 H77  Scotland Outbreak Control Team (2001) 
 H511 Scotland SCIEH (2001) 
 1477/AI Scotland Cowden (1997) 
    
SF VTEC O157:NM H2687 Scotland Locking et al. (2004) 
 H8824, H8432, H8489, H8757, H8478 Scotland 2006 Scottish outbreak cluster 
 340/97, 080/01, E02/879, E06/486 Germany H. Karch,  
Műnster University, Germany 





2.2 Bacterial culture conditions, media and chemicals 
All chemicals used were from Sigma-Aldrich unless otherwise stated.  All bacterial 
strains were stored on Protect beads (Technical Service Consultants Ltd) at -70°C.  
Strains were routinely cultured at 37°C in Luria-Bertani (LB) broth (Melford) or on 
LB agar (Formedium), prepared according to manufacturer’s instructions.  The 
ability of VTEC O157 isolates recovered in Scotland to ferment sorbitol was 
confirmed by plating on sorbitol MacConkey agar (Merck), prepared according to 
manufacturer’s instructions.  In Vero cell cytotoxicity assays and for secreted protein 
analysis, Dulbecco’s modified eagle medium with 25mM HEPES (DMEM-HEPES; 
Gibco) was used to culture E. coli O26 isolates while minimal essential medium with 
25mM HEPES (MEM-HEPES; Sigma-Aldrich), supplemented with glucose (final 
concentration of 0.2%) and 0.25 µM Fe(NO3)3, was used to culture E. coli O157 
isolates.  In adherence assays, bacteria were cultured on CFA agar plates and in 
CDMT broth (see Appendix 1 for recipes).  LB, CFA and CDMT broths were used to 
culture bacteria in biofilm assays.  To screen for surface curli expression bacteria 
were cultured on CFA-Congo red (CR) indicator plates (0.01% CR).   
 
2.3 Cell culture conditions 
Vero (African green monkey kidney) cells were grown in Eagle minimum essential 
medium with Earle’s salts (Sigma-Aldrich) supplemented with 10% (v/v) foetal 
bovine serum (FBS, Sigma-Aldrich), 1% non-essential amino acids (Sigma-Aldrich), 
2 mM L-glutamine (Invitrogen), penicillin (100 U/ml) and streptomycin (100 µg/ml) 
(Gibco).  The Vero cells were a kind gift from Karla Sanchez and the cells used in 
experiments had been sub-cultured between 27 and 35 times.  Caco-2 cells were 
maintained in DMEM (Sigma-Aldrich) supplemented with 10% (v/v) FBS, 1% non-
essential amino acids, 2 mM L-glutamine, penicillin (100 U/ml) and streptomycin 
(100 µg/ml).  The Caco-2 cells were also kindly provided by Karla Sanchez and the 
cells used in experiments had been sub-cultured between 15 and 25 times.  All 







2.4 DNA analysis and genetic manipulation methods 
2.4.1 Genomic DNA extraction from E. coli isolates 
Genomic DNA was extracted from E. coli isolates using the ChargeSwitch gDNA 
Mini Bacteria Kit (Invitrogen), according to manufacturer’s instructions for Gram 
negative bacteria.  Aliquots of purified DNA were stored at -20°C.  Genomic DNA 
was diluted 1:500 in MQ water (Sigma-Aldrich) before used as template DNA in 
PCR reactions. 
 
2.4.2 Preparation of crude DNA extracts from E. coli isolates 
Crude DNA preparations were used as templates in PCR screens.  A bacterial colony 
from overnight growth on LB agar was suspended in 100 µl sterile phosphate-
buffered saline (PBS) and boiled for 15 min in a heated block.  Aliquots of bacterial 
lysate were stored at -20°C and 1 µl of lysate was used as DNA template in PCR 
reactions. 
 
2.4.3 Plasmid DNA extraction from E. coli strains 
Plasmids were extracted from bacteria, cultured overnight in 5 ml LB broth 
supplemented with the appropriate antibiotic, using the PureLink HiPure plasmid 
miniprep kit (Invitrogen).  
 
2.4.4 DNA amplification by polymerase chain reaction (PCR) 
PCRs were typically carried out in sterile thin-wall tubes in 50 µl reaction volumes.  
Generally, PCRs contained 1 µl template DNA, 200 µM dNTP mixture (Roche), 1 
µM each primer (Table 2.2), 1 x ThermoPol Taq reaction buffer [20 mM Tris-HCl, 
10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton X-100, pH 8.8 at 25°C] 
(NEB), 2 U Taq DNA polymerase (NEB) and MQ water to the final volume.  Some 
of the virulence gene screening PCRs were carried out using Platinum Blue PCR 
SuperMix (Invitrogen), according to manufacturer’s instructions, and contained 1 µl 
template DNA and 1 µM each primer.  The genes for MLST (section 2.4.10) and the 
vtx2 genes for sequencing were amplified by PCR using a Taq PCR core kit (Qiagen), 
according to manufacturer’s instructions.  These PCR reactions contained 2 µl 




solution, 2.5 U Taq DNA polymerase and MQ water to the final volume.  For 
sequence analysis of the region required for curli formation, high-fidelity 
amplification of DNA template was achieved using iProof high-fidelity DNA 
polymerase (Bio-Rad), according to manufacturer’s instructions.  These reactions 
contained 1 µl template DNA, 200 µM each dNTP, 0.5 µM each primer, 1 x HF 
buffer (Bio-Rad), 0.4 U iProof DNA polymerase and MQ water to the final volume.  
iProof DNA polymerase comprises a unique Pyrococcus-like proofreading enzyme 
fused to a dsDNA binding protein, Sso7d, and is more accurate than Taq DNA 
polymerase.  
 
All PCRs were performed in a Thermo-Hybaid PCR Express cycler and the cycling 
conditions for each PCR are detailed in Table 2.2.  Amplification products were 
resolved by agarose gel electrophoresis, as described in section 2.4.5.  DNA negative 
PCR controls, which contained all reagents except template DNA, were performed in 
every PCR run and all reactions were repeated if the negative controls contained 
amplification products.  Positive and negative controls were also performed in every 
PCR screen using template DNA from positive and negative reference E. coli strains.  
Test strains were regarded as positive if they produced amplicons of the correct size 





Table 2.2. Primers and PCR conditions.  The primer name and sequence are listed, together with the PCR conditions for each primer 
pair.  The table is sectioned to group primers used for similar purposes: top – characterisation PCRs; second – MLST; third – DNA 
sequencing; bottom – amplification of promoter regions for cloning purposes. 
 
PCR conditionsb Primer name Primer sequence (5’→3’)a 




O26wzxF GCGCTGCAATTGCTTATGTA 94°C, 30 s 54°C, 45 s 72°C, 30 s 152 
O26wzxR TTTCCCCGCAATTTATTCAG     
DebRoy et 
al. (2004) 
       
O26wzyF TAAATTGCGGGGAAAGAATG 94°C, 30 s 60°C, 45 s 72°C, 30 s 276 “ 
O26wzyR GACTTCATGGGTACCGCCTA      
       
vtx1F ATAAATCGCCATTCGTTGACTAC 94°C, 30 s 60°C, 45 s 72°C, 30 s 180 
vtx1R AGAACGCCCACTGAGATCATC     




vtx2F GGCACTGTCTGAAACTGCTCC 94°C, 30 s 60°C, 45 s 72°C, 30 s 255 “ 
vtx2R TCGCCAGTTATCTGACATTCTG      
       
eaeAF GACCCGGCACAAGCATAAGC 94°C, 30 s 60°C, 45 s 72°C, 30 s 384 “ 
eaeAR CCACCTGCAGCAACAAGAGG      
       
hlyAF GCATCATCAAGCGTACGTTCC 94°C, 30 s 60°C, 45 s 72°C, 30 s 534 “ 
hlyAR AATGAGCCAAGCTGGTTAAGCT      
       
sepLF GCTAAGCCTGGGATATCGC 94°C, 30 s 60°C, 45 s 72°C, 60 s 725 This study 
sepLR ACAATCGATACCCGAGAAGG      
       
cad1 TGGACGGAGTAACAAGCC 94°C, 30 s 52°C, 60 s 72°C, 120 s 947 P. Benkelc 




Table 2.2 continued      
PCR conditionsb Primer name Primer sequence (5’→3’)a 




espB73 TTCAGCATAACGGCAAGC 94°C, 30 s 52°C, 60 s 72°C, 120 s 1480 P. Benkelc 
espB52 TTAGCCAACAGATAGATG      
       
univ tccP/tccP2-F GTAAAAACCAGCTCACCTTTTTC 94°C, 60 s 64°C, 60 s 72°C, 90 s variable 
tccP-R TCACGAGCGCTTAGATGTATTAAT     
      
Kozub-
Witkowski 
et al. (2008)  
tccP-F ATGATTAACAATGTTTCTTCACTT 94°C, 60 s 54°C, 60 s 72°C, 90 s variable 
      
Garmendia 
et al.(2005b)  
tccP2-F ATGATAAATAGCATTAATTCTTT 94°C, 60 s 54°C, 60 s 72°C, 90 s variable 
      
Ogura et al. 
(2007) 
tirY474-F CATATTTATGATGAGGTCGCTC 94°C, 30 s 52°C, 60 s 72°C, 60 s 401 “ 
tir-R TAAAAGTTCAGATCTTGATGACAT      
       
tirS478-F TCTGTTCAGAATATGGGGAATA 94°C, 30 s 58°C, 60 s 72°C, 60 s 407 “ 
       
FLIC1F ATGGCACAAGTCATTAATACCCAAC 94°C, 30 s 60°C, 60 s 72°C, 120 s  1758 
FLIC2R CTAACCCTGCAGCAGAGACA     
Fields et al. 
(1997) 
       
STS-1 CTCAAGCATAAAAATTTTAAACTAACTG 94°C, 60 s 62°C, 60 s 72°C, 60 s  943 
CON-2 ACGTCCCTGAACCTGGGTAGGTTA     
Li et al. 
(1997) 
       
2535 GCCGGATTATGGGAAAGA 94°C, 45 s 50.5°C, 45 s 72°C, 90 s  603 
3137 GCCGCTGTAGAACTGAGG     
Holden et 
al. (2006) 
      
adkF ATTCTGCTTGGCGCTCCGGG 94°C, 60 s 54°C, 60 s 72°C, 120 s 583 







Table 2.2 continued      
PCR conditionsb Primer name Primer sequence (5’→3’)a 




fumCF TCACAGGTCGCCAGCGCTTC 94°C, 60 s 54°C, 60 s 72°C, 120 s 806 
fumCR GTACGCAGCGAAAAAGATTC     




gyrBF TCGGCGACACGGATGACGGC 94°C, 60 s 60°C, 60 s 72°C, 120 s 911 “ 
gyrBR ATCAGGCCTTCACGCGCATC      
       
icdF ATGGAAAGTAAAGTAGTTGTTCCGGCACA 94°C, 60 s 54°C, 60 s 72°C, 120 s 878 “ 
icdR GGACGCAGCAGGATCTGTT      
       
mdhF ATGAAAGTCGCAGTCCTCGGCGCTGCTGGCGG 94°C, 60 s 60°C, 60 s 72°C, 120 s 932 “ 
mdhR TTAACGAACTCCTGCCCCAGAGCGATATCTTTCTT      
       
purAF CGCGCTGATGAAAGAGATGA 94°C, 60 s 54°C, 60 s 72°C, 120 s 816 “ 
purAR CATACGGTAAGCCACGCAGA      
       
recAF CGCATTCGCTTTACCCTGACC 94°C, 60 s 58°C, 60 s 72°C, 120 s 780 “ 
recAR TCGTCGAAATCTACGGACCGGA      
       
espAF CCTTCTCGGGTATCGATTGTCG 94°C, 60 s 58°C, 60 s 72°C, 120 s 1012 This study 
espAR CAGAGGGCGTCACTAATGAGTG      
       
LEE1promF CGAATGGTACGGTTATGCGGG 94°C, 60 s 58°C, 60 s 72°C, 120 s 645 This study 
LEE1promR GCTCTCGCAGTCGCTTTGCTTCC      
       
vtx2Aseq_F1 TACCAGGCTCGCTTTTGCGG 94°C, 30s 60°C, 45s 72°C, 80s 1110 This study 




Table 2.2 continued      
PCR conditionsb Primer name Primer sequence (5’→3’)a 




vtx2Aseq_F2  CCATGACAACGGACAGCAG     This study 
vtx2Aseq_R1 CTGTATCTGCCTGAAGCGTAAGGC     This study 
       
vtx2Bseq_F  CCAGAATGTCAGATAACTGGC 94°C, 30s 58°C, 45s 72°C, 30s 476 This study 
vtx2Bseq_R GGCAACTGTCAACTGACTG      
       
curli1F CGCTTAAACAGTAAATGCCG 98°C, 10se 60°C, 30se 72°C, 35se 1046 This study 
curli1R CCGCATGGTGACCAACGA      
       
curli2F TTCCTTATGAAGCTGGGGC 98°C, 10se 60°C, 30se 72°C, 35se 1054 This study 
curli2R CGGAATCAGCCCTCCTTAC      
       
curli3F CGCTGATGAACAACGAACG 98°C, 10se 60°C, 30se 72°C, 35se 1028 This study 
curli3R CCCGTCGCTGATTGCTGC      
       
curli4F CTCCACACCACCGTGGAC 98°C, 10se 60°C, 30se 72°C, 35se 1047 This study 
curli4R GCTTGCAGAGCAAGTGCAG      
       
curli5F GGCAGGTGTTGTTCCTCAG 98°C, 10se 60°C, 30se 72°C, 35se 886 This study 
curli5R CCTTGAGGGTTGTGTTATCC      
       
T3 AATTAACCCTCACTAAAGGGAA      
T7 GTAATACGACTCACTATAGG      
       
sfpprom_F cgcggatccATCAACGCCAAATGTGTTTAC 94°C, 15 s 60°C, 30 s 72°C, 60 s 800 This study 




Table 2.2 continued      
PCR conditionsb Reference Primer name Primer sequence (5’→3’)a 
Denaturing Annealing Extension 
Amplicon 
size (bp)  
csgBACprom_F cgcggatccGTTGTACATTTGGTTTTTATTGCAC 94°C, 15 s 60°C, 30 s 72°C, 60 s 524 This study 
csgBACprom_R cggggtaccCAATTTGTTTTTCATGTTGTCACC      
a The lowercase portions of some sequences are non-matching and the underlined bases show the incorporation of restriction sites. 
b Unless otherwise stated, PCR cycling conditions included an initial denaturing step of 94°C for 4 min, and after 30 cycles a final 
extension step of 72°C for 10 min was performed. 
c Primer sequences were designed during a PhD study by P. Benkel at Justus-Liebig University, Giessen, Germany. 
d E. coli MLST website (http://mlst.ucc.ie/mlst/dbs/Ecoli). 
e PCR cycling conditions included an initial denaturing step of 98°C for 30 sec, and after 35 cycles a final extension step of 72°C for 10 






2.4.5 DNA electrophoresis 
DNA fragments were resolved by electrophoresis in 1% (w/v) agarose gels in 1 x 
Tris-borate/EDTA (TBE) buffer [89 mM Tris-borate and 2 mM EDTA, pH 8.3 
(Sigma-Aldrich)], containing ethidium bromide or SafeView (NBS Biologicals) for 
DNA staining.  Electrophoresis was performed in 1 x TBE buffer at constant voltage 
(100 V) using Bio-Rad systems.  DNA samples were mixed with DNA loading 
buffer (Invitrogen) before loading and fragment sizes were determined by 
comparison to molecular size markers [1 kb or 100 bp (Invitrogen)].  DNA fragment 
visualisation was achieved under UV illumination in a Flowgen MultiImage light 
cabinet (Shenstone, England) and images were captured using ChemiImager 4000i 
v.4.04 software. 
   
2.4.6 DNA fragment purification 
2.4.6.1 Column and gel purification 
DNA fragments from PCR and restriction digests were purified directly using the 
PureLink PCR purification kit (Invitrogen), or were purified from agarose gels using 
the PureLink Quick gel extraction kit (Invitrogen), following manufacturer’s 
instructions in both cases. 
 
2.4.6.2 PEG purification 
Amplification products from MLST PCRs were purified using the polyethylene 
glycol (PEG) method.  This is a simple, cost-effective method for purifying DNA 
fragments following PCR amplification in 96-well plates.  Briefly, 60 µl 20% 
PEG/2.5 M NaCl solution was added to each well of the PCR plate containing 50 µl 
PCR reaction.  The plate was sealed tightly with adhesive film and the contents of 
the wells mixed using a vortex mixer.  The plate was centrifuged briefly at 500 x g to 
ensure the contents were at the bottom of the wells before it was incubated at room 
temperature for 30 min.  PCR products were pelleted by centrifugation (2,750 x g, 1 
h at 4ºC) and the supernatants were discarded by gently inverting the plate and 
centrifuging it (500 x g, 1 min at 4ºC) upside down on tissues.  The DNA pellets 




10 min at 4ºC).  Supernatants were discarded by centrifuging inverted as before.  
PCR pellets were resuspended in 50 µl MQ water.   
 
2.4.7 Characterisation PCRs 
The primer sequences and cycling conditions for the PCRs are detailed in Table 2.2.  
The presence of the O26 wzx (O-unit flippase) and O26 wzy (O-unit polymerase) 
genes were detected by PCR, using primer pairs O26wzxF and O26wzxR and 
O26wzyF and O26wzyR, respectively, as previously described (DebRoy et al., 
2004).  The detection of genes encoding verocytotoxin 1 (vtx1), verocytotoxin 2 
(vtx2), intimin (eae) and enterohaemolysin (hlyA) was performed using the multiplex 
PCR developed by Paton and Paton (1998).  The primer sequences were the same as 
those described previously (Paton & Paton, 1998) but the PCR cycling conditions 
were simplified for this research.  The possession of the LEE pathogenicity island 
was confirmed by PCR screening for sepL (SepL) using primer pair sepLF and 
sepLR.  The pheU tRNA gene was screened for the presence of the LEE by PCR 
using three different primer pair combinations.  Primer pair cad1 and LS1 amplified 
the left junction of the LEE inserted into pheU and primer pair espB73 and espB52 
amplified the right junction of the LEE inserted into pheU.  Intact pheU was detected 
by PCR screening with primer pair cad1 and espB52 and produced a 1.26 kb 
amplicon.  The detection of genes encoding TccP (tccP) and TccP2 (tccP2) was 
performed by PCR using a universal primer pair, univ tccP/tccP2-F and tccP-R.  The 
specific detection of tccP and tccP2 was achieved by PCR amplification using 
forward, gene-specific primers (tccP-F and tccP2-F, respectively) with a conserved 
reverse primer (tccP-R).  Forward, gene-specific primers (tirY474-F, tirS478-F) were 
used with a conserved reverse primer (tir-R) to discriminate between tirE2348/69 and 
tirEDL933 gene types.  PCR to detect the presence of the 16 bp deletion in the fim 
switch that controls type 1 fimbriae expression was performed using primer pair 
STS-1 and CON-2, as previously described (Li et al., 1997). 
 
2.4.8 H-typing by fliC PCR-restriction fragment length polymorphism (RFLP) 
The gene encoding the flagellin subunit (fliC) was detected and characterised using 




fliC gene was amplified by PCR using primer pair FLIC1F and FLIC2R (Table 2.2).  
The purified PCR product (5 µl) was digested with RsaI (NEB) in a 10 µl reaction, 
according to manufacturer’s instructions.  Digestion was performed at 37°C for 2 h 
and the restriction fragments were separated on a 2% agarose gel.  
 
2.4.9 fim switch orientation assay 
Orientation of the fim switch was carried out as described previously (Holden et al., 
2006; Leathart & Gally, 1998; Roe et al., 2001).  Briefly, PCR using primers 2535 
and 3137 (Table 2.2) was used to amplify a 603 bp region that incorporates the 
invertible fimA promoter element.  Template DNA for the PCR was prepared by 
adding 50 µl of bacterial culture (following 3 days of consecutive subculture in LB 
broth) or a colony from cultures grown on CFA agar to 50 µl MQ water and boiling 
at 100°C for 15 min.  The PCR-amplified product (4 µl) was digested asymmetrically 
with HinfI (NEB) in a 10 µl reaction at 37°C for 1 h.  The digests were mixed with 
10 x loading buffer (65% sucrose, 0.25% bromophenol blue, 0.25% xylene cyanol) 
and DNA fragments were separated by electrophoresis in a 4% polyacrylamide TBE 
gel [4% acrylamide-bisacrylamide, 0.1% ammonium persulphate (APS), 0.001% 
N,N,N’,N’-tetramethylethylenediamine (TEMED) in 1 x TBE buffer].  
Electrophoresis was performed in 1 x TBE buffer at constant voltage (160 V) for 2 h 
30 min using a Hoefer SE600 Midi gel electrophoresis unit.  Fragments were 
visualised after staining with ethidium bromide. 
 
2.4.10 Multilocus sequence typing (MLST) 
MLST was performed using a published scheme for E. coli (Wirth et al., 2006).  The 
nucleotide sequences of internal fragments of the following seven housekeeping 
genes (protein products are shown in parentheses) were determined: adk (adenylate 
kinase), fumC (fumarate hydratase), gyrB (DNA gyrase), icd 
(isocitrate/isopropylmalate dehydrogenase), mdh (malate dehydrogenase), purA 
(adenylosuccinate dehydrogenase) and recA (ATP/GTP binding motif).  Also 
sequenced were the espA gene (EspA) and the region upstream of LEE1, likely to 
contain the promoter sequence.  The gene fragments were amplified from genomic 




the primer pairs detailed in Table 2.2.  The primers used to amplify espA and the 
region upstream of LEE1 were designed using sequence data for E. coli O26 isolate 
413/89-1 (GenBank accession no. AJ277443).  The initial ‘high-throughput’ runs of 
PCR reactions were performed in 96-well plates and products were purified using the 
PEG method (section 2.4.6.2).  Unsuccessful PCR or sequencing reactions were 
repeated and, in these instances, PCR was performed in thin-wall tubes and 
amplicons were purified using the PureLink PCR purification kit (Invitrogen), 
following manufacturer’s instructions.  PCR products were sequenced directly with 
the PCR primers (section 2.4.11).  The sequences obtained for the housekeeping 
genes were assigned allele numbers in accordance with the E. coli MLST website 
(http://mlst.ucc.ie/mlst/dbs/Ecoli).  Novel alleles discovered were confirmed by 
repeating the PCR and sequencing reactions before they were submitted to the E. coli 
MLST database.  The sequence type (ST) and ST complex of each isolate was 
designated in accordance with the E. coli MLST website.  Sequence data for espA 
and the region upstream of LEE1 were compared using ClustalX.  Each unique 
sequence at each loci was given a different allele number and allele numbers were 
assigned in the order in which they were discovered.  
 
2.4.11 DNA sequencing 
Nucleotide sequencing for MLST purposes was performed by the zoology 
sequencing service, University of Oxford.  All remaining DNA sequencing in this 
research was carried out by the GenePool, School of Biological Sciences, University 
of Edinburgh and was performed using an ABI Prism BigDye terminator cycle 
sequencing kit version 3.1 (Applied Biosystems), and reactions were analysed on an 
ABI 3730 DNA sequencer. 
 
The nucleotide sequences of vtx2 from the six Scottish SF VTEC O157:NM isolates 
were determined following PCR amplification of vtxA2 and vtxB2 using a taq PCR 
core kit (Qiagen) and primer pairs vtx2Aseq_F1 and vtx2Aseq_R2 and vtx2Bseq_F 
and vtx2Bseq_R, respectively (Table 2.2).  These primers were designed using 
sequence data for E. coli O157:H7 EDL933 (GenBank accession no. NC_002655).  




internal vtxA2 primers vtx2Aseq_F2 and vtx2Aseq_R1 (Table 2.2).  For sequence 
analysis of the region required for curli formation (csgBAC and csgDEFG operons 
and the csgB-to-csgD intergenic region), the entire region was amplified with five 
separate PCRs using iProof high-fidelity DNA Polymerase (Bio-Rad) and primer 
pairs curli1F and curli1R, curli2F and curli2R, curli3F and curli3R, curli4F and 
curli4R and curli5F and curli5R (Table 2.2).  PCR products were purified, cloned 
into the StrataClone PCR cloning vector, pSC-B, with a StrataClone Blunt PCR 
cloning kit (Stratagene), and sequenced with primers T3 and T7. 
 
2.4.12 DNA sequence analysis 
A double-stranded DNA sequence for the region of interest was assembled using the 
Staden package release v1.6.0.  Briefly, DNA sequencing chromatogram files were 
prepared for assembly and analysis with pregap4 and were then assembled into 
contigs using gap4.  Sequence data was then viewed and edited using gap4.  
Assembled DNA sequences were aligned and compared using ClustalX 1.8 
(Thompson et al., 1997) and alignments were annotated using GeneDoc version 2.5.  
 
2.4.13 Construction of plasmid-based promoter-GFP fusions   
The promoters for sfpA (Sfp fimbriae main subunit) and csgBAC (curli main subunit) 
were amplified by PCR from isolate H8824 using primer pairs sfpprom_F and 
sfpprom_R and csgBACprom_F and csgBACprom_R, respectively (Table 2.2).  
These primers incorporated BamHI (sfpprom_F, csgBACprom_F) and KpnI 
(sfpprom_R, csgBACprom_R) sites at their termini and allowed the promoters to be 
cloned in frame to gfp in pAJR70 (Roe et al., 2003), creating translational fusions.  
Briefly, the PCR-amplified products were gel purified and cloned into pSC-B with a 
StrataClone Blunt PCR cloning kit.  The nucleotide sequences of the amplified 
promoters were confirmed by sequencing.  Vector and insert DNA were prepared for 
cloning by digesting pAJR70 and pSC-B containing the promoter of interest 
sequentially with BamHI (Roche) and KpnI (Roche), according to manufacturer’s 
instructions.  Linearised pAJR70 was treated with shrimp alkaline phosphatase 
(NEB) to dephosphorylate 5’ restricted termini and prevent vector re-ligation.  




T4 DNA ligase (NEB) and 1 µl 10 x ligase reaction buffer (NEB) [final 
concentration: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM ATP, 10 mM dithiothreitol, 
pH 7.5 at 25°C] and incubated at room temperature for 3 h 30 min to allow ligation.  
The promoter for csgD (positive transcriptional regulator of the csgBAC operon) 
cloned into pAJR70 was constructed previously (Low et al., 2006).   
 
2.4.14 Transformation of competent E. coli 
E. coli strains were made competent for transformation with plasmid DNA using the 
methods described in Sambrook et al. (1989). 
 
2.4.14.1    Preparation and transformation of chemically-competent E. coli cells 
E. coli K-12 DH5α was cultured in 5 ml LB broth with shaking (200 rpm) at 37ºC 
overnight.  The following day the overnight bacterial culture was diluted 1:100 in LB 
broth and cultured under the same conditions to an optical density at 600 nm (OD600) 
of 0.5 – 0.7.  The culture was chilled on ice for 30 min before it was centrifuged 
(4,000 x g, 8 min at 4ºC).  Cell pellets were gently suspended in 0.4 volumes of ice-
cold transformation buffer I (TFB I, see Appendix 1) and kept on ice for 10 min.  
Cells were harvested as described above and gently suspended in 0.04 volumes of 
ice-cold TFB II (see Appendix 1).  Aliquots (100 µl) of cells were stored at -70ºC. 
 
Chemically-competent DH5α cells were defrosted on ice and a 10 µl ligation 
reaction (section 2.4.13) was added to 100 µl of cells.  The cell-ligation mixture was 
kept on ice for 30 min before it was heat-shocked at 42ºC in a waterbath for 45 sec.  
Immediately after heat-shock, the transformation reaction was placed on ice for 2 
min before 350 µl of SOC medium (Invitrogen) was added, and the cells suspended 
by pipetting.  Transformants were recovered after incubating at 37ºC for 1 hr by 
spreading 250 µl of cell suspension onto appropriate antibiotic plates and incubating 
at 37ºC overnight.  
 
2.4.14.2    Preparation and transformation of electro-competent E. coli cells 
All plasmid transformations in wild-type VTEC O157 isolates were performed by 




cultured in the same way to those for chemically-competent cells.  Culture pellets 
were washed twice by suspending in 0.25 volumes of ice-cold 10% (v/v) glycerol 
and then centrifuging (4,000 x g, 8 min at 4ºC).  The cell pellet was suspended in 
0.005 volumes of ice-cold 10% glycerol and aliquots (45 µl) of cells were stored at   
-70ºC. 
 
Electro-competent cells were defrosted on ice and 1 µl of purified plasmid DNA was 
added to 45 µl of cells.  The cell-plasmid mixture was kept on ice for 1 min before 
electroporating at 2.5 kV in a 2 mm gap electroporation cuvette (Flowgen).  SOC 
medium (1 ml) was added immediately and the cells suspended by gentle pipetting.  
The cell suspension was transferred to a micro-centrifuge tube and transformants 
were recovered after incubating at 37ºC for 1 hr by spreading 200 µl of cell 
suspension onto appropriate antibiotic plates and incubating at 37ºC overnight.  
 
2.5 Indirect immunofluorescence staining  
2.5.1 Immunostaining of O26 and O157 antigen on E. coli isolates 
The serogroup of the E. coli O26 and E. coli O157 isolates was confirmed by 
immunostaining with appropriate antisera.  Isolates were cultured in LB broth 
overnight at 37°C and a 100 µl aliquot of culture was fixed in 900 µl of 4% 
paraformaldehyde (PFA).  Aliquots of fixed bacteria were air dried onto multispot 
slides [C.A. Hendley (Essex) Ltd].  Bacterial samples were incubated with rabbit E. 
coli O26 antisera (Mast Assure) or rabbit E. coli O157 antisera (Mast Assure), as 
appropriate, diluted 1:100 in PBS, for 45 min at room temperature.  Following three 
washes with PBS, the samples were incubated with fluorescein isothiocyanate 
(FITC)-conjugated goat anti-rabbit immunoglobulin secondary antibody (Sigma-
Aldrich), diluted 1:500 in PBS, for 45 min at room temperature.  The slides were 
washed a further three times with PBS.  Slides were examined by fluorescence 
microscopy and images were captured with Leica software. 
 
2.5.2 Immunostaining of EspA filaments 
E. coli O26 bacteria were grown as described for secreted protein analysis (section 




Aliquots of fixed bacteria were air dried onto multispot slides and incubated with 
mouse anti-EspA monoclonal antibody (T. Chakraborty, Justus Liebig University, 
Giessen), prepared at 1:100 in PBS, for 1 hour at room temperature.  Following three 
washes with PBS, the samples were incubated with FITC-conjugated sheep anti-
mouse immunoglobulin secondary antibody (Sigma-Aldrich), prepared at 1:500 in 
PBS, for 1 hour at room temperature and then the slides were washed a further three 
times with PBS.  Slides were examined by microscopy and ten fields for each isolate 
were selected under phase contrast microscopy using an x100 objective.  Phase 
contrast and fluorescent images were captured of each field with Leica software.  For 
each field, the total number of bacteria and the number of bacteria expressing EspA 
filaments were counted.      
 
2.5.3 Immunostaining of surface fimbriae 
Bacteria were cultured on CFA agar and in CFA and CDMT broths for 24 h at 37°C.  
Bacterial cultures were fixed in 4% PFA and aliquots of fixed bacteria were air dried 
onto multispot slides.  Sfp fimbriae were labelled by incubating with rabbit anti-SfpA 
serum (Brunder et al., 2001), diluted 1:20,000 in PBS, and then FITC-conjugated 
anti-rabbit immunoglobulin secondary antibody (Sigma-Aldrich), diluted 1:500 in 
PBS, for 1 hour at room temperature.  Curli fimbriae were labelled using mouse anti-
SEF17 monoclonal antibody (Dr R. La Ragione, VLA Weybridge), diluted 1:100 in 
PBS, and FITC-conjugated anti-mouse immunoglobulin secondary antibody (Sigma-
Aldrich), diluted 1:500 in PBS, incubating for 1 hour at room temperature.  Slides 
were examined by fluorescence microscopy using an x100 objective and images 
were captured with Leica software. 
 
2.6 Motility assays 
Motility was determined using soft-agar plates (see Appendix 1), which were 
prepared the day before use and left at room temperature overnight.  A bacterial 
colony from an LB agar plate was stabbed into the middle of a soft-agar plate using a 






2.7  Vero cell cytotoxicity assays 
2.7.1 Preparation of culture filtrates 
E. coli O26 isolates were cultured in DMEM-HEPES, supplemented with Fe(NO3)3 
to a final concentration of 62 µM (iron-replete medium) and 0.62 µM (low-iron 
medium).  E. coli O157 isolates were grown in MEM-HEPES, supplemented with 
glucose (final concentration of 0.2%) and 0.25 µM Fe(NO3)3.  Bacteria were cultured 
in appropriate medium with shaking (200 rpm) at 37°C for 24 h.  Mitomycin C (0.5 
µg/ml) was added when required to cultures at an OD600 of 0.3.  Bacterial cultures 
were centrifuged (4,000 x g, 20 min at 4°C) and supernatants filter sterilised through 
low-protein-binding 0.45 µm filters (Millipore).  Culture filtrates were diluted in 
fresh medium to normalise for differences in OD600 between cultures. 
 
2.7.2 Vero cell cytotoxicity 
Vero cells were seeded into 96-well flat-bottom tissue culture plates (Nunc) at a 
density of 1 x 104 cells/well and incubated at 37ºC in 5% CO2 for 48 h prior to 
cytotoxicity assays.  For E. coli O26 samples, two-fold serial dilutions of the culture 
filtrates were made in serum-free cell culture medium.  For E. coli O157 samples, 
culture filtrates were diluted 1 in 3 in serum-free cell culture medium.  Samples (200 
µl) were added to the Vero cells and the cytotoxicity assay was performed at 37ºC in 
5% CO2 for 72 h.  Untreated controls not exposed to bacterial culture filtrates were 
included on each plate.  Following incubation, detached cells and samples were 
removed from the wells.  The remaining Vero cells were washed with PBS and fixed 
with 2% formalin in PBS.  Quantification of viable Vero cells was determined by 
staining with crystal violet solution (see Appendix 1) for 1 h.  Plates were rinsed with 
dH2O and air dried.  Crystal violet was released from the cells with 10% acetic acid 
and absorbance measurements were taken at 590 nm.  Vero cell survival was 
calculated relative to untreated controls not exposed to bacterial culture filtrates.  For 
the E. coli O26 samples, the verocytotoxin titre was defined as the reciprocal of the 
highest dilution of the culture filtrate that caused cytotoxicity in 50% of Vero cells.  
Vero cell cytotoxicity assays were repeated at least two times for the E. coli O26 





2.8 Secreted protein analysis 
2.8.1 Protein precipitation 
E. coli O26 isolates were cultured in DMEM-HEPES and  E. coli O157 isolates were 
grown in MEM-HEPES, supplemented with glucose (final concentration of 0.2%) 
and 0.25 µM Fe(NO3)3.  Bacteria were cultured in appropriate medium with shaking 
(200 rpm) at 37°C to an OD600 of 0.8.  Suspensions were centrifuged (4,000 x g, 20 
min at 4°C) and the supernatants filter sterilised through low-protein-binding 0.45 
µm filters.  Bovine serum albumin (BSA; NEB) (4 µg/ml) was added to the 
supernatants and supernatant proteins were precipitated by the addition of 10% (v/v) 
trichloroacetic acid (TCA) with overnight incubation at 4°C.  The precipitates were 
harvested by centrifugation (4,000 x g, 30 min at 4°C) and the protein pellets air 
dried and suspended in 1.5 M Tris-HCl (pH 8.8).  Protein samples were aliquoted 
and stored at -20°C.  Each isolate was cultured on three separate occasions. 
 
2.8.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE)  
Secreted protein samples were separated by SDS-PAGE using either Bio-Rad Mini-
PROTEAN II gel apparatus (Bio-Rad) or a Hoefer SE600 Midi gel electrophoresis 
unit.  Protein samples were mixed 1:1 with 2 X Laemmli sample buffer (Sigma-
Aldrich) and incubated at 100°C on a heated block for 3 min.  Protein samples were 
loaded in a 5% stacking gel [5% acrylamide-bisacrylamide, 0.125 M Tris-HCl (pH 
6.8), 0.1% SDS, 0.1% APS, 0.001% TEMED] and resolved in a 12% resolving gel 
[12% acrylamide-bisacrylamide, 0.375 M Tris-HCl (pH 8.8), 0.1% SDS, 0.1% APS, 
0.001% TEMED] by electrophoresis.  Electrophoresis was performed in Tris-glycine 
running buffer [25 mM Tris-HCl (pH 8.3), 192 mM glycine, 0.1% SDS] at constant 
voltage (100 V for mini gels and 150 V for midi gels).  Molecular weight markers 
[low molecular weight range SigmaMarker (Sigma-Aldrich) and full range Rainbow 
molecular weight marker (Amersham Biosciences)] were used to determine protein 







2.8.3 Colloidal blue staining of SDS-PAGE gels 
Proteins separated in polyacrylamide gels were visualised by staining with Colloidal 
blue (Severn Biotech) overnight.  Gels were destained in dH2O and images captured 
using a Flowgen MultiImage light cabinet and ChemiImager 4000i v.4.04 software. 
 
2.8.4   Western blotting for EspA 
Protein samples were separated by SDS-PAGE and transferred from the 
polyacrylamide gel onto Hybond ECL nitrocellulose membrane (Amersham 
Biosciences) using a Trans-Blot electrophoretic transfer cell (Bio-Rad).  Briefly, the 
gel and nitrocellulose membrane were ‘sandwiched’ together between filter paper 
and sponge pads, pre-soaked in transfer buffer [20 mM Tris, 154 mM glycine, 20% 
(v/v) methanol], in a gel holder cassette.  The transfer of proteins was performed in 
transfer buffer at constant voltage (60 V) for 90 min.  Nitrocellulose membranes 
were then blocked with 8% (w/v) Marvel milk powder in PBS at 4°C overnight.  
Membranes were washed three times with 15 min washes in PBST [PBS containing 
0.05% (v/v) Tween 20], and then incubated with mouse anti-EspA monoclonal 
antibody, prepared at a 1:4000 dilution in PBST, for 1 hour at room temperature on a 
rocking platform.  Excess primary antibody was removed with three 15 min washes 
in PBST and membranes were then incubated with horseradish peroxidase (HRP)-
conjugated rabbit anti-mouse immunoglobulin secondary antibody (Dako), prepared 
at 1:4000 in PBST, for 1 hour at room temperature on a rocking platform.  Excess 
secondary antibody was removed with three 15 min washes in PBST.  Membranes 
were then incubated in ECL solution (see Appendix 1) for 5 min at room temperature 
on a rocking platform.  Chemiluminescence was detected on Hyperfilm ECL 
chemiluminescence film (Amersham Biosciences) developed in a Protec automatic 
film processor (Optimax).  Images were taken using a Flowgen MultiImage light 
cabinet and ChemiImager 4000i v.4.04 software.  
 
2.9 Adherence assays to Caco-2 cells 
2.9.1 Bacterial culture conditions 
E. coli O26 isolates were cultured on CFA agar plates and E. coli O157 isolates were 




previously to promote fimbrial expression (Brunder et al., 2001; Evans et al., 1977).  
Bacteria were cultured at 37ºC for 24 h and were harvested from CFA plates in PBS.  
Bacterial cultures were diluted to an OD600 of 0.5.  
 
2.9.2 Adherence assays 
Caco-2 cells were seeded into eight-chamber microscope slides (Becton & 
Dickinson) at a density of 1 x 105 cells/well and incubated at 37ºC in 5% CO2 for 48 
h prior to adherence assays.  Bacterial cultures (300 µl) were added to the Caco-2 
cells and adherence assays were performed at 37ºC in 5% CO2 for 2 h.  Following 
incubation, the bacterial suspension was removed and the cells were washed with 
PBS three times prior to fixation with 4% PFA.  Bacteria attached to cells were 
labelled by indirect immunofluorescence by incubating with rabbit E. coli O26 
antisera or rabbit E. coli O157 antisera as appropriate, diluted 1:100 in PBS, for 45 
min at room temperature.  Following three washes with PBS, the slides were 
incubated with Alexa Fluor 568 secondary antibody (Molecular Probes), prepared at 
1:1,000 in PBS, for 45 min at room temperature, and then the slides were washed a 
further three times with PBS.  Slides were examined by fluorescence microscopy and 
the number of bacteria per field was counted for randomly selected fields in each 
well for at least 20 fields.  Images were captured with Leica software.  Adherence 
assays were repeated at least three times for each isolate.  
 
2.9.3 Inhibition adherence assays 
Bacteria were cultured on CFA agar and before adding bacteria to Caco-2 cells, 
aliquots of bacterial cultures were incubated for 30 min at room temperature in the 
presence or absence of a reagent which should interact with a specific adhesin.  3% 
(w/v) mannose was used to competitively inhibit type 1 fimbrial binding to receptors 
containing -D-mannose.  Anti-SfpA serum (diluted 1:400) and anti-curli 
monoclonal antibody (diluted 1:100) were used to attempt to inhibit adherence due to 
Sfp fimbriae and curli, respectively.  Adherence to Caco-2 cells and subsequent 






2.10 Biofilm assays 
Bacteria were cultured statically overnight at 28°C or 37°C in LB, CFA and CDMT 
broths.  Cultures were diluted 1:100 in fresh medium and 200 µl/well was added to 
96-well flat-bottom polystyrene tissue culture plates (Nunc).  Plates were incubated 
at 28°C or 37°C for 24 h and 48 h.  Bacterial adherence to microtitre well surfaces 
was determined by crystal violet staining, as described in section 2.7.2, except that 
washes were done with PBS.  Sterile medium was included as a control, and the 
absorbance (590 nm) was subtracted from the other values.  Biofilm assays were 
repeated three times for each isolate.  
 
2.11 Yeast cell agglutination 
A single colony of the isolate to be tested was inoculated into 5 ml LB broth and 
incubated statically at 37°C for 24 h.  The culture was subcultured into a further 5 ml 
LB broth and incubated statically for another 24 h.  Subculturing was repeated once 
more.  Yeast cell agglutination was carried out by mixing 15 µl bacterial culture with 
an equal volume of baker’s yeast suspension (10 mg/ml) on glass slides and the 
degree of clumping was assessed.  Mannose inhibition of agglutination was 
confirmed using 3% α-D-mannose in the yeast suspension. 
 
2.12 Measurement of plasmid-based promoter-GFP fusions   
To investigate sfpA, csgBAC and csgD promoter activity in different VTEC O157 
backgrounds, the appropriate isolates were transformed with promoter-GFP 
translational fusions (see sections 2.4.13 and 2.4.14.2).  Single transformants were 
cultured on CFA agar and in CDMT broth (both containing 25 µl ml-1 
chloramphenicol [CAM]) for 24 h at 37°C, and bacteria were harvested from CFA-
CAM agar plates in CFA-CAM broth.  Total green fluorescent protein (GFP) 
produced by the population was determined by analysing 100 µl aliquots of culture 
(OD600 of 0.5) in a fluorimeter (FLUOstar Optima).  Promoterless plasmid pAJR70 
in each strain background acted as a control for background fluorescence and was 
subtracted from the other values.  Promoter activity in each isolate was measured on 





2.13 Statistical analysis  
Associations between observation data were tested using the chi-square test or 
Fisher’s exact test if data sets contained a small number of observations.  For 
comparisons of Vtx titres from non-induced VTEC O26 isolates, the median Vtx titre 
values were log10 transformed and analysed using two-sample t tests.  For 
comparisons of Vtx titres without and after induction, the Vtx titres values were log10 
transformed and differences assessed with the paired t test.  For the VTEC O26 
Caco-2 adherence assays, bacteria per field counts were log10 transformed and 
analysed by analysis of variance (ANOVA).  Individual differences were 
investigated using Tukey’s test for multiple comparisons, with a family error rate of 
1%.  The VTEC O157 Vero cell cytotoxicity and biofilm assay data were analysed 
by ANOVA.  For the initial VTEC O157 Caco-2 adherence assays and the inhibition 
adherence assays, bacteria per field counts were log10 transformed and analysed with 
mixed models using the REML (restricted maximum likelihood) directive, dropping 
non-significant terms for fixed effects.  A difference between predicted means was 
considered significant if it was greater than twice the standard error of difference.  
For graphical representation, predicted means and confidence intervals were back-
transformed.  Caco-2 adherence assays with the curli deletion mutant and the 
European SF VTEC O157:NM isolates, and the promoter expression data were 
analysed using two-sample t tests.  All statistical analyses were performed using 
Genstat, 10th edition, and Minitab 15. 
 
2.14 Nucleotide sequence accession numbers  
Nucleotide sequences from this research have been deposited in the GenBank 

















H2687 vtx2 1,248 EU526759 
H8824 vtx2 1,248 EU526760 
H8432 vtx2 1,248 EU526761 
H8489 vtx2 1,248 EU526762 
H8757 vtx2 1,248 EU526763 
H8478 vtx2 1,248 EU526764 
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Section I   
 
Characterisation of Escherichia coli O26 isolates 
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Verocytotoxin-producing E. coli (VTEC) serogroup O26 has emerged as the most 
common non-O157 VTEC serotype associated with human infection in continental 
Europe and has been responsible for serious clinical disease including HUS (Caprioli 
et al., 1997; Gerber et al., 2002; Tozzi et al., 2003; Zhang et al., 2000).  VTEC O26 
has exceeded VTEC O157 as the principal cause of haemorrhagic colitis and HUS in 
Italy (Tozzi et al., 2003).  In contrast, although human infections associated with E. 
coli O26 have been recognised in Scotland and the rest of the United Kingdom 
(McMaster et al., 2001; SCIEH, 2003; Willshaw et al., 2001), they are uncommon 
and do not appear to result in such serious disease.  Instead, Scotland has relatively 
high rates of human infection with E. coli O157:H7, with many cases associated with 
exposure to livestock, such as cattle and sheep, which are major reservoirs of this 
pathogen (Chase-Topping et al., 2008).  The observation that VTEC O26 strains are 
common and widely dispersed in Scottish cattle (Pearce et al., 2006) has raised 
concern that bovine VTEC O26 strains may emerge as the cause of serious human 
infections in Scotland. 
 
This study had two main objectives.  The first was to characterise E. coli O26 
isolates from different backgrounds to determine whether there are 
similarities/differences and the second was to investigate the potential of E. coli O26 
strains from Scottish cattle to cause human infection.  Genotypic and phenotypic 
characterisation of E. coli O26 isolates from human infections of varying severity 
may identify characteristics which allow these strains to cause more serious disease.  
To achieve this it was necessary to compare E. coli O26 isolates from different 
geographical origins – those isolated from human infections in continental Europe 
included ones associated with life-threatening HUS whereas those isolated from 
patients in Scotland were generally associated with simple diarrhoea.  Additionally, 
comparing E. coli O26 isolates from Scottish cattle to those recovered from human 
infections, may indicate whether strains from the Scottish food-chain represent a 

















The fact that E. coli O26 isolates have been recovered from human infections of 
different clinical severity prompted the investigation of the genomic ‘make-up’ and 
gene repertoire from several clinical isolates, with the aim to identify genotypic 
characteristics which may allow strains to cause more serious clinical disease.  In 
addition, genotypic analysis of E. coli O26 isolates from Scottish cattle may indicate 
the potential of these bovine isolates to cause human infection.  This chapter 
describes the genotypic characterisation of human and bovine E. coli O26 isolates by 
multilocus sequence typing (MLST) and the presence of known virulence genes. 
 
3.1 E. coli O26 isolates  
Sixty eight E. coli O26 isolates from different backgrounds were collected for this 
study.  The collection contained 35 isolates recovered from cases of human infection 
with different forms of clinical disease and 33 isolates from Scottish cattle.  A full 
description of the isolates used in this study is detailed in section 2.1.2 and Table 
2.1(B) and the information stated was provided by the supplier of the isolates.  
  
3.1.1 Confirmation that the isolates were E. coli serogroup O26 
To confirm that the isolates included in this research were E. coli serogroup O26, 
PCR to detect the presence of the wzx (O-unit flippase) and wzy (O-unit polymerase) 
genes, present in the O26 antigen gene cluster (DebRoy et al., 2004), was used to 
analyse the isolates and reference E. coli strains [Table 2.1(A) and (B)].  Reference 
E. coli O26 strains (413/89-1, ZAP078 and ZAP194) were positive for both the O26 
wzx and wzy genes whereas the non-O26 E. coli strains tested (E. coli O157:H7 
strains NCTC 12900 and EDL933, K-12 MG1655 and EPEC O127:H6 strain 
E2348/69) were negative for these genes.  All isolates contained both the O26 wzx 
and wzy genes, with the exception of ZAP1110_S1, ZAP1113_S4 and ZAP1148_I31, 
which carried neither of these genes.  This indicated that while the majority of the 
isolates were serogroup O26, isolates ZAP1110_S1, ZAP1113_S4 and ZAP1148_I31 
were not.  Examples of the agarose gels obtained following PCR of the O26 wzx and 










Figure 3.1.  PCR detection of O26 wzx and wzy genes.  (A) PCR of O26 wzx from isolates 
ZAP1110_S1 (lane 1), ZAP1111_S2 (lane 2), ZAP1112_S3 (lane 3), ZAP1113_S4 (lane 4), 
ZAP1114_S6 (lane 5), ZAP1115_S7 (lane 6), ZAP1116_S8 (lane 7), ZAP1117_S9 (lane 8), 
ZAP1118_S10 (lane 9), ZAP1119_S11 (lane 10), ZAP1120_S12 (lane 11), ZAP1121_G13 
(lane 12), ZAP1122_G14 (lane 13), ZAP1123_G15 (lane 14) and ZAP1124_G16 (lane 15).  
The majority of the isolates generated a 152 bp product indicating the presence of the O26 
wzx gene.  O26 wzx was absent in isolates ZAP1110_S1 and ZAP1113_S4.  (B) PCR of O26 
wzy from isolates ZAP1125_G17 (lane 1), ZAP1126_G18 (lane 2), ZAP1127_G19 (lane 3), 
ZAP1128_G20 (lane 4), ZAP1129_G21 (lane 5), ZAP1130_G22 (lane 6), ZAP1131_G23 
(lane 7), ZAP1132_G24 (lane 8), ZAP1133_G25 (lane 9), ZAP1134_G26 (lane 10), 
ZAP1135_G27 (lane 11) and ZAP1136_G28 (lane 12).  These twelve isolates generated a 
276 bp product indicating the presence of the O26 wzy gene.  Lane 13, E. coli O157:H7 
isolate NCTC 12900 (negative control); lane 14, E. coli O26 isolate 413/89-1 (positive 
control); lane 15, DNA negative (PCR control).  Lane M, 100 bp molecular size marker. 
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Additional confirmation that the isolates were E. coli serogroup O26 was provided 
by immunostaining with O26 antisera.  While the majority of the isolates exhibited 
fluorescent surface staining isolates ZAP1110_S1, ZAP1113_S4 and ZAP1148_I31 
were negative.  A selection of phase-contrast and fluorescence micrographs is shown 
in Figure 3.2.  Taken together, PCR and immunostaining analysis indicated that all 
the isolates, with the exception of ZAP1110_S1, ZAP1113_S4 and ZAP1148_I31, 

















Figure 3.2.  Detection of the O26 antigen by immunofluorescence microscopy.  Phase-
contrast (left panel) and fluorescence (right panel) micrographs are shown for the indicated 
isolates stained for the O26 antigen using O26 antisera.  Slides were examined using an x100 
objective and images were captured with Leica software.  While the majority of the isolates 
exhibited fluorescent surface staining, isolates ZAP1110_S1, ZAP1113_S4 and 





3.2 Multilocus sequence typing (MLST) of E. coli O26 isolates 
Multilocus sequence typing (MLST) is widely used to investigate the clonal 
relationship between bacteria (Cooper & Feil, 2004) and it has been used 
successfully to identify the more virulent clones in certain bacterial species, 
including Streptococcus pneumoniae and Neisseria meningitidis (Brueggemann et 
al., 2003; Maiden et al., 1998).  Although pulsed-field gel electrophoresis (PFGE) is 
the most widely used method for molecular typing of E. coli strains, MLST is 
increasingly being employed as an alternative method (Adiri et al., 2003; Beutin et 
al., 2005; Gilmour et al., 2005; Wirth et al., 2006).  In this study, MLST was 
performed on 63 E. coli O26 isolates from different backgrounds for two main 
purposes.  Firstly, it was used to determine the genetic relatedness among the 
isolates; to establish if the E. coli O26 isolates recovered from patients in Scotland 
were closely related to those isolated from patients in continental Europe and to 
ascertain if the bovine isolates were related to the isolates from human infections.  
Secondly, it permitted an investigation of whether MLST could identify the more 
virulent E. coli O26 pathogens. 
 
3.2.1 Nucleotide sequencing of housekeeping genes 
Internal fragments of seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA 
and recA) from the 63 E. coli O26 isolates were sequenced and the allele numbers 
and sequence types (STs) were assigned in accordance with the E. coli MLST 
website (http://mlst.ucc.ie/mlst/dbs/Ecoli).  MLST analysis resolved the 63 E. coli 
O26 isolates into six STs (Table 3.1 and Appendix 2).  The allelic profile for each ST 
is detailed in Table 3.2.   
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Table 3.1. Multilocus sequence typing of E. coli O26 isolates. 
 
Isolate STa ST cplxa  Isolate STa ST cplxa
ZAP1077_B1 29 29  ZAP1111_S2  574 29 
ZAP1078_B2  21 29  ZAP1112_S3  29 29 
ZAP1079_B3  21 29  ZAP1114_S6  21 29 
ZAP1080_B4  21 29  ZAP1115_S7  21 29 
ZAP1081_B5 21 29  ZAP1116_S8  29 29 
ZAP1082_B6 29 29  ZAP1117_S9  10 10 
ZAP1083_B7  21 29  ZAP1118_S10  29 29 
ZAP1084_B8  21 29  ZAP1119_S11  575 29 
ZAP1085_B9  21 29  ZAP1120_S12  29 29 
ZAP1086_B10  21 29  ZAP1152_S35 21 29 
ZAP1087_B11  986 10  ZAP1153_S36 21 29 
ZAP1088_B12 21 29  ZAP1121_G13 29 29 
ZAP1089_B13  29 29  ZAP1122_G14  21 29 
ZAP1090_B14 29 29  ZAP1124_G16 21 29 
ZAP1091_B15 21 29  ZAP1125_G17 29 29 
ZAP1092_B16  29 29  ZAP1126_G18 21 29 
ZAP1093_B17 21 29  ZAP1127_G19 21 29 
ZAP1094_B18  21 29  ZAP1128_G20  29 29 
ZAP1095_B19 21 29  ZAP1129_G21  21 29 
ZAP1096_B20 29 29  ZAP1130_G22 21 29 
ZAP1097_B21 21 29  ZAP1131_G23  21 29 
ZAP1098_B22 29 29  ZAP1132_G24  21 29 
ZAP1099_B23 29 29  ZAP1133_G25 21 29 
ZAP1100_B24 21 29  ZAP1134_G26  29 29 
ZAP1101_B25 21 29  ZAP1135_G27  29 29 
ZAP1102_B26 29 29  ZAP1146_I29 21 29 
ZAP1103_B27 21 29  ZAP1147_I30 21 29 
ZAP1104_B28 10 10  ZAP1149_I32 21 29 
ZAP1105_B29  21 29  ZAP1150_I33 21 29 
ZAP1106_B30 21 29  ZAP1151_I34 21 29 
ZAP1107_B31  21 29     
ZAP1108_B32  21 29     
ZAP1109_B33  21 29     
a The sequence type (ST) and ST complex were assigned in accordance with the E. 






Table 3.2. The allelic profile for each sequence type (ST) among the E. coli O26 
isolates. 
 
Allelic profile ST ST 
complex 




21 29 16 4 12 16 9 7 7 40 
29 29 6 4 12 16 9 7 7 18 
574 29 16 135 12 16 9 7 7 1 
575 29 6 4 12 116 9 7 7 1 
10 10 10 11 4 8 8 8 2 2 
986 10 10 134 4 8 8 8 2 1 
 
 
The most frequently recovered STs among the E. coli O26 isolates were ST21 and 
ST29.  Together these two STs accounted for 92% of all of the isolates examined.  
Strains of ST21 and ST29 differ by a single nucleotide in the adk locus (Table 3.2).  
Due to the close genetic relationship between ST21 and ST29, both these STs were 
assigned to ST complex 29 (Table 3.2).  MLST analysis identified two new STs 
(ST574 and ST575) which were also assigned to ST complex 29.  The ST574 isolate 
(ZAP1111_S2) differed from strains of ST21 by a single nucleotide in the fumC 
locus (Table 3.2) and the isolate assigned to ST575 (ZAP1119_S11) differed from 
strains of ST29 by a single nucleotide in the icd locus (Table 3.2).  Three of the E. 
coli O26 isolates analysed (ZAP1087_B11, ZAP1104_B28, ZAP1117_S9) belonged 
to a clone (ST complex 10) which is genetically distant (differs at all seven loci) to 
ST complex 29 (Table 3.2).  Two of these isolates were ST10 and one was ST986.  
ST986 differs from ST10 by a single nucleotide in the fumC locus (Table 3.2).  
 
Strains of ST21 and ST29 were isolated from patients in both Scotland and 
continental Europe and also from cattle (Table 3.1).  This indicates that closely 
related clones of E. coli O26 reside in patients from different countries and in 
different hosts. 
 
The STs of isolates associated with different clinical outcomes was investigated to 
determine the ability of MLST to identify the more virulent E. coli O26 pathogens.  
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Isolates belonging to both ST21 and ST29 were recovered from patients suffering 
from disease of varying severity (Table 3.3) and statistical analysis found no 
evidence of an association between MLST ST and the severity of disease elicited.  
However, it is interesting to note that the majority (83%) of isolates associated with 
HUS belonged to ST21 and the majority (67%) of isolates belonging to ST29 were 
associated with diarrhoea (Table 3.3).  This suggests that strains belonging to ST21 
may have an increased likelihood of causing serious disease following human 
infection.  The majority (67%) of the Scottish cattle isolates were ST21.   
 
 
Table 3.3. Sequence types (STs) of E. coli O26 isolates associated with different 
forms of clinical disease. 
 
Number of isolates that belong to ST Clinical forma Number of 
isolates 10 21 29 575 986 
Diarrhoea 14 1 6 6 1 0 
Bloody Diarrhoea/HC 3 0 2 1 0 0 
HUS 12 0 10 2 0 0 
Cattle 33 1 22 9 0 1 




3.2.2 Nucleotide sequencing of espA and the promoter for LEE1 
To supplement the MLST scheme and look for greater genetic discrimination of the 
E. coli O26 isolates, the nucleotide sequence of two additional targets, which may 
have a higher degree of diversity, was determined.  One of the targets was espA, 
which encodes the surface-associated protein, EspA.  This gene was selected because 
it was hypothesised that products exposed on the cell surface are a potential target of 
the immune system and under possible pressure to mutate.  The second target was the 
region upstream of LEE1, which is likely to contain the LEE1 promoter.  
 
The three isolates which belong to ST complex 10 failed to generate amplicons 
following PCR of espA and the region upstream of LEE1 and, therefore, could not be 
included in this analysis.  The nucleotide sequence of these two targets was 
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determined for the remaining 60 isolates.  Sequence data at each loci was compared 
using ClustalX and each unique sequence was given a different allele number; allele 
numbers were assigned in the order in which they were discovered.  The results of 
this analysis are detailed in Table 3.4 (and Appendix 2).   
 
The nucleotide sequences of espA in all but one of the 60 E. coli O26 isolates were 
identical (Table 3.4) and the same as E. coli O26 isolate 413/89-1 (GenBank 
accession no. AJ277443).  Isolate ZAP1118_S10 differed from the other isolates by a 
single nucleotide in espA (G at base 19 instead of A) and encoded a protein which 
differed by a single amino acid residue (Ala at residue 7 instead of Thr). 
 
In contrast to the lack of sequence diversity in espA, differences in the nucleotide 
sequence of the region upstream of LEE1 were identified among E. coli O26 isolates.  
Six different sequences were discovered for the region upstream of LEE1 in the 60 E. 
coli O26 isolates examined (Table 3.4) and a comparison of these six alleles is shown 
in Figure 3.3.  Figure 3.3 also displays the nucleotide sequence alignment of these E. 
coli O26 alleles with that from E. coli O157:H7, in which LEE regulation has been 
extensively studied.  E. coli O26 alleles 1, 2, 3 and 4 only differ from each other by a 
single nucleotide substitution and, aside from these single nucleotide substitutions, 
alleles 5 and 6 differ from the other 4 alleles by the insertion of one and two thymine 
base(s), respectively (Figure 3.3).  Interestingly, from the approximately 644 bp 
sequenced, all sequence variation between the E. coli O26 alleles occurs within a 91 
bp region upstream of Ler, in the region where regulators are known to act in E. coli 




Table 3.4. Allele numbers for espA and the region upstream of LEE1 from E. 
coli O26 isolates. 
 
Allele numberb  Allele numberb  
Isolate 
 






STa espA upstream 
of LEE1 
ZAP1077_B1 29 1 3  ZAP1111_S2  574 1 2 
ZAP1078_B2  21 1 1  ZAP1112_S3  29 1 4 
ZAP1079_B3  21 1 2  ZAP1114_S6  21 1 2 
ZAP1080_B4  21 1 2  ZAP1115_S7  21 1 2 
ZAP1081_B5 21 1 2  ZAP1116_S8  29 1 1 
ZAP1082_B6 29 1 1  ZAP1117_S9  10 ND ND 
ZAP1083_B7  21 1 2  ZAP1118_S10  29 2 5 
ZAP1084_B8  21 1 2  ZAP1119_S11  575 1 1 
ZAP1085_B9  21 1 2  ZAP1120_S12  29 1 6 
ZAP1086_B10  21 1 2  ZAP1152_S35 21 1 2 
ZAP1087_B11  986 ND ND  ZAP1153_S36 21 1 2 
ZAP1088_B12 21 1 2  ZAP1121_G13 29 1 1 
ZAP1089_B13  29 1 4  ZAP1122_G14 21 1 2 
ZAP1090_B14 29 1 1  ZAP1124_G16 21 1 2 
ZAP1091_B15 21 1 2  ZAP1125_G17 29 1 1 
ZAP1092_B16  29 1 4  ZAP1126_G18 21 1 1 
ZAP1093_B17 21 1 2  ZAP1127_G19 21 1 2 
ZAP1094_B18  21 1 2  ZAP1128_G20 29 1 1 
ZAP1095_B19 21 1 2  ZAP1129_G21 21 1 2 
ZAP1096_B20 29 1 1  ZAP1130_G22 21 1 1 
ZAP1097_B21 21 1 2  ZAP1131_G23 21 1 1 
ZAP1098_B22 29 1 4  ZAP1132_G24 21 1 2 
ZAP1099_B23 29 1 1  ZAP1133_G25 21 1 1 
ZAP1100_B24 21 1 2  ZAP1134_G26 29 1 1 
ZAP1101_B25 21 1 2  ZAP1135_G27 29 1 1 
ZAP1102_B26 29 1 1  ZAP1146_I29 21 1 1 
ZAP1103_B27 21 1 2  ZAP1147_I30 21 1 1 
ZAP1104_B28 10 ND ND  ZAP1149_I32 21 1 1 
ZAP1105_B29  21 1 1  ZAP1150_I33 21 1 1 
ZAP1106_B30 21 1 2  ZAP1151_I34 21 1 1 
ZAP1107_B31  21 1 2      
ZAP1108_B32  21 1 2      
ZAP1109_B33  21 1 2      
 a The sequence type (ST) was assigned in accordance with the E. coli MLST website 
(http://mlst.ucc.ie/mlst/dbs/Ecoli) following sequencing of housekeeping genes. 
b The allele numbers at each loci were assigned in the order in which they were 






Figure 3.3.                                                                      
                     *        20         *        40         *       
Allele 1  : --CGAATGGTACGGTTATGCGGGGGGGACAAACA-TGGTTGCTTGTTCT- :  46 
Allele 2  : --................................-..............- :  46 
Allele 3  : --................................-..............- :  46 
Allele 4  : --................................-..............- :  46 
Allele 5  : --................................-..............- :  46 
Allele 6  : --................................-..............- :  46 
O157:H7   : TG.TGGCT...-.C.....TCC...AA...GCT.A.A.A.ATA.A.A..C :  49             
                                                                   
                    60         *        80         *       100       
Allele 1  : GCCATTTGTTCC-TTGTTCCTTTTTATACCGCCGCCGCTCCCGGTCAGCA :  95 
Allele 2  : ............-..................................... :  95 
Allele 3  : ............-..................................... :  95 
Allele 4  : ............-..................................... :  95 
Allele 5  : ............-..................................... :  95 
Allele 6  : ............-..................................... :  95 
O157:H7   : .T...ACT.CAAG...CATG.GC.GCG..T..GTT....TA.CCCA.T.. :  99             
                                                                      
                     *       120         *       140         *       
Allele 1  : CTGGGGAATAGGGGGTT---GAGGTATATCTGCTCCTTATGTCAGGGGAA : 142 
Allele 2  : .................---.............................. : 142 
Allele 3  : .................---.............................. : 142 
Allele 4  : .................---.............................. : 142 
Allele 5  : .................---.............................. : 142 
Allele 6  : .................---.............................. : 142 
O157:H7   : ..TACTT..GTAA.C.CCTG.G.A.TC.CTC...TGCCGCC.TCCT.T.. : 149             
                                                                      
                   160         *       180         *       200       
Allele 1  : CAGGTAATAGCTA---TATAGCGGAACGTCTTAGTGCTGTAGTTATTCCA : 189 
Allele 2  : .............---.................................. : 189 
Allele 3  : .............---.................................. : 189 
Allele 4  : .............---.................................. : 189 
Allele 5  : .............---.................................. : 189 
Allele 6  : .............---.................................. : 189 
O157:H7   : .TC.A.T..AG..GAG.....T.A....GT.C..CTTG..TT......TG : 199             
                                                                      
                     *       220         *       240         *       
Allele 1  : TTTTGCT-ATTTGTCTAATAGGACTAATCTTAAAGAAAACAAAACGATTA : 238 
Allele 2  : .......-.......................................... : 238 
Allele 3  : .......-.......................................... : 238 
Allele 4  : .......-.......................................... : 238 
Allele 5  : .......-.......................................... : 238 
Allele 6  : .......-.......................................... : 238 
O157:H7   : ....AT.TG...A.GC...GA..TCT......T.A.G.--G.....C... : 247             
                                                                      
                   260         *       280         *       300       
Allele 1  : ACTAAATGGAAAGGCAATTGTTAATGGCGTTTGCTAAAGAGATGAAGTTC : 288 
Allele 2  : .................................................. : 288 
Allele 3  : .............................................G.... : 288 
Allele 4  : .................................................. : 288 
Allele 5  : .................................................. : 288 
Allele 6  : .................................................. : 288 
O157:H7   : ............T......A....A.T......T...C.......TT... : 297             
-218 
Figure 3.3 continued 
  
                     *       320         *       340         *       
Allele 1  : TTCTACTTTATTGATTTTGAATGATTTTTAAGAA-ATATGATTTTTTT-- : 335 
Allele 2  : ..................T...............-.............-- : 335 
Allele 3  : ..................................-.............-- : 335 
Allele 4  : ..................................-.............-- : 335 
Allele 5  : ..................................-.............T- : 336 
Allele 6  : ..................................-.............TT : 337 
O157:H7   : .....TA.C.........A....GA......A..T.............-- : 345             
           -173                      
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                   360         *       380         *       400       
Allele 1  : GTTGACATTTAATGATAATGTGTTTTACACATTATACATCGGTGATTAAT : 385 
Allele 2  : .................................................. : 385 
Allele 3  : .................................................. : 385 
Allele 4  : ....................................T............. : 385 
Allele 5  : ....................................T............. : 386 
Allele 6  : .................................................. : 387 
O157:H7   : .....................A............G.A.AAA.A..A.... : 395             
             -123                    
                     *       420         *       440         *       
Allele 1  : AACTTTTATAAGGATTTTGTTTGATGAAGTAGATGTGTTCTAATTTGATA : 435 
Allele 2  : .................................................. : 435 
Allele 3  : .................................................. : 435 
Allele 4  : .................................................. : 435 
Allele 5  : .................................................. : 436 
Allele 6  : .................................................. : 437 
O157:H7   : ...A...-.....TGG............A.........C........... : 444             
                                                                      
                   460         *       480         *       500       
Allele 1  : GATAAAACGTTATCTCACATAATTTATATCATTCGATTAATTGTTGATCC : 485 
Allele 2  : .................................................. : 485 
Allele 3  : .................................................. : 485 
Allele 4  : .................................................. : 485 
Allele 5  : .................................................. : 486 
Allele 6  : .................................................. : 487 
O157:H7   : ......-..........................T............G... : 493             
            
                     *       520         *       540         *       
Allele 1  : TTCCTGATAAGGATAAGATTGCTAATAGCTTAATATATTAAAGCATGCGG : 535 
Allele 2  : .................................................. : 535 
Allele 3  : .................................................. : 535 
Allele 4  : .................................................. : 535 
Allele 5  : .................................................. : 536 
Allele 6  : .................................................. : 537 
O157:H7   : ............------.C.............A................ : 537             
          +1               Start of Ler             
                   560         *       580         *       600       
Allele 1  : AGATTATTTATTATGAATATGGAAACTAATTCGCACACAACAAGCCCATA : 585 
Allele 2  : .................................................. : 585 
Allele 3  : .................................................. : 585 
Allele 4  : .................................................. : 585 
Allele 5  : .................................................. : 586 
Allele 6  : .................................................. : 587 
O157:H7   : .........................A......A..T........T..... : 587             
                                                                    
                     *       620         *       640         *       
Allele 1  : CATTCAGCTTATTGAGCAAATTGAAGTGTTACAACAGGAAGCAAAGCGAC : 635 
Allele 2  : .................................................. : 635 
Allele 3  : .................................................. : 635 
Allele 4  : .................................................. : 635 
Allele 5  : .................................................. : 636 
Allele 6  : .................................................. : 637 
O157:H7   : ............A..........C...TC....G...........----- : 632             
                             
                             
Allele 1  : TGCGAGAGC : 644 
Allele 2  : ......... : 644 
Allele 3  : ......... : 644 
Allele 4  : ......... : 644 
Allele 5  : ......... : 645 
Allele 6  : ......... : 646 
O157:H7   : --------- :   - 
 
 
Figure 3.3.  Alignment of the nucleotide sequences of the six alleles discovered for the 
region upstream of LEE1 in E. coli O26 isolates and the region upstream of LEE1 in E. 
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coli O157:H7 TUV93-0.  Approximately 644 bp of sequence data was determined and the 
numbering on the right-hand side reflects this.  Dots indicate nucleotides identical to those of 
the top sequence (allele 1 of E. coli O26) and hyphens (-) indicate the absence of 
nucleotides.  Yellow shaded letters highlight nucleotide differences between the E. coli O26 
alleles.  Grey shaded areas denote nucleotide differences between E. coli O26 and E. coli 
O157:H7.  Red shaded nucleotides indicate the general areas of the LEE1 promoter region 
where regulators act in E. coli O157:H7 [information obtained from Sharp & Sperandio 
(2007); see Appendix 3] and the numbering of these nucleotides is in relation to the P2 LEE1 
promoter transcriptional start site (marked +1 and highlighted in green).  Turquoise shaded 
area corresponds to the IHF (integration host factor)-binding site in E. coli O157:H7 
(information obtained from Sharp & Sperandio, 2007).  The start codon of Ler is marked by 








From the six alleles discovered among the E. coli O26 isolates, the two most 
prevalent were alleles 1 and 2 which were present in 23/60 (38%) and 30/60 (50%) 
of the isolates, respectively.  The sequence of the region upstream of LEE1 possessed 
by E. coli O26 isolates belonging to different MLST STs is detailed in Table 3.5.  
Allele 2 was only ever discovered in isolates belonging to ST21 or the closely related 
ST574 and statistical analysis found strong evidence of an association (p < 0.001) 
between the carriage of allele 2 by isolates and them belonging to ST21.  Allele 1, 
however, was present in equal numbers of ST21 and ST29 isolates and in the isolate 
belonging to ST575.  The less common alleles, alleles 3, 4, 5 and 6, were only 
detected in isolates belonging to ST29.   
 
 
Table 3.5. Prevalence of alleles for the region upstream of LEE1 among E. coli 
O26 isolates belonging to different MLST STs. 
 
Number of isolates possessing allele number  





of isolates 1 2 3 4 5 6 
21 40 11  29  0 0 0 0 
29 18 11  0 1  4  1  1 
574 1 0 1 0 0 0 0 
575 1 1 0 0 0 0 0 
 
 
The sequence of the region upstream of LEE1 possessed by E. coli O26 isolates 
recovered from different backgrounds is detailed in Table 3.6.  There is strong 
evidence of an association (p = 0.001) between the origin of the isolate and the 
sequence of the region upstream of LEE1.  The vast majority (14/19, 74%) of human 
isolates recovered in continental Europe carried allele 1 whereas only a limited 
number of isolates from patients and cattle in Scotland possessed this allele (20% and 
23%, respectively) (Table 3.6).  Instead, half of the human isolates recovered in 
Scotland and the majority of Scottish cattle isolates harboured allele 2 (Table 3.6).  
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Table 3.6. Prevalence of alleles for the region upstream of LEE1 among E. coli 
O26 isolates recovered from different backgrounds. 
 
Number of isolates possessing allele number 
for region upstream of LEE1 
 
Origin of isolate 
 
Number 
of isolates 1 2 3 4 5 6 
Human  
(Scotland) 
10 2 5 0 1 1 1 
Human  
(continental Europe) 
19 14 5 0 0 0 0 
Cattle 31 7 20 1 3 0 0 
  
 
There is no evidence of an association between the sequence of the region upstream 
of LEE1 and the severity of disease following human infection.  For both allele 1 and 
allele 2, a similar or equivalent number of isolates were associated with both simple 
diarrhoea and HUS. 
 
3.2.3 Summary of MLST results 
Nucleotide sequencing of housekeeping genes found very little genetic variation in 
the genomic ‘backbone’ among the vast majority of E. coli O26 isolates indicating 
that closely related strains reside in patients from different countries and in different 
hosts.  Only three isolates had marked variation in their genomic ‘backbone’ and 
were genetically distant from the other isolates.  Nucleotide sequencing of the region 
upstream of LEE1 found sequence differences between isolates recovered from 
different backgrounds.  While the majority of human isolates recovered in 
continental Europe carried allele 1, most of the isolates from patients and cattle in 




3.3 Virulence gene carriage by E. coli O26 isolates  
Further genotypic characterisation of the E. coli O26 isolates was achieved by 
determining their carriage of known virulence factors.  All isolates were screened by 
PCR for the genes encoding verocytotoxin 1 (vtx1), verocytotoxin 2 (vtx2) and 
enterohaemolysin (hlyA).  The possession of the LEE pathogenicity island was 
determined by screening for intimin (eae) and SepL (sepL) by PCR.  Examples of the 
agarose gels obtained following multiplex PCR of vtx1, vtx2, eae and hlyA genes and 
PCR of sepL are shown in Figure 3.4.  The virulence genes carried by each of the E. 
coli O26 isolates is detailed in Table 3.7 (and Appendix 2). 
 
The virulence gene profile for isolates ZAP1123_G15 and ZAP1136_G28 did not 
agree with the information provided by the supplier of the isolates.  ZAP1123_G15 
was recorded as positive for vtx2 but was found to be positive for vtx1 and 
ZAP1136_G28 was shown to be positive for vtx2 although it should have been 
positive for vtx1.  Due to the uncertainty with regard to the information about these 
two isolates, ZAP1123_G15 and ZAP1136_G28 were omitted from further study. 
 
The major virulence factor of E. coli strains is the production of verocytotoxin (Vtx).  
More than half (55%) of the E. coli O26 isolates recovered from patients in Scotland 
did not possess a gene encoding Vtx.  Of the five isolates which were vtx gene 
positive, three carried vtx1 alone and two possessed vtx1 in combination with vtx2.  
No Scottish human isolate carried the vtx2 gene alone.  All combinations of vtx gene 
carriage were observed among the E. coli O26 isolates recovered from patients in 
continental Europe; five carried vtx1 alone, six carried vtx2 alone, four carried vtx1 
and vtx2 and four were vtx gene negative.  Among the 33 Scottish cattle isolates 
analysed 23 harboured vtx genes - sixteen possessed vtx1 alone and seven possessed 








Figure 3.4.  PCR detection of virulence genes.  (A) Multiplex PCR of vtx1, vtx2, eae and 
hlyA genes and (B) PCR of sepL from isolates ZAP1077_B1 (lane 1), ZAP1078_B2 (lane 2), 
ZAP1079_B3 (lane 3), ZAP1080_B4 (lane 4), ZAP1081_B5 (lane 5), ZAP1082_B6 (lane 6), 
ZAP1083_B7 (lane 7), ZAP1084_B8 (lane 8), ZAP1085_B9 (lane 9), ZAP1086_B10 (lane 
10), ZAP1087_B11 (lane 11), ZAP1088_B12 (lane 12), ZAP1089_B13 (lane 13), 
ZAP1090_B14 (lane 14), ZAP1091_B15 (lane 15), ZAP1092_B16 (lane 16), ZAP1093_B17 











Table 3.7. PCR detection of virulence genes carried by E. coli O26 isolatesa. 
 
  LEE  
Isolate vtxb eae sepL hlyA 
ZAP1077_B1 – + + – 
ZAP1078_B2  1, 2 + + + 
ZAP1079_B3  1 + + + 
ZAP1080_B4  1 + + + 
ZAP1081_B5 1 + + + 
ZAP1082_B6 – + + + 
ZAP1083_B7  1 + + + 
ZAP1084_B8  1 + + + 
ZAP1085_B9  1 + + + 
ZAP1086_B10  1, 2 + + + 
ZAP1087_B11  1 – – – 
ZAP1088_B12 1 + + + 
ZAP1089_B13  – + + + 
ZAP1090_B14 – + + – 
ZAP1091_B15 1 + + + 
ZAP1092_B16  – + + + 
ZAP1093_B17 1 + + + 
ZAP1094_B18  1, 2 + + + 
ZAP1095_B19 1 + + + 
ZAP1096_B20 – + + + 
ZAP1097_B21 1 + + + 
ZAP1098_B22 – + + + 
ZAP1099_B23 – + + – 
ZAP1100_B24 1, 2 + + + 
ZAP1101_B25 1 + + + 
ZAP1102_B26 – + + – 
ZAP1103_B27 1 + + + 
ZAP1104_B28 – – – – 
ZAP1105_B29  1, 2 + + + 
ZAP1106_B30 1, 2 + + + 
ZAP1107_B31  1 + + + 
ZAP1108_B32  1 + + + 
ZAP1109_B33  1, 2 + + + 
ZAP1111_S2  1 + + + 
ZAP1112_S3  – + + + 
ZAP1114_S6  1 + + + 
ZAP1115_S7  1 + + + 
ZAP1116_S8  – + + – 
ZAP1117_S9  – – – – 
ZAP1118_S10  – + + + 
ZAP1119_S11  – + + + 
ZAP1120_S12  – + + – 
ZAP1152_S35 1, 2 + + + 
ZAP1153_S36 1, 2 + + + 
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Table 3.7 continued 
  LEE  
Isolate vtxb eae sepL hlyA 
ZAP1121_G13 – + + – 
ZAP1122_G14  1, 2 + + + 
ZAP1123_G15 1 + + – 
ZAP1124_G16 1 + + – 
ZAP1125_G17 – + + + 
ZAP1126_G18 1, 2 + + – 
ZAP1127_G19 1 + + + 
ZAP1128_G20  2 + + + 
ZAP1129_G21  1, 2 + + – 
ZAP1130_G22 1, 2 + + + 
ZAP1131_G23  1 + + – 
ZAP1132_G24  2 + + – 
ZAP1133_G25 – + + – 
ZAP1134_G26  2 + + + 
ZAP1135_G27  – + + + 
ZAP1136_G28  2 + + + 
ZAP1146_I29 1 + + + 
ZAP1147_I30 2 + + + 
ZAP1149_I32 2 + + + 
ZAP1150_I33 2 + + + 
ZAP1151_I34 1 + + + 
a +, gene present; –, gene absent. 





The vast majority (95%) of the E. coli O26 isolates examined carried the LEE 
pathogenicity island.  Only three isolates did not harbour the LEE; one was isolated 
from a patient in Scotland and two were isolated from Scottish cattle.  To determine 
if the LEE is inserted in the pheU tRNA gene, as in E. coli O26 isolate 413/89-1, 
PCRs were performed on all LEE-positive isolates using primer pairs that link the 5’ 
and 3’ ends of the island with the adjacent region of pheU.  Primer pair cad1-LS1 
(Table 2.2) amplifies the left junction of the pathogenicity island inserted into pheU, 
producing a 947 bp amplicon, and primer pair espB73-espB52 (Table 2.2) amplifies 
the right junction of the island inserted into pheU, yielding a 1.48 kb product.  
Amplicons of the expected size were obtained in both of these PCRs for the majority 
of the E. coli O26 isolates examined.  However, for some of the isolates, only one 
junction of the LEE inserted in pheU was positive by PCR.  This may be explained 
by variation in the DNA sequence at the ends of the LEE between isolates.  This 
analysis demonstrated that in LEE-positive E. coli O26 isolates the LEE 
pathogenicity island is always inserted in pheU.  The insertion of LEE in pheU was 
confirmed in each of these isolates by the absence of a product in the PCR, using 
primer pair cad1-espB52, designed to span intact pheU. 
 
Forty seven (75%) of the 63 E. coli O26 isolates analysed possessed the hlyA gene.  
Of the LEE-positive VTEC O26 isolates, 100% of Scottish human isolates, 67% of 
European human isolates and 100% of Scottish cattle isolates carried hlyA. 
 
The carriage of virulence genes by E. coli O26 isolated from patients suffering from 
different forms of clinical disease is shown in Table 3.8.  The majority (9/14, 64%) 
of the isolates associated with diarrhoea were vtx-negative.  Of the five VTEC O26 
isolates associated with diarrhoea, four possessed the vtx1 gene alone and only one 
isolate carried both vtx1 and vtx2.  No isolate associated with diarrhoea harboured the 
vtx2 gene alone.  The three isolates associated with bloody diarrhoea or haemorrhagic 
colitis had different Vtx genotypes.  While one isolate carried vtx2 alone and one 
possessed both vtx1 and vtx2, the third isolate was vtx-negative.  Every E. coli O26 
isolate associated with HUS was vtx-positive and harboured either vtx1, vtx2 or vtx1 in 
combination with vtx2.  The LEE was detected in 93% of isolates associated with 
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diarrhoea and 100% of isolates associated with bloody diarrhoea, haemorrhagic 
colitis and HUS.  The hlyA gene was present in 9/14 isolates associated with 
diarrhoea, 2/3 isolates associated with bloody diarrhoea or haemorrhagic colitis and 
8/12 isolates associated with HUS.          
 
 
Table 3.8. Prevalence of virulence genes among E. coli O26 isolates associated 
with different forms of clinical disease. 
 
Number of isolates positive Clinical 
forma 
Number 
of isolates vtx1 vtx2 vtx1vtx2 vtx neg LEE hly 
Diarrhoea  14 4  0 1  9  13  9  
BD/HC 3 0 1  1  1  3  2  
HUS  12 3 5  4  0 12 8  
Cattle  33 16 0 7 10  31 27 




The virulence genes carried by E. coli O26 isolates belonging to different MLST STs 
is detailed in Table 3.9.  All but one of the 40 ST21 isolates analysed were vtx-
positive and the closely related ST574 strain harboured vtx1.  The vast majority 
(16/18, 89%) of the ST29 isolates did not possess a vtx gene; the two exceptions to 
this were isolates recovered from patients in Germany which contained the vtx2 gene.  
The ST575 isolate which was most closely related to ST29 strains was also vtx-
negative.  The three E. coli O26 isolates which belonged to ST complex 10 were the 
only strains analysed which did not contain the LEE pathogenicity island.  While the 





Table 3.9. Prevalence of virulence genes among E. coli O26 isolates belonging to 
different MLST STs. 
 





isolates vtx1 vtx2 vtx1vtx2 vtx neg LEE hly 
21 29 40 22  4  13  1  40  34  
29 29 18 0 2  0 16  18  11  
574 29 1 1  0 0 0 1  1  
575 29 1 0 0 0 1  1  1  
10 10 2 0 0 0 2  0 0 
986 10 1 1  0 0 0 0 0 
 
 
The carriage of vtx genes by E. coli O26 isolates possessing different sequences for 
the region upstream of LEE1 is shown in Table 3.10.  Statistical analysis found 
strong evidence of an association (p < 0.001) between the carriage of vtx genes and 
the nucleotide sequence for the region upstream of LEE1.  Although similar numbers 
of isolates carrying allele 1 for the region upstream of LEE1 were vtx-positive and 
vtx-negative (12/23 and 11/23, respectively), allele 2 was only discovered in vtx-
positive isolates and the less common alleles (alleles 3, 4, 5 and 6) were only 
detected in vtx-negative isolates. 
 
It is interesting to note that while all (5/5) of the vtx-positive Scottish human isolates 
and the vast majority (20/22, 91%) of the vtx-positive Scottish cattle isolates carried 
allele 2, only a limited number (5/15, 33%) of the vtx-positive isolates from patients 
in continental Europe harboured this allele (Table 3.10).  The majority (10/15, 67%) 






Table 3.10. Prevalence of verocytotoxin genes among E. coli O26 isolates 
possessing different sequences for the region upstream of LEE1. 
 
 
Number of isolates positive 
Allele number for region 
upstream of LEE1, 
origin of isolate 
Number 
of 
isolates vtx1 vtx2 vtx1vtx2 vtx neg 
Allele 1 23 3 5 4 11 
 Human (Scotland) 2 0 0 0 2 
 Human (cont. Europe) 14 3 5 2 4 
 Cattle 7 0 0 2 5 
       
Allele 2 30 20 1 9 0 
 Human (Scotland) 5 3 0 2 0 
 Human (cont. Europe) 5 2 1 2 0 
 Cattle 20 15 0 5 0 
       
Allele 3 1 0 0 0 1 
 Cattle 1 0 0 0 1 
       
Allele 4 4 0 0 0 4 
 Human (Scotland) 1 0 0 0 1 
 Cattle 3 0 0 0 3 
       
Allele 5 1 0 0 0 1 
 Human (Scotland) 1 0 0 0 1 
       
Allele 6 1 0 0 0 1 
 Human (Scotland) 1 0 0 0 1 
 
 
3.3.1 Summary of virulence gene carriage results 
The majority of E. coli O26 isolates recovered from patients in Scotland were vtx-
negative but among those which were vtx-positive, only the carriage of vtx1 alone or 
vtx1 in combination with vtx2 was detected.  No Scottish human isolate carried the 
vtx2 gene alone.  Among the isolates recovered from patients in continental Europe, 
all combinations of vtx gene carriage were observed (vtx1 alone, vtx2 alone, vtx1 and 
vtx2 and vtx-negative).  Among the isolates recovered from Scottish cattle the 
presence of the vtx1 gene alone and vtx1 with vtx2 was detected.  No Scottish cattle 
isolate carried vtx2 alone.  The vast majority of E. coli O26 isolates carried the LEE 




Although the majority of isolates associated with diarrhoea were vtx gene negative, 
isolates which carried either vtx1 alone or both vtx1 and vtx2 were also detected.  No 
isolate associated with diarrhoea possessed vtx2 alone.  In contrast, every isolate 
associated with HUS was vtx-positive and harboured either vtx1 alone, vtx2 alone or 
vtx1 in combination with vtx2.  
 
In general, E. coli O26 isolates that belonged to MLST ST21 were vtx gene positive 
and those that belonged to ST29 were vtx-negative.  E. coli O26 that did not contain 
the LEE were genetically distant to the LEE-positive isolates.  Isolates which carried 
allele 1 for their sequence of the region upstream of LEE1 were either vtx-positive or 
vtx-negative whereas those which carried allele 2 were vtx-positive and those which 
carried alleles 3, 4, 5 or 6 were vtx-negative.  The majority of vtx-positive isolates 
recovered in Scotland, from both human and bovine hosts, carried allele 2 for their 
sequence of the region upstream of LEE1 whereas the majority of vtx-positive 




3.4 Carriage of tccP and tccP2 by E. coli O26 isolates 
The ability of E. coli strains to colonise the intestinal mucosa via the formation of 
attaching and effacing (A/E) lesions is important for their pathogenicity.  A 
characteristic feature of the A/E lesion is the formation of an actin-rich pedestal-like 
structure in the host cell underneath intimately attached bacteria (Kaper et al., 1998).  
Until recently, it was considered that EPEC and EHEC induce actin polymerisation 
by distinct mechanisms.  A detailed description of the actin polymerisation pathways 
in EPEC and EHEC is given in section 1.7.2.2.1.  Briefly, actin polymerisation by 
EPEC O127:H6 requires tyrosine (Y474) phosphorylation of Tir and subsequent 
recruitment of the N-WASP activator protein, Nck, whereas actin polymerisation by 
EHEC O157:H7 utilises the N-WASP activator TccP.  The gene tccP is carried on 
prophage CP-933U/Sp14 and TccP consists of a unique 80 amino acid amino-
terminal region and several almost identical 47 amino acid proline-rich repeats 
(PRRs) (Campellone et al., 2004; Garmendia et al., 2006).  TccP2 is functionally 
equivalent to TccP and the gene which encodes it (tccP2) has been found in SF 
EHEC O157:NM and the majority of non-O157 EHEC (serogroups O26, O103, 
O111, O121 and O145) (Ogura et al., 2007). 
 
The importance of TccP and TccP2 in actin polymerisation and subsequent A/E 
lesion formation prompted an investigation of the carriage of tccP and tccP2 in E. 
coli O26 isolates, with the aim to determine whether the possession of these genes 
was associated with the ability of E. coli O26 to cause more serious clinical disease.  
In addition, it also allowed an investigation of whether there was a difference in the 
distribution of tccP and tccP2 between cattle and human isolates. 
 
The presence of tccP and tccP2 genes in the 63 E. coli O26 isolates was determined 
by PCR.  The detection of both tccP and tccP2 gene sequences was achieved using a 
universal primer pair.  Universal primers found that the majority (62%) of the 
isolates analysed were positive for tccP/tccP2.  Single amplicons, which varied in 
size between isolates, were observed for all tccP/tccP2-positive isolates, with the 




The specific detection of tccP and tccP2 was achieved using gene-specific primers.  
All isolates which were positive for universal tccP/tccP2 were found to be negative 
for tccP and positive for tccP2.  The tccP2 amplicons exhibited variation in size, 
ranging from approximately 750 bp to 1,400 bp (Table 3.11).  On a few occasions, 
two products were observed following PCR of tccP2.  Generally, there was always a 
prominent band and a second, much fainter, band.  The fainter band was probably the 
consequence of non-specific primer annealing and so only the size of the prominent 
band was recorded.  Isolate ZAP1125_G17 was the exception to this in that tccP2 
PCR generated two well-defined products of equal intensities.  It is likely that 
ZAP1125_G17 possesses two copies of tccP2 with different numbers of PRRs.  It 
should be noted that due to sequence variation, the primers used in this screen might 
not amplify all the tccP/tccP2 variants. 
 
The three isolates that were LEE-negative (ZAP1087_B11, ZAP1104_B28 and 
ZAP1117_S9) did not carry the tccP2 gene (Table 3.11) and were omitted from 
further analysis in this section.  Analysis of the sixty LEE-positive E. coli O26 found 
that while only half (5/10) of the isolates recovered from patients in Scotland 
possessed the gene encoding TccP2, the vast majority (17/19, 89%) of isolates 
recovered from patients in continental Europe harboured this gene.  Among the 31 
LEE-positive Scottish cattle isolates analysed, only 17 (55%) carried the tccP2 gene 
(Table 3.11).  Analysis of tccP2 amplicon size in relation to the origin of the isolate 
found that tccP2-positive E. coli O26 isolated in continental Europe possessed only 
the smaller variants of tccP2 (750 bp, 850 bp and 900 bp) (Table 3.11).  None of the 
tccP2-positive Scottish clinical isolates harboured the 750 bp or 850 bp tccP2 
variants; they generally carried a larger tccP2 gene (ranging from 900 bp to 1,400 
bp) (Table 3.11).  tccP2 amplicon sizes from the Scottish cattle isolates were 








Table 3.11. PCR detection of tccP2 among E. coli O26 isolates. 
 
Isolate tccP2a  Isolate tccP2a 
ZAP1077_B1 + (1050bp)  ZAP1111_S2 – 
ZAP1078_B2 –  ZAP1112_S3 + (900bp) 
ZAP1079_B3 –  ZAP1114_S6 – 
ZAP1080_B4 + (750bp)  ZAP1115_S7 – 
ZAP1081_B5 + (750bp)  ZAP1116_S8 + (1050bp) 
ZAP1082_B6 + (1050bp)   ZAP1117_S9 – 
ZAP1083_B7 –  ZAP1118_S10 + (950bp) 
ZAP1084_B8 –  ZAP1119_S11 + (1250bp) 
ZAP1085_B9 –  ZAP1120_S12 + (1400bp) 
ZAP1086_B10 –  ZAP1152_S35 – 
ZAP1087_B11 –  ZAP1153_S36 – 
ZAP1088_B12 –  ZAP1121_G13 + (900bp) 
ZAP1089_B13 + (750bp)  ZAP1122_G14 + (750bp) 
ZAP1090_B14 + (1050bp)   ZAP1124_G16 + (750bp) 
ZAP1091_B15 + (750bp)  ZAP1125_G17 + (900bp, 750bp) 
ZAP1092_B16 + (900bp)  ZAP1126_G18 + (750bp) 
ZAP1093_B17 –  ZAP1127_G19 + (750bp) 
ZAP1094_B18 –  ZAP1128_G20 + (850bp) 
ZAP1095_B19 + (750bp)  ZAP1129_G21 + (750bp) 
ZAP1096_B20 + (1050bp)  ZAP1130_G22 + (750bp) 
ZAP1097_B21 –  ZAP1131_G23 + (750bp) 
ZAP1098_B22 + (750bp)  ZAP1132_G24 – 
ZAP1099_B23 + (1050bp)  ZAP1133_G25 + (900bp) 
ZAP1100_B24 –  ZAP1134_G26 + (900bp) 
ZAP1101_B25 + (750bp)  ZAP1135_G27 + (900bp) 
ZAP1102_B26 + (1050bp)  ZAP1146_I29 – 
ZAP1103_B27 + (750bp)  ZAP1147_I30 + (900bp) 
ZAP1104_B28 –  ZAP1149_I32 + (900bp) 
ZAP1105_B29 + (750bp)  ZAP1150_I33 + (900bp) 
ZAP1106_B30 –  ZAP1151_I34 + (750bp) 
ZAP1107_B31 –    
ZAP1108_B32 + (750bp)    
ZAP1109_B33 –    




The carriage of tccP2 by E. coli O26 isolated from patients suffering from different 
forms of clinical disease is shown in Table 3.12.  There was no evidence of an 
association between the possession of tccP2 and the ability of E. coli O26 to cause 
more serious clinical disease.  The majority (22/28, 79%) of clinical isolates carried 
tccP2, regardless of the severity of disease elicited (Table 3.12).  
 
 
Table 3.12. Prevalence of tccP2 among E. coli O26 isolates associated with 
different forms of clinical disease. 
 
Clinical forma Number of isolates Number of isolates 
positive for tccP2 
Diarrhoea 13 10 
Bloody Diarrhoea/HC 3 2 
HUS 12 10 
Cattle 31 17 
a HC, haemorrhagic colitis; HUS, haemolytic uraemic syndrome. 
 
 
The carriage of tccP2 by isolates with different Vtx genotypes recovered from 
different origins is detailed in Table 3.13.  Notably, 100% of the vtx-negative 
isolates, regardless of country of origin or host, carried the tccP2 gene (Table 3.13).  
Interestingly, while none of the five VTEC O26 isolates recovered from clinical 
cases in Scotland possessed tccP2, the majority (13/15, 87%) of VTEC O26 isolated 
from patients in continental Europe carried this gene (Table 3.13).  Among the 22 
VTEC O26 isolates recovered from Scottish cattle only eight (36%) harboured tccP2; 
seven of these isolates possessed vtx1 alone and only one carried vtx1 in combination 
with vtx2 (Table 3.13). 
 
Investigation of the carriage of tccP2 by E. coli O26 isolates possessing different 
sequences for the region upstream of LEE1 found strong evidence of an association 
(p < 0.001) between the two.  The vast majority (21/23, 91%) of isolates carrying 
allele 1 for the region upstream of LEE1 harboured the tccP2 gene and all of the 
isolates carrying alleles 3, 4, 5 or 6 contained this gene.  In contrast, the majority 
(19/30, 63%) of isolates carrying allele 2 did not possess tccP2. 
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Table 3.13. Prevalence of tccP2 among E. coli O26 isolates from different origins 
with different verocytotoxin genotypes. 
 
Origin of isolate,  
verocytotoxin genotype 
Number of isolates Number of isolates 
positive for tccP2 
Human (Scotland)   
 vtx neg 5 5 
 vtx1 3 0 
 vtx1vtx2 2 0 
    
Human (continental Europe)   
 vtx neg 4 4 
 vtx1 5 4 
 vtx2 6 5 
 vtx1vtx2 4 4 
    
Cattle   
 vtx neg 9 9 
 vtx1 15 7 
 vtx1vtx2 7 1 
 
 
3.4.1 Tir typing of E. coli O26 isolates 
In addition to examining the carriage of tccP and tccP2 among the E. coli O26 
isolates, it was also determined whether the isolates possess an EHEC O157:H7 
(EDL933)-like Tir (that is, a serine at reside 478) or an EPEC O127:H6 (E2348/69)-
like Tir that can undergo tyrosine (Y474) phosphorylation and utilise the Nck actin 
polymerisation pathway.  Discriminatory PCR, using gene-specific forward primers 
with a conserved reverse primer, revealed that all E. coli O26 isolates contained an 
EPEC-like Tir.   
 
3.4.2 Summary of tccP / tccP2 carriage results 
None of the E. coli O26 isolates carried the tccP gene whereas the majority (62%) 
harboured tccP2.  The three LEE-negative isolates did not possess the tccP2 gene.  
tccP2 exhibited size polymorphism among the isolates and it appeared that E. coli 
O26 isolates from patients in continental Europe carried smaller variants than those 




There was no evidence of an association between the carriage of tccP2 and the 
ability to cause more serious clinical disease.  All of the vtx-negative isolates, 
regardless of country of origin or host, carried tccP2.  None of the VTEC O26 
isolates from patients in Scotland harboured tccP2 whereas the majority of such 
isolates recovered from patients in continental Europe carried this gene.  Only 36% 





VTEC serogroup O26 is an important human pathogen in continental Europe, 
frequently being associated with life-threatening HUS (Caprioli et al., 1997; Gerber 
et al., 2002; Tozzi et al., 2003; Zhang et al., 2000).  This is in contrast to the 
situation in Scotland and the rest of the United Kingdom where human infections 
associated with E. coli O26 are uncommon and are generally associated with simple 
diarrhoea.  The finding that VTEC O26 strains are common and widely dispersed in 
Scottish cattle (Pearce et al., 2006) is concerning if these have the potential to cause 
serious human disease.  This study characterised E. coli O26 isolates from different 
backgrounds with two main objectives.  Firstly, the study investigated E. coli O26 
isolates from human infections of varying severity in an attempt to identify 
characteristics that allow these strains to cause more serious disease.  This analysis 
included the majority of E. coli O26 isolates recovered from patients in Scotland, 
most of which were associated with simple diarrhoea, and a selection of isolates from 
patients in Germany and Italy, deliberately chosen because they possessed various 
combinations of virulence genes and were associated with different clinical forms of 
disease, including HUS.  Secondly, the study compared E. coli O26 isolates from 
cattle in Scotland to those recovered from human infections to investigate the 
potential of Scottish cattle isolates to cause human disease.  The cattle isolates 
examined were from a previous study (Pearce et al., 2006) and were selected because 
they possessed different combinations of virulence genes.  Among those deliberately 
chosen, the majority carried the gene(s) for verocytotoxin as these are considered to 
be more pathogenic.  This chapter described the genotypic characterisation of E. coli 
O26 isolates by MLST and the presence of virulence genes to identify genetic traits 
which may allow these strains to cause more serious clinical disease. 
  
The genetic relationship between the 63 E. coli O26 isolates from different 
backgrounds was analysed by MLST and further genetic analysis of the isolates was 
achieved by PCR detection of virulence genes.  MLST revealed two genetically 
distant clones among the collection of E. coli O26 isolates.  While the vast majority 
of isolates belonged to ST complex 29, three of the isolates grouped into a different 
ST complex, ST complex 10.  Interestingly, these three isolates were shown to be 
98 
 
LEE-negative and were close evolutionary relatives to the non-pathogenic E. coli   
K-12 MG1655.  It is possible that these isolates acquired the O26 O-antigen gene 
cluster by homologous recombination since previous research has shown that O-
antigen gene clusters of different E. coli strains have conserved flanking regions 
(Wang & Reeves, 1998).  Such a recombination event has been proposed to account 
for strains with very similar genotypes but different serotypes (Adiri et al., 2003; 
Coffey et al., 1998; Stine et al., 2000).  This demonstrates that the O serogroup 
cannot be considered as an indicator of genetic relatedness for E. coli.  Furthermore, 
we should be cautious to draw conclusions about the pathogenic potential of E. coli 
O26 strains based on their serogroup alone.   
 
The majority of the E. coli O26 isolates examined only differed by a single 
nucleotide in the adk locus and were resolved into two STs, ST21 and ST29.  Despite 
the close genetic relationship between strains of ST21 and ST29, strains belonging to 
ST21 may have an increased likelihood of causing serious disease following human 
infection.  This is interesting since previous research has found an association 
between MLST genotype and virulence potential.  The majority of cases of invasive 
meningococcal disease are attributed to a small number of hypervirulent clones of N. 
meningitidis (Jolley et al., 2000; Maiden et al., 1998) and certain clones of S. 
pneumoniae appear to be more virulent than others, although the close correlation 
between MLST genotype and serotype means it is possible that serotype was a more 
important marker of virulence potential than genotype in this instance (Brueggemann 
et al., 2003).  These results are in contrast to a study of S. aureus which found no 
evidence of a correlation between MLST genotype and virulence potential (Feil et 
al., 2003).  
 
The finding that ST21 isolates may have a greater virulence potential is perhaps not 
surprising since the principal marker of strains belonging to ST21 was the possession 
of the vtx gene (either vtx1, vtx2 or vtx1 and vtx2 in combination), characterising them 
as typical VTEC.  Only one isolate which was negative for vtx was grouped with 
these VTEC strains by MLST.  It is possible that this isolate (which was recovered 
from a patient in Germany) lost its phage-borne vtx gene(s) during the course of 
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infection since previous studies observed a rapid loss of vtx in a subset of EHEC 
strains during the course of HUS (Bielaszewska et al., 2007; Mellmann et al., 2005; 
Mellmann et al., 2008).  However, it is also possible that this strain lost vtx during 
subculture as reported for other VTEC (Bielaszewska et al., 2007; Karch et al., 1992; 
Schmidt et al., 1999b). 
 
In this study, the E. coli O26 strains belonging to ST29 were generally vtx-negative 
and were thus characterised as atypical EPEC (aEPEC).  The two exceptions to this 
were vtx2-positive isolates recovered from patients in Germany.  It is possible that 
these strains were aEPEC but recently acquired the vtx2 phage since the ability of 
aEPEC to gain vtx2-harbouring bacteriophages has been demonstrated previously 
(Bielaszewska et al., 2007).  The association between vtx gene carriage and the 
separation of E. coli O26 isolates into ST21 and ST29 observed in this study was 
corroborated by investigation of the E. coli MLST database 
(http://mlst.ucc.ie/mlst/dbs/Ecoli).  Analysis of the E. coli O26 strains that had their 
“pathogen type” entered when they were submitted to the database revealed that 75% 
(9 of 12) of the strains belonging to ST21 were classified as EHEC or VTEC and 
92% (11 of 12) of the ST29 strains were EPEC.   
 
MLST analysis in this study identified minimal variation in the nucleotide sequences 
of housekeeping genes among E. coli O26 isolates.  Variations in nucleotide 
sequence of housekeeping genes have been observed previously among E. coli O78 
strains (Adiri et al., 2003) and among strains within a single serotype of other 
bacterial species (Feil et al., 2000; Maiden et al., 1998; Stine et al., 2000).  However, 
a previous study performed MLST on strains of E. coli O26:H11 and found very 
little genetic diversity (Gilmour et al., 2005).  This result is likely to be due to the 
fact that all of the strains analysed were isolated from human patients and harboured 
vtx1 alone, with the exception of one strain which carried vtx1 and vtx2.  Interestingly, 
MLST does not identify any sequence variation in housekeeping genes of E. coli 
O157:H7 isolates.  MLST analysis on 77 E. coli O157:H7 isolates demonstrated that 
all strains had identical sequences for the seven housekeeping genes examined 
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(Noller et al., 2003).  Furthermore, all E. coli O157:H7 strains in the E. coli MLST 
database have an identical allelic profile and belong to ST11 (Wirth et al., 2006).  
 
Nucleotide sequencing of housekeeping genes found very little genetic variation in 
the genomic ‘backbone’ among the majority of E. coli O26 isolates, which 
corroborates the findings of Anjum et al. (2003).  This indicated that closely related 
strains reside in patients from different countries and in different hosts.  To look for 
greater genetic discrimination of the isolates, the nucleotide sequence of two 
additional targets, which may have a higher degree of diversity, was determined.  
Although the nucleotide sequences of espA in all but one of the E. coli O26 isolates 
were identical, differences in the sequence of the region upstream of LEE1 were 
identified.  The six different sequences discovered were assigned allele numbers 1 to 
6.  Alleles 1 and 2 were the most prevalent among the isolates and were carried by 
38% and 50% of the isolates, respectively.  The observations that allele 2 was only 
discovered in isolates belonging to MLST ST21 (or the closely related ST574); 
alleles 3 to 6 were only detected in isolates belonging to ST29; and allele 1 was 
present in both ST21 and ST29 isolates correlated with the results of vtx gene 
carriage by isolates possessing different alleles for the region upstream of LEE1.  
That is, while allele 2 was only detected in vtx-positive isolates and alleles 3 to 6 
were only discovered in vtx-negative isolates, isolates carrying allele 1 were either 
vtx-positive or vtx-negative. 
 
Importantly, the nucleotide sequences for the region upstream of LEE1 begin to 
differentiate E. coli O26 isolates recovered from different backgrounds.  While the 
majority of human isolates recovered in continental Europe carried allele 1, most of 
the isolates from patients and cattle in Scotland harboured allele 2.  Notably, all of 
the vtx-positive Scottish human isolates and the vast majority of the vtx-positive 
Scottish cattle isolates carried allele 2.  Only vtx-negative isolates recovered from 
patients and cattle in Scotland and two vtx-positive cattle isolates were found to 
possess allele 1.  In contrast, only a small number of the vtx-positive isolates from 
patients in continental Europe carried allele 2.  The majority of all human isolates 
from continental Europe harboured allele 1. 
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Since MLST found little genetic variation in the genomic ‘backbone’ among the 
majority of E. coli O26, the differences in pathogenic potential between isolates is 
presumed to be a consequence of additional virulence genes that have inserted into 
their genome.  Indeed, PFGE analysis has proven that there is considerable 
heterogeneity in the O26 genome (L. Allison, personal communication; Zhang et al., 
2000).  Therefore, the presence of the genes encoding the virulence factors Vtx1, 
Vtx2, LEE and enterohaemolysin was determined for each E. coli O26 isolate by 
PCR, and associations between the virulence factors possessed and the severity of 
disease elicited by the human isolates were considered.  The production of Vtx is a 
major virulence determinant of E. coli strains.  The majority of the isolates associated 
with diarrhoea were vtx-negative.  Of the five isolates which were vtx-positive, four 
possessed the vtx1 gene alone and only one isolate carried both vtx1 and vtx2.  No 
isolate associated with diarrhoea harboured the vtx2 gene alone.  All of the isolates 
associated with HUS were vtx-positive; 3/12 possessed vtx1 alone, 5/12 possessed 
vtx2 alone and 4/12 possessed vtx1 and vtx2.  While a reasonable number of the 
isolates associated with HUS carried vtx1 as their sole vtx gene this is not 
representative of the situation at large.  Two of the three isolates originated from 
Italy although very few Vtx1-producing strains have ever been isolated from cases of 
human infection, particularly from severe cases, in Italy (S. Morabito, personal 
communication).  These isolates were originally included in this study to identify 
additional factor(s) possibly responsible for their increased pathogenicity.  It was not 
possible to perform statistical analysis on these results since the European isolates 
were deliberately chosen because they possessed different combinations of vtx genes 
associated with different forms of disease.  However, previous research has shown 
that the presence of the vtx2 gene in the infecting strain is strongly associated with 
severe disease in humans (Boerlin et al., 1999; Brooks et al., 2005; Friedrich et al., 
2002).  Furthermore, the administration of purified Vtx2, but not of Vtx1, has been 
shown to cause HUS in experimentally treated primates (Siegler et al., 2003). 
 
A further virulence factor of certain E. coli strains is the presence of the LEE 
pathogenicity island which carries the genes required for the formation of A/E 
lesions.  Carriage of the LEE was determined by detecting two genes encoded on 
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separate operons within the pathogenicity island (eae in the LEE5 operon and sepL in 
the LEE4 operon).  There was an absolute correlation between the presence of eae 
and the presence of sepL, suggesting that either gene could be used alone when 
determining the carriage of the LEE.  A previous study corroborates this finding by 
showing an absolute correlation between the presence of eae and the presence of 
eight other genes of the LEE (Bertin et al., 2004).  The LEE was present in all but 
one of the human isolates analysed, recovered from patients suffering from disease of 
varying severity, ranging from simple diarrhoea to life-threatening HUS.  A close 
association between infections with LEE-positive VTEC and severe disease in 
humans has been demonstrated previously (Boerlin et al., 1999; Jenkins et al., 2003).  
However, it has also been shown that certain LEE-negative strains of VTEC were 
associated with bloody diarrhoea and HUS (Boerlin et al., 1999; Bonnet et al., 1998), 
indicating that the LEE is not essential for the virulence of certain VTEC for humans. 
 
The hlyA gene was detected in 9/14 isolates associated with diarrhoea, 2/3 isolates 
associated with bloody diarrhoea or haemorrhagic colitis and 8/12 isolates associated 
with HUS.  This suggests that enterohaemolysin is not a major virulence factor 
involved in severe human disease.  Similarly, a previous study found no association 
between the presence of the hly gene and HUS (Jenkins et al., 2003).  However, 
enterohaemolysin from vtx-negative E. coli O26 isolates associated with HUS was 
shown to be responsible for the microvascular endothelial cell cytotoxicity of these 
strains (Aldick et al., 2007).  This suggested that enterohaemolysin may also cause 
endothelial damage during infection and contribute to the progression to HUS 
(Aldick et al., 2007).  In addition, patients suffering from HUS have been shown to 
have a specific immune response against enterohaemolysin (Schmidt et al., 1995).   
 
Since one of the isolates, recovered from a patient in Scotland suffering from 
diarrhoea, did not possess any of the virulence factors screened for, it suggests that 
occasionally the disease process may involve the possession of unknown virulence 




The ability of E. coli strains to form A/E lesions contributes to their pathogenicity by 
promoting colonisation of the intestinal mucosa.  A characteristic feature of the A/E 
lesion is the formation of an actin-rich pedestal-like structure in the host cell 
underneath the membrane at the site of attachment.  Until recently, it was widely 
believed that EHEC and EPEC induce actin polymerisation by distinct mechanisms.  
Tir EPEC O127:H6 requires tyrosine (Y474) phosphorylation and the N-WASP 
activator protein Nck, whereas Tir EHEC O157:H7 utilises the N-WASP activator 
TccP.  However, analysis of a large number of non-O157 EHEC and EPEC strains 
has broken the prevailing dogma and it appears that many EPEC and EHEC strains 
have the ability to use both the Nck and TccP pathways to trigger actin 
polymerisation (Garmendia et al., 2005b; Ogura et al., 2007; Ooka et al., 2007; 
Whale et al., 2006; Whale et al., 2007).  TccP2 is functionally equivalent to TccP 
and the gene which encodes TccP2 (tccP2) has been detected in SF EHEC O157:NM 
and the majority of non-O157 EHEC (serogroups O26, O103, O111, O121 and 
O145) (Ogura et al., 2007).   
 
This study found all LEE-positive E. coli O26 isolates contained an EPEC-like Tir so 
presumably triggering actin polymerisation using the Nck pathway, although 
functional studies would need to be done to confirm this.  The carriage of tccP and 
tccP2 among the LEE-positive isolates was determined by PCR.  None of the sixty 
isolates contained the tccP gene.  Although sequence variation could explain why the 
primers may not amplify all tccP variants, it should be noted that the primers used 
have successfully amplified tccP from E. coli O26 in a previous study (Garmendia et 
al., 2005b).  Indeed, Garmendia et al. (2005b) found tccP in 5 of 27 (18.5%) EHEC 
O26 strains analysed, although none of the eleven EPEC O26 isolates examined 
carried the gene.   
 
The majority (65%) of the LEE-positive E. coli O26 isolates investigated in this 
study contained tccP2.  As has been noted in previous studies, tccP2 exhibited size 
polymorphism among the isolates analysed, ranging from 750 bp to 1,400 bp.  
Different sized tccP2 genes are likely to encode polypeptides which vary in the 
number of PRRs.  Generally, it appeared that E. coli O26 isolates from clinical cases 
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in continental Europe contained smaller tccP2 variants than those isolated from 
patients in Scotland.  A previous study showed similar results in that the VTEC O26 
of human origin isolated in the UK carried a larger tccP2 variant (1,200 bp) than 
isolates recovered in continental Europe (1,050 bp and smaller) (Ogura et al., 2007).  
A recent functional study has shown that, although TccP consisting of the N-terminal 
translocation domain and two PRRs is both necessary and sufficient for actin 
polymerisation, there is a direct correlation between the number of PRRs and the 
affinity of TccP to N-WASP (Garmendia et al., 2006).  However, it is presently not 
known if there is an association between the number of PRRs and the efficiency of 
actin pedestal formation during infection. 
 
It is interesting to note that one of the isolates (ZAP1125_G17) appeared to carry two 
copies of tccP2, which differed in the number of PRRs they encode.  Although such 
an observation has not been reported previously, it is possible that other strains 
investigated harbour multiple copies of the gene which are the same size and will not 
be distinguished by PCR.  Southern blotting could be employed to determine the 
number of copies of tccP2 carried by the isolates. 
 
The majority (79%) of the clinical isolates carried tccP2 but there was no evidence of 
an association between the carriage of tccP2 and the ability to cause more serious 
clinical disease.  This is in part due to the fact that a large number of the diarrhoea 
cases were associated with aEPEC isolates and this study found that 100% of the 
aEPEC isolates carried the tccP2 gene.  A previous study looking at a larger number 
of isolates also revealed that the vast majority (82%) of aEPEC O26 harboured tccP2 
(Ooka et al., 2007).  aEPEC are likely to rely on A/E lesion formation as a major 
virulence trait.  Therefore, it may be advantageous for the bacterium to express 
TccP2 if co-translocation of Tir with its adaptor protein increases the efficiency of 
A/E lesion formation and colonisation, as has been suggested previously (Garmendia 
et al., 2005b).  It is interesting that the carriage of tccP2 is different between VTEC 
O26 clinical isolates from Scotland and continental Europe.  None of the VTEC O26 
isolates recovered from humans in Scotland harboured tccP2, whereas the majority 
(87%) of VTEC O26 isolated from clinical cases in continental Europe carried the 
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gene.  It is possible that the tccP2-negative Scottish clinical VTEC O26 isolates 
belong to a particular “Scottish” clone because previous examination of a single 
VTEC O26 of human origin isolated in the UK revealed that it was tccP2 positive 
(Ogura et al., 2007).  The possession of tccP2 by the majority of VTEC O26 isolates 
recovered in Germany and Italy corroborates previous findings (Ogura et al., 2007). 
 
It is interesting to note that there is an association between the carriage of tccP2 by 
E. coli O26 isolates and the nucleotide sequence for the region upstream of LEE1.  
The fact that almost all of the isolates carrying allele 1 for the region upstream of 
LEE1 harboured tccP2 can be explained by the fact allele 1 is carried by many of the 
vtx-negative isolates and the majority of European human isolates, both of which 
have been found to be associated with the carriage of tccP2.  Furthermore, the fact 
that all of the isolates carrying alleles 3, 4, 5 or 6 harboured tccP2 is likely to be due 
to the fact that these alleles are only carried by vtx-negative isolates.  Finally, the fact 
that the majority of isolates carrying allele 2 did not possess tccP2 can be explained 
by the fact allele 2 is carried by all VTEC O26 from patients in Scotland and the 
majority of VTEC O26 from Scottish cattle, both of which generally lack the tccP2 
gene.     
 
Molecular typing data suggests that the majority of VTEC O26 from clinical cases in 
continental Europe and all aEPEC O26, regardless of background, have the potential 
to trigger actin polymerisation by both the Nck and TccP2 pathways.  However, 
functional studies would need to be done to confirm this.  The ability of E. coli O26 
isolates to be bimodal for actin polymerisation confirms the importance of A/E lesion 
formation to these pathogens and perhaps the possession of TccP2 may offer these 
strains a competitive advantage in the environment, facilitating their survival and 
transmission. 
 
The fact that the majority of the E. coli O26 isolates recovered from patients in 
Scotland were vtx-negative or carried vtx1 alone begins to explain why, in Scotland, 
human infections associated with E. coli O26 generally only result in simple 
diarrhoea.  In continental Europe, the occurrence of E. coli O26 strains which 
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harbour vtx2, either alone or in combination with vtx1, serves as one explanation why 
it is experiencing serious human infection.  Although MLST analysis identified that 
the E. coli O26 isolates associated with human infection in Scotland and continental 
Europe were very closely related, the importance of vtx genes in strains associated 
with severe human disease indicates that the ability of strains to cause serious human 
infection depends more on horizontally acquired DNA than on the vertically 
inherited genotype. 
 
Furthermore, despite the initial observation that E. coli O26 isolates recovered from 
patients in Scotland and continental Europe were closely related, differences between 
these two groups of isolates emerged following investigation of the nucleotide 
sequence for the region upstream of LEE1 and the carriage of tccP2.  Although the 
aEPEC isolates from both groups were very similar, there were clear differences 
between the VTEC isolates.  While all the VTEC O26 isolates recovered from 
patients in Scotland carried allele 2 for the region upstream of LEE1 and were 
negative for tccP2, the majority of the VTEC O26 isolates from patients in 
continental Europe carried allele 1 and were positive for tccP2.  Although this would 
suggest that the carriage of allele 1 and tccP2 are indicators of greater virulence 
potential, this may not be the case since these are also traits of the aEPEC isolates 
which are generally associated with mild clinical disease.  However, if this genotype 
is in a VTEC background, particularly in a strain harbouring vtx2, there may be a 
strong possibility that this strain could cause severe human disease.  
 
MLST analysis revealed that the E. coli O26 strains residing in cattle in Scotland 
were closely related to the pathogenic human isolates.  This suggests that there is a 
risk of cattle isolates becoming important human pathogens if they possess the 
necessary virulence determinants.  The majority (51%) of E. coli O26 shed by cattle 
in Scotland are vtx-negative and among those which are vtx-positive, most (75%) 
harboured vtx1 alone (Pearce et al., 2006).  No Scottish cattle isolate possessed vtx2 
alone (Pearce et al., 2006).  In addition, my study found that the majority of VTEC 
O26 isolates recovered from Scottish cattle carried allele 2 for the region upstream of 
LEE1 and were negative for tccP2.  Therefore, it appears that the majority of Scottish 
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cattle isolates have different genotypic characteristics to those causing serious human 
disease and this could explain the low incidence of E. coli O26 infections in 
Scotland.  However, it could be concerning that one of the Scottish cattle isolates 
carried vtx1, vtx2, LEE, hlyA, tccP2 and allele 1 for the region upstream of LEE1, and 
was thus indistinguishable from an isolate recovered from a case of HUS in 

















Although knowledge of the complement of virulence genes harboured by a strain is 
important, an understanding of the ability of the organism to express them is also 
essential.  Phenotypic characterisation assays were performed on E. coli O26 clinical 
isolates to give a read out of expression differences between isolates, with the aim of 
identifying traits which allow strains to cause more serious clinical disease.  In 
addition, phenotypic analysis of E. coli O26 isolates recovered from Scottish cattle 
may indicate the potential of bovine isolates to cause human infection.  This chapter 
describes the phenotypic characterisation of human and bovine E. coli O26 isolates 
by Vero cell cytotoxicity assays to investigate levels of verocytotoxin production; 
LEE secreted protein analysis; and adherence assays to Caco-2 cells. 
 
4.1 Vero cell cytotoxicity assays 
The production of verocytotoxin (Vtx) is a major virulence trait of VTEC and is 
thought to be the principal factor responsible for the serious complications of VTEC 
infection (World Health Organisation, 1998).  A number of observations indicate that 
the amount of Vtx produced by infecting VTEC strains may correlate with the 
clinical outcome of infection (Eklund et al., 2002; Muniesa et al., 2003).  Therefore, 
it was investigated whether increased Vtx production by certain VTEC O26 isolates 
could account for why they were associated with more serious disease.  This work 
also examined whether Scottish cattle isolates produced comparable amounts of Vtx 
to human isolates.  Analysis of Vtx production was achieved by determining the Vtx 
titres in culture filtrates from a subset of the VTEC O26 isolates using the Vero cell 
cytotoxicity assay.  A total of thirty VTEC O26 isolates were examined.  Twelve 
isolates carried vtx1 alone, six harboured vtx2 alone and twelve possessed vtx1 and 
vtx2.  Among the strains containing either vtx1 or vtx1 and vtx2, an equal number of 
isolates from cattle and cases of human infection were analysed.  
 
The basal level of Vtx production by each isolate was assessed by culturing the 
isolates in DMEM (iron-replete) for 24 h.  The Vtx titre in the culture filtrate of each 
isolate was determined using the results from two or three independent experiments 




Table 4.1. Verocytotoxin (Vtx) titres of VTEC O26 isolates cultured in DMEM 
by Vero cell cytotoxicity assay. 
 
  Vtx titreb 
 Isolatea Range Geometric mean Median 
ZAP1079_B3 64 64 64 
ZAP1081_B5 16 to 64 32 40 
ZAP1088_B12 8 to 64 23 36 
ZAP1095_B19 8 to 64 23 36 
ZAP1103_B27 4 to 32 11 18 
ZAP1107_B31 16 to 64 32 32 
ZAP1114_S6 [D] 8 to 64 20 16 
ZAP1115_S7 [D] 32 to 64 45 48 
ZAP1124_G16 [HUS] 32 to 64 45 48 
ZAP1127_G19 [D] 64 64 64 






ZAP1151_I34 [HUS] 64 64 64 
ZAP1128_G20 [HUS] <2 to 2 <2 2 
ZAP1132_G24 [HUS] <2 to 8 2 <2 
ZAP1134_G26 [HUS] <2 <2 <2 
ZAP1147_I30 [HC] <2 <2 <2 






ZAP1150_I33 [HUS] <2 <2 <2 
ZAP1078_B2 16 to 32 20 16 
ZAP1086_B10 <2 to 16 4 8.5 
ZAP1094_B18 32 32 32 
ZAP1100_B24 <2 to 32 6 16.5 
ZAP1106_B30 16 to 64 32 32 
ZAP1109_B33 2 to 16 6 9 
ZAP1122_G14 [HUS] 64 to 256 128 128 
ZAP1126_G18 [HUS] 64 64 64 
ZAP1129_G21 [HUS] 16 to 64 32 40 
ZAP1130_G22 [HUS] <2 to 64 8 32.5 











ZAP1153_S36 [BD] <2 to 32 6 16.5 
a The associated clinical disease is indicated in parenthesis: D, diarrhoea; BD, bloody 
diarrhoea; HC, haemorrhagic colitis; HUS, haemolytic uraemic syndrome. 
b The Vtx titre was defined as the reciprocal of the highest dilution of the culture 
filtrate that caused a cytotoxic effect in 50% of the Vero cells after 3 days of 
incubation.  The Vtx titre in the culture filtrate of each isolate was determined using 





While isolates possessing a particular vtx genotype generally had similar Vtx titres, 
the culture filtrate from the vtx1-positive isolate ZAP1146_I29 had a higher Vtx titre 
than the culture filtrates from the other isolates harbouring vtx1 (Table 4.1).  With the 
exception of isolate ZAP1146_I29 which was recovered from a patient with HUS 
and had a higher Vtx titre, the Vtx titres from Vtx1-producing isolates recovered 
from cases of diarrhoea and HUS were comparable (Table 4.1).  In addition, the Vtx 
titres of isolates positive for vtx1 and vtx2 recovered from diarrhoea, bloody diarrhoea 
and HUS infections were also similar (Table 4.1).   
 
Comparison of the Vtx titres of VTEC O26 isolates that harboured different vtx 
genotypes showed that culture filtrates from isolates carrying vtx1 alone and vtx1 in 
combination with vtx2 were cytotoxic to Vero cells (Table 4.2).  The culture filtrates 
from isolates that possessed both vtx1 and vtx2 had slightly reduced cytotoxicty to 
Vero cells than those from isolates that carried vtx1 alone (Table 4.2), but this 
difference was not statistically significant.  The culture filtrates from isolates 
harbouring vtx2 alone had no cytotoxic activity on Vero cells (Table 4.2).  
Investigation of Vtx production by VTEC O26 isolates recovered from cases of 
human infection found that, among the isolates harbouring either vtx1 alone or both 
vtx1 and vtx2, the culture filtrates from isolates recovered in continental Europe 
tended to have a greater Vtx titre than those from isolates recovered in Scotland with 
the same vtx genotype (Table 4.2).  However, these differences were not found to be 
statistically significant.  The culture filtrates from Scottish cattle VTEC O26 isolates 
carrying vtx1 alone and both vtx1 and vtx2 had a comparable Vtx titre to those from 
VTEC O26 isolates from clinical cases in Scotland, but a lower Vtx titre than those 
from isolates recovered from patients in continental Europe, with the same vtx 
genotype (Table 4.2).  
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Table 4.2. Verocytotoxin (Vtx) titres of VTEC O26 isolates with different vtx 
genotypes from different origins using the Vero cell cytotoxicity assay. 
 
Vtx titrea vtx genotype,  
origin of isolate 
No. of 
isolates Range Geometric mean Median 
vtx1  12 4 to 512 38.9 64 
 Human (Scotland)  2 8 to 64 27.9 32 
 Human (cont. Europe)  4 32 to 512 95.1 64 
 Cattle  6 4 to 64 27.3 32 
      
vtx2  6 <2 to 8 <2 <2 
      
vtx1 and vtx2  12 <2 to 256 19.1 32 
 Human (Scotland) 2 <2 to 128 11.3 18 
 Human (cont. Europe)  4 <2 to 256 43.5 64 
 Cattle  6 <2 to 64 13.1 16 
a The Vtx titre was defined as the reciprocal of the highest dilution of the culture 
filtrate that caused a cytotoxic effect in 50% of the cells in the Vero cell monolayer 
after 3 days of incubation. 
 
 
The level of Vtx production by each isolate was also determined following the 
culture of the isolates in the presence of mitomycin C and in low-iron medium.  
Mitomycin C has been shown to induce vtx expression (al-Jumaili et al., 1992; 
Ritchie et al., 2003) and low-iron concentrations can increase Vtx1 production 
(Ritchie et al., 2003).  Initial experiments made two-fold serial dilutions of culture 
filtrates in a single 96-well microtitre plate and the maximum dilution prepared was 
1:4,096.  In many cases the inducing conditions increased Vtx titres to values in 
excess of 4,096 and thus no definitive values were obtained.  Additional experiments 
preparing dilutions of culture filtrates up to 1:16,777,216 were performed on certain 
isolates.  For many of the isolates there was at least one Vtx titre under both of the 
inducing conditions that was not a definitive value and, therefore, it was not possible 
to calculate an average Vtx titre for each isolate.  However, since every condition 
(non-induced, in the presence of mitomycin C and in low-iron medium) for any one 
isolate was examined in the same experiment, it was possible to select a 
representative data set for each isolate (Table 4.3).  Definitive Vtx titres were 
obtained for all the isolates examined harbouring vtx1 alone and vtx2 alone which 
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allowed the effect of culturing these isolates under different inducing conditions to 
be analysed. 
 
Culturing the VTEC O26 isolates in the presence of mitomycin C increased the Vtx 
titre in the culture filtrates of all isolates with the exception of ZAP1128_G20, which 
showed no change in its Vtx titre (Table 4.3).  There was a significant increase (P < 
0.001) in the Vtx titres of the cattle isolates harbouring vtx1 alone following 
mitomycin C treatment.  Increases of 7-fold or greater were observed for five of six 
of these isolates (median fold increase = 8.5) (Figure 4.1).  In contrast, mitomycin C 
treatment of human isolates that carried vtx1 alone resulted generally in a lower 
increase in the Vtx titres (median fold increase = 4) (Figure 4.1).  The exception to 
this was isolate ZAP1127_G19, which had a dramatic increase (18-fold) in its Vtx 
titre following mitomycin C treatment.  Although Vtx titres increased more for the 
cattle isolates than for the human isolates harbouring vtx1 in response to mitomycin C 
treatment, there was no significant difference in the Vtx titres between these two 
groups following mitomycin C induction (median Vtx titres for the cattle and human 
isolates were 2048 and 1024, respectively).  There was no evidence of an association 
between the level of increase in Vtx titres by the vtx1-positive human isolates 
following mitomycin C treatment and the severity of disease. 
 
Culturing the VTEC O26 isolates which carried vtx2 alone in the presence of 
mitomycin C increased the Vtx titres in the culture filtrates from the majority (5 of 6) 
of the isolates to levels which were cytotoxic to Vero cells (Table 4.3).  However, 
these culture filtrates exhibited a much lower cytotoxic activity on Vero cells 
compared to those from mitomycin C-induced VTEC O26 isolates that harboured 
solely vtx1 or both vtx1 and vtx2 (Table 4.3; median Vtx titres for VTEC O26 strains 




Table 4.3. Verocytotoxin (Vtx) titres of VTEC O26 isolates cultured under 
different conditions by Vero cell cytotoxicity assay. 
 
  Vtx titreb 
 Isolatea Non-inducedc Mitomycin Cd Low-irone 
ZAP1079_B3 64 1024 1024 
ZAP1081_B5 16 8192 16,777,216 
ZAP1088_B12 8 1024 524,288 
ZAP1095_B19 8 2048 131,072 
ZAP1103_B27 4 2048 8192 
ZAP1107_B31 16 8192 2,097,152 
ZAP1114_S6 [D] 16 128 32,768 
ZAP1115_S7 [D] 32 1024 1,048,576 
ZAP1124_G16 [HUS] 32 512 16,384 
ZAP1127_G19 [D] 64 16,777,216 16,777,216 






ZAP1151_I34 [HUS] 64 1024 4096 
ZAP1128_G20 [HUS] 2 2 16 
ZAP1132_G24 [HUS] <2 64 8 
ZAP1134_G26 [HUS] <2 8 <2 
ZAP1147_I30 [HC] <2 32 <2 






ZAP1150_I33 [HUS] <2 64 16 
ZAP1078_B2 32 1024 >4096 
ZAP1086_B10   16 >4096 >4096 
ZAP1094_B18 32 >4096 >4096 
ZAP1100_B24 32 >4096 >4096 
ZAP1106_B30 16 16,384 131,072 
ZAP1109_B33 16 >4096 1024 
ZAP1122_G14 [HUS] 256 >4096 >4096 
ZAP1126_G18 [HUS] 64 >4096 >4096 
ZAP1129_G21 [HUS] 16 512 >4096 
ZAP1130_G22 [HUS] 64 512 >4096 











ZAP1153_S36 [BD] 32 >4096 >4096 
a The associated clinical disease is indicated in parenthesis: D, diarrhoea; BD, bloody 
diarrhoea; HC, haemorrhagic colitis; HUS, haemolytic uraemic syndrome. 
b The Vtx titre was defined as the reciprocal of the highest dilution of the culture 
filtrate that caused a cytotoxic effect in 50% of the Vero cells after 3 days of 
incubation.  The Vtx titre values for each isolate were obtained from one representative 
experiment. 
c Isolates were cultured in DMEM (iron-replete). 
d Isolates were cultured in DMEM (iron-replete) in the presence of mitomycin C (0.5 
µg/ml). 










Figure 4.1.  Increase in verocytotoxin (Vtx) titre following mitomycin C treatment of 
VTEC O26 isolates that harbour vtx1 alone.  The bars represent the fold change in Vtx 
titre of mitomycin C-treated cultures compared to non-induced cultures.  The Vtx titre values 
for each isolate were obtained from one representative experiment and are detailed in Table 
4.3.  The clinical disease associated with each human isolate is indicated in parenthesis after 





Since low-iron concentrations have been shown previously to induce Vtx1 
production (Ritchie et al., 2003), it was not surprising that the Vtx titres were greater 
following culture in low-iron medium for all VTEC O26 isolates that carried the vtx1 
gene (Table 4.3).  Moreover, the increase in Vtx titre from isolates harbouring vtx1 
alone was significantly greater (P = 0.01) following growth in low-iron medium 
(median fold increase = 12.5) than in the presence of mitomycin C (median fold 
increase = 6).  Culturing the vtx1-positive isolates in low-iron medium resulted in 
variable increases in Vtx titres among both the cattle and human isolates (Figure 4.2).   
 
Similar to the situation following mitomycin C treatment, the median fold increase in 
Vtx titre by the vtx1-positive cattle isolates (median = 15) was greater than that by the 
vtx1-positive human isolates (median = 10) in response to low-iron concentrations, 
although this difference was not statistically significant.  There was a large difference 
in the Vtx titres between these two groups of isolates after culture in low-iron 
medium (median Vtx titres for the cattle and human isolates were 327,680 and 
49,152, respectively) but, again, this difference was not statistically significant.  The 
vtx1-positive isolates recovered from patients with diarrhoea appeared to have greater 
increases in Vtx titres in response to low-iron concentrations than those recovered 
from patients with HUS (Figure 4.2).  
 
Culture of the vtx2-positive VTEC O26 isolates in low-iron medium increased the 
Vtx titres in the culture filtrates from four of the six isolates (Table 4.3).  However, 
the median fold increase in Vtx titre from isolates harbouring vtx2 alone was less in 












Figure 4.2.  Increase in verocytotoxin (Vtx) titre following culture in low-iron medium 
of VTEC O26 isolates that harbour vtx1 alone.  The bars represent the fold change in Vtx 
titre of cultures grown in low-iron medium compared to non-induced cultures.  The Vtx titre 
values for each isolate were obtained from one representative experiment and are detailed in 
Table 4.3.  The clinical disease associated with each human isolate is indicated in parenthesis 
after the isolate number: D, diarrhoea; HUS, haemolytic uraemic syndrome.  
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An observation following the Vero cell cytotoxicity assays was that the culture 
filtrates from isolates harbouring vtx2 alone had no or little cytotoxic activity on Vero 
cells.  Since previous research has shown that VTEC strains, including those 
belonging to serogroup O26, can lose their verocytotoxin genes during subculture 
(Bielaszewska et al., 2007; Karch et al., 1992), the stability of the vtx genes in a 
selection of the isolates under the experimental culture conditions analysed was 
tested.  To confirm the vtx genotype of the inoculum, a single colony was suspended 
in PBS and ten-fold dilutions inoculated onto LB agar.  After overnight incubation, 
ten colonies from plates with approximately 100 well-separated colonies were PCR 
screened for vtx1 and vtx2.  Following culture of the isolates under non-inducing 
conditions, in the presence of mitomycin C and in low-iron medium, ten-fold 
dilutions of the liquid cultures were inoculated onto LB agar and the presence of vtx1 
and vtx2 genes in up to ten colonies were determined by PCR.  None of the VTEC 
O26 isolates examined had lost their vtx gene(s) during culture.  Therefore, the low 
or non-existent Vtx titres from isolates carrying vtx2 alone cannot be explained by the 
loss of vtx2 in vitro.    
 
4.1.1 Summary of Vero cell cytotoxicity results 
Vero cell cytotoxicity assays revealed that culture filtrates from VTEC O26 isolates 
harbouring vtx2 alone had no or low cytotoxic activity on Vero cells whereas those 
from VTEC O26 isolates containing vtx1, either alone or in combination with vtx2, 
had significantly higher cytotoxic activity.  The Vero cell assay also demonstrated 
that the culture filtrate from the non-induced vtx1-positive isolate ZAP1146_I29 had 
a higher Vtx titre than the culture filtrates from other isolates harbouring vtx1 alone 
and this isolate was recovered from a patient suffering from HUS.  However, 
generally, there was no evidence of an association between greater Vtx titres and 
more serious clinical disease.   
 
The culture filtrates from non-induced Scottish cattle VTEC O26 isolates carrying 
vtx1 alone and both vtx1 and vtx2 had comparable Vtx titres to those from non-
induced VTEC O26 isolates recovered from patients in Scotland, but lower Vtx titres 
to those from non-induced VTEC O26 isolates recovered from patients in continental 
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Europe, with the same vtx genotype.  Mitomycin C treatment of the vtx1-positive 
isolates increased Vtx titres more for the cattle isolates than for the human isolates 
and there was no significant difference in the Vtx titres between these two groups 
following mitomycin C induction.  
 
4.2 LEE-encoded protein secretion 
The ability of certain E. coli strains to form A/E lesions on intestinal epithelial cells 
is considered an important marker for their pathogenicity.  The formation of A/E 
lesions is dependent on the LEE pathogenicity island.  Following initial attachment 
of the bacterium to the host cell, type III secretion of Tir through an EspA filament 
and an EspB/EspD pore in the host cell membrane promotes intimate attachment via 
intimin and Tir (Frankel et al., 1998).  The continued production and secretion of 
LEE-encoded proteins results in host cell actin rearrangement and the formation of 
A/E lesions (Frankel et al., 1998). 
 
Previous research by the ZAP group has shown considerable variation in the levels of 
LEE-secreted proteins among E. coli O157 strains (Roe et al., 2003; unpublished 
results).  The aim of this analysis was to examine if there are differences in the level 
of secretion of LEE-encoded proteins by E. coli O26 isolates.  In particular, it was to 
investigate whether variations in the amount of LEE protein secretion could be 
detected between, (1) isolates associated with infections of different severity and (2) 
isolates from cases of human disease and from cattle.  This characterisation was 
performed on the E. coli O26 isolates which were LEE-positive and carried the genes 
for both Vtx1 and Vtx2.  Such strains were selected for analysis because they are the 
isolates present in Scottish cattle which, based solely on their vtx genotype, are 




4.2.1 Level of secretion of LEE-encoded proteins 
In order to determine the level of secretion of LEE-encoded proteins by E. coli O26 
isolates, the proteins present in the supernatants of the thirteen isolates, seven bovine 
and six human, positive for both vtx1 and vtx2 genes were analysed.  It has been 
shown that DMEM medium is permissive for type III secretion of EspA and EspB by 
EPEC and VTEC (Ebel et al., 1996; Kenny & Finlay, 1995).  Therefore, isolates 
were cultured in DMEM-HEPES to an OD600 of 0.8 and supernatant proteins were 
TCA precipitated, separated by SDS-PAGE and visualised by Colloidal blue 
staining.  The isolates were cultured on three separate occasions and the secreted 
protein profiles in each instance are shown in Figure 4.3A. 
 
Three prominent protein bands were observed in the majority of the samples.  The 
protein of 66 kDa detected in all samples is BSA, which was added to the 
supernatants before precipitation to serve as a co-precipitant to maximise protein 
recovery.  Similar levels of BSA were present in all protein samples (Figure 4.3A) 
which indicates that the precipitation procedure was efficient and allows comparison 
of protein levels between isolates.  The secreted protein profiles of the VTEC O26 
isolates are comparable to those published previously for EPEC and VTEC strains 
cultured in DMEM or MEM (Ebel et al., 1996; Kenny & Finlay, 1995; Kenny et al., 
1997; Yoh et al., 2003), although minor variations in the apparent molecular weights 
of the secreted proteins were observed between strains.  Consequently, the identity of 
the prominent secreted protein bands could be predicted.  The dominant protein of 
approximately 33 kDa is likely to be a doublet of proteins, consisting of 
predominantly EspB but also containing EspD.  Occasionally, the two proteins were 
more clearly resolved with EspB and EspD having molecular weights of 
approximately 33 kDa and 34 kDa, respectively.  The protein of approximately 22 
kDa was assumed to be EspA and this was confirmed by Western blotting.  The 
results of EspA Western blotting on the secreted protein samples are shown below 
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Figure 4.3.  Analysis of LEE-encoded protein secretion by VTEC O26 isolates.  Each isolate was cultured on three separate occasions and the 
results obtained in each instance are shown in three separate columns (columns I, II and III).  (A) Secreted protein profiles from VTEC O26 isolates, 
ZAP1078_B2 (lane 1), ZAP1086_B10 (lane 2), ZAP1094_B18 (lane 3), ZAP1100_B24 (lane 4), ZAP1105_B29 (lane 5), ZAP1106_B30 (lane 6), 
ZAP1109_B33 (lane 7), ZAP1122_G14 (HUS, lane 8), ZAP1126_G18 (HUS, lane 9), ZAP1129_G21 (HUS, lane 10), ZAP1130_G22 (HUS, lane 11), 
ZAP1152_S35 (diarrhoea, lane 12) and ZAP1153_S36 (bloody diarrhoea, lane 13).  Bacteria were cultured in DMEM-HEPES to an OD600 of 0.8 and 
supernatant proteins were TCA precipitated, separated by SDS-PAGE and visualised by staining with Colloidal blue.  The positions of the co-
precipitant BSA (66 kDa) and the secreted proteins EspD/EspB (~ 33 kDa) and EspA (~ 22 kDa) are indicated.  (B) Western blot detection of EspA in 
the secreted protein samples shown in Figure 4.3A.  (C) Percentage of bacteria expressing EspA filaments.  Bacteria were cultured as described for 
secreted protein precipitation and aliquots of bacterial culture were stained for EspA filaments with EspA antibody.  Proportions of bacteria expressing 
EspA filaments were determined by immunofluorescence microscopy as described in materials and methods.  Error bars indicate standard deviations.  
(D) Allele number for the nucleotide sequence of the region upstream of LEE1 in each of the isolates.  Allele numbers were determined as described in 





There were clear differences in the levels of protein secretion between VTEC O26 
isolates cultured in DMEM.  Moreover, there was noticeable heterogeneity in the 
levels of secretion by many of the isolates when they were cultured on different 
occasions.  For example, while isolate ZAP1078_B2 secreted very low levels of 
LEE-encoded proteins, with no EspA detected by Western blotting, on two occasions 
(Figure 4.3A and B, columns I and III, lane 1); in one instance, Western blotting 
identified reasonable levels of EspA secretion (Figure 4.3B, column II, lane 1).  
Isolates ZAP1086_B10, ZAP1109_B33 and ZAP1122_G14 (Figure 4.3A and B, 
columns I, II and III, lanes 2, 7 and 8, respectively) appeared to consistently secrete 
high levels of LEE-encoded proteins while isolate ZAP1105_B29 (Figure 4.3A and 
B, columns I, II and III, lane 5) seemed to uniformly secrete low levels of protein.   
 
The six human isolates examined harboured the genes for both Vtx1 and Vtx2 and 
the majority (four) were associated with HUS.  However, the two isolates from cases 
of infection in Scotland were associated with milder disease – one was isolated from 
a patient with bloody diarrhoea and the second from a patient with simple diarrhoea.  
The results from these six human isolates suggest that there does not appear to be an 
association between the level of LEE protein secretion and the severity of disease.  
While one of the four isolates associated with HUS (ZAP1122_G14; Figure 4.3A and 
B, lane 8) consistently secreted high levels of protein, the remaining three isolates 
(ZAP1126_G18, ZAP1129_G21 and ZAP1130_G22; Figure 4.3A and B, lanes 9, 10 
and 11, respectively) generally secreted much lower quantities of LEE-encoded 
protein.  However, ZAP1129_G21 appeared more heterogeneous in its level of LEE 
protein secretion.  Isolates ZAP1152_S35 and ZAP1153_S36 (Figure 4.3A and B, 
lanes 12 and 13, respectively) recovered from patients with diarrhoea and bloody 
diarrhoea, respectively, secreted variable levels of protein.  The level of secretion by 
these Scottish isolates was comparable to or greater than that by the low-secreting 
HUS-associated isolates.   
 
Comparison of the results from the bovine and human isolates examined suggests 
that the cattle isolates generally secrete higher levels of LEE-encoded protein than 
the majority of the human isolates.  However, human isolate ZAP1122_G14 (Figure 
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4.3A and B, lane 8) secretes protein at levels comparable to the high-secreting bovine 
isolates and some cattle isolates secrete low levels of LEE effector proteins. 
    
While twelve of the thirteen isolates had a similar secreted protein profile, albeit with 
variable levels of protein secretion, isolate ZAP1129_G21 had a different profile 
(Figure 4.3A, lane 10).  The supernatants of isolate ZAP1129_G21 contained 
additional proteins which were clearly visible following SDS-PAGE and Colloidal 
blue staining.  Although this isolate may genuinely secrete additional proteins, it is 
also possible that during culture of this isolate in DMEM a proportion of bacteria 
were lysed. 
   
4.2.2 EspA filamentation 
There is thus marked heterogeneity in the level of EspA, EspB and EspD secretion 
by VTEC O26 isolates when they are cultured in DMEM.  To investigate whether 
this heterogeneity correlated with different proportions of the bacterial population 
expressing EspA filaments, the percentage of bacteria expressing EspA filaments 
was determined.  An aliquot of bacterial culture (OD600 of 0.8) was fixed in PFA 
before the culture was centrifuged for protein precipitation.  Fixed bacteria were then 
immunostained for surface EspA filaments and, following immunofluorescence 
microscopy, the percentage of bacteria expressing filaments was calculated.  The 
proportion of the bacterial population expressing EspA filaments was determined on 
two occasions for each isolate investigated and the results are shown below the 
corresponding secreted protein profile and EspA western blot (Figure 4.3C).  A 
representative phase contrast and fluorescence micrograph for each isolate is shown 
in Figure 4.4.   
 
There was a correlation between the proportion of the bacterial population expressing 
EspA filaments and the levels of EspA, EspB and EspD secretion by VTEC O26 
isolates.  High-secreting strains had a higher percentage of EspA-positive bacteria 
than did low-secreting strains.  High-secreting strains produced populations that had 
more than 90% of the bacteria expressing EspA filaments on their surface whereas 
low-secreting strains had less than 50%.   
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ZAP1078_B2 (medium) ZAP1086_B10 (high) ZAP1094_B18 (high) 
ZAP1100_B24 (medium) ZAP1105_B29 (low) ZAP1106_B30 (high) 
ZAP1109_B33 (high) ZAP1122_G14 (high) ZAP1126_G18 (low) 













Figure 4.4.  Detection of EspA filaments by immunofluorescence microscopy.  Phase 
contrast (left panel) and fluorescence (right panel) micrographs are shown for the indicated 
VTEC O26 isolates stained for EspA filaments with EspA antibody.  Bacteria were cultured 
in DMEM-HEPES to an OD600 of 0.8.  The images presented are from the samples shown in 
Figure 4.3, column II and the status of the isolate for its level of LEE-protein secretion on 
this occasion is indicated in parenthesis.  Slides were examined using an x100 objective and 







Immunofluorescence microscopy revealed that even isolates which had no detectable 
levels of EspA in their supernatants were expressing EspA filaments on their surface.  
These isolates produced populations containing 10 to 48% EspA-positive bacteria 
(Figure 4.3, column III, lanes 1, 5, 9 and 11).  Analysis of the fluorescence 
micrographs did not reveal any noticeable differences in the level of EspA 
filamentation on an individual EspA-positive bacterium between high- and low-
secreting strains (Figure 4.4). 
 
4.2.3 Nucleotide sequence of the promoter for LEE1 
The obvious heterogeneity in the level of LEE-protein secretion by VTEC O26 
isolates prompted investigation of the nucleotide sequence of the LEE1 promoter 
possessed by each of the isolates examined.  The region upstream of LEE1, which is 
likely to contain the LEE1 promoter, was sequenced to supplement the MLST 
analysis of E. coli O26 isolates (section 3.2.2) and the allele number for this locus for 
each of the isolates is detailed in Figure 4.3D.  There appears to be an association 
between the nucleotide sequence for the region upstream of LEE1 and the level of 
LEE-protein secretion.  Those isolates which possess allele 1 for the region upstream 
of LEE1 were typically low-secreting strains whereas those which possess allele 2 
were generally medium- to high-secreting strains.  This association can be seen most 
clearly in Figure 4.3, column III.  
 
4.2.4 Summary of LEE protein secretion results 
There is considerable variation in the level of LEE-encoded protein secretion by 
VTEC O26 isolates when they are cultured in DMEM and the level of secretion 
correlated with the proportion of the bacterial population expressing EspA filaments.  
Among the VTEC O26 isolates analysed, it appeared that those isolates which 
possess allele 1 for the region upstream of LEE1 were typically low-secreting strains 
whereas those which possess allele 2 were generally medium- to high-secreting 
strains.  There did not appear to be an association between the level of LEE-encoded 
protein secretion and the ability to cause more serious disease.  However, in general, 
the Scottish cattle isolates appeared to secrete higher levels of protein than the human 
isolates.   
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4.3 Adherence assays 
While type III secretion-based intimate attachment and A/E lesion formation are 
likely to be important for intestinal colonisation, adherence of the bacterium 
mediated by surface-expressed factors such as fimbriae may also contribute.  It was 
investigated whether VTEC O26 isolates associated with more serious disease could 
adhere to human intestinal epithelial cells at higher levels than those associated with 
mild disease and whether Scottish cattle isolates could adhere to human intestinal 
epithelial cells. 
 
Thirteen VTEC O26 isolates, seven bovine and six human, positive for both vtx1 and 
vtx2 genes were cultured on CFA agar at 37ºC and tested for their capacity to adhere 
to Caco-2 cells within 2 h.  CFA medium has been used previously to promote 
fimbrial expression (Evans et al., 1977).  The average number of bacteria attached to 
Caco-2 cells per field of vision for each VTEC O26 isolate is shown in Figure 4.5.  
One-way analysis of variance analysis of the number of bacteria attached to Caco-2 
cells per field for the thirteen VTEC O26 isolates demonstrated significant variation 
(P < 0.001).  Individual differences were investigated using Tukey’s test for multiple 
comparisons, with a family error rate of 1%.  This analysis divided the isolates into 
three groups based on their levels of adherence to Caco-2 cells.  Isolates 
ZAP1078_B2, ZAP1130_G22 and ZAP1153_S36 adhered to Caco-2 cells at 
significantly higher levels than the remaining VTEC O26 isolates.  Isolates 
ZAP1105_B29, ZAP1126_G18, ZAP1129_G21 and ZAP1152_S35 adhered to Caco-
2 cells at moderate levels, while isolates ZAP1086_B10, ZAP1094_B18, 
ZAP1100_B24, ZAP1106_B30, ZAP1109_B33 and ZAP1122_G14 adhered to 

















Figure 4.5.  Adherence of VTEC O26 isolates to Caco-2 cells.  The indicated isolates were 
cultured on CFA agar at 37ºC and adherence assays were performed at 37ºC for 2 h.  
Microscopy was used to determine the number of bacteria per field attached to Caco-2 cells 
for 30 fields.  Adherence assays for each isolate were performed on at least three separate 
occasions.  The bars represent the average number of attached bacteria per field and error 
bars indicate standard errors of the means.  The clinical disease associated with each human 
isolate is indicated in parenthesis after the isolate number: D, diarrhoea; BD, bloody 





VTEC O26 isolates recovered from clinical cases of human infection appear to 
adhere to Caco-2 cells at higher levels than isolates recovered from Scottish cattle.  
The majority (5/6, 83%) of human isolates adhered to Caco-2 cells at moderate to 
high levels whereas most (5/7, 71%) of the cattle isolates only adhered at low levels 
(Figure 4.5).  There does not appear to be an association between the level of 
adherence by human isolates and the severity of disease.  While one of the four 
isolates associated with HUS (ZAP1122_G14) adhered to Caco-2 cells at low levels, 
the remaining three isolates adhered at higher levels.  Isolates ZAP1152_S35 and 
ZAP1153_S36, recovered from patients with diarrhoea and bloody diarrhoea, 
adhered to Caco-2 cells at moderate and high levels, respectively (Figure 4.5).  
 
Interestingly, the VTEC O26 isolates which typically secreted low levels of LEE-
encoded proteins [namely, ZAP1078_B2, ZAP1105_B29, ZAP1126_G18 and 
ZAP1130_G22 (Figure 4.3)] adhered to Caco-2 cells at much higher levels than 
those isolates which consistently secreted high levels of LEE-encoded proteins 
[namely, ZAP1086_B10, ZAP1109_B33 and ZAP1122_G14 (Figure 4.3)]. 
  
Microscopy revealed that, in addition to many individual bacteria, isolates 
ZAP1078_B2 and ZAP1130_G22 also had small aggregates of bacteria attached to 
Caco-2 cells.  Thin aggregative fimbriae called curli are an established adhesin and, 
therefore, the ability of VTEC O26 to express curli was investigated.  Congo red 
(CR) binding is a well-established method to demonstrate surface curli expression by 
bacteria (Barnhart & Chapman, 2006; Hammar et al., 1995; Uhlich et al., 2001).  
Curliated bacteria are able to bind CR dye and stain red.  The VTEC O26 isolates 
were cultured on CFA-CR indicator plates at 37ºC and while the majority of isolates 
were negative, isolates ZAP1078_B2 and ZAP1130_G22 were positive.  This data 
indicates that isolates ZAP1078_B2 and ZAP1130_G22 express curli at 37ºC on 







4.3.1 Summary of adherence assay results 
Adherence assays were performed for a standard 2 h at 37°C on Caco-2 cells which 
had been incubated at 37°C in 5% CO2 for 48 h prior to the experiment.  There is 
significant variation in the capacity of VTEC O26 isolates to adhere to Caco-2 cells 
following culture on CFA agar at 37°C.  Human VTEC O26 isolates appeared to 
adhere to Caco-2 cells at higher levels than the cattle isolates, but there did not 
appear to be an association between the level of adherence by human isolates and the 
severity of disease.  The VTEC O26 isolates which typically secreted low levels of 
LEE proteins adhered to Caco-2 cells at moderate to high levels whereas those which 
secreted high levels of LEE proteins only adhered at low levels.  Two of the isolates 
which adhered to Caco-2 cells at higher levels stained red on CFA-CR indicator 





The presence of a vtx gene, particularly vtx2, and the LEE pathogenicity island in an 
infecting strain is considered an important indicator of human pathogenic potential.  
However, knowledge of whether these genes are, in fact, functional and an 
understanding of their level of expression in certain strains is also highly relevant.  
This chapter described certain phenotypic characteristics of VTEC O26 isolates by 
investigating levels of verocytotoxin production and LEE-protein secretion.  It also 
considered the ability of VTEC O26 to adhere to Caco-2 cells. 
  
Vtx production is the principal virulence attribute of E. coli strains and appears to be 
an important factor in the development of serious human disease.  It is possible that 
progression to more severe disease could be accounted for by increased Vtx 
production.  The production of Vtx by VTEC O26 isolates was investigated using an 
accepted technique, the Vero cell cytotoxicity assay, where the Vtx titre is dependent 
upon the level of toxin secreted and the cytotoxic activity of the toxin towards Vero 
cells. 
 
A key observation following the Vero cell cytotoxicity assays was that culture 
filtrates from non-induced VTEC O26 isolates harbouring vtx2 alone were not 
cytotoxic to Vero cells.  Filtrates from VTEC O26 isolates containing vtx1, either 
alone or in combination with vtx2, were verocytotoxic.  Furthermore, while 
mitomycin C induction increased the Vtx titres in the culture filtrates of the majority 
of vtx2-positive isolates to levels which were cytotoxic to Vero cells, these filtrates 
had a much lower cytotoxic activity on Vero cells compared to those from 
mitomycin C-induced VTEC O26 isolates that carried vtx1.  Since Vtx2-producing 
VTEC appear to have a greater pathogenicity in clinical situations, it was surprising 
to find that culture filtrates supposedly containing Vtx2 were not as cytotoxic to Vero 
cells as those containing Vtx1.  Although previous research has shown that VTEC 
strains, including those belonging to serogroup O26, can lose their vtx genes during 
subculture (Bielaszewska et al., 2007; Karch et al., 1992), none of the VTEC O26 
isolates examined in this study has lost their vtx gene(s) through culture.  Therefore, 
the much lower cytotoxic activity on Vero cells by culture filtrates from isolates 
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harbouring vtx2 alone cannot be explained by the loss of the vtx2 gene.  However, 
there are other possible explanations for the lower cytotoxic activity on Vero cells by 
culture filtrates from isolates carrying vtx2 alone.   
 
Firstly, it is possible that the Vero cells are not as sensitive to Vtx2 as they are to 
Vtx1.  An earlier study by Strockbine et al. (1986) compared the biological activities 
of Vtx1 and Vtx2 by analysing the cytotoxin in the cell lysates of E. coli K-12 
lysogenised with phage 933J (Vtx1) and phage 933W (Vtx2) from E. coli O157:H7 
EDL933.  While both toxins were cytotoxic to Vero cells, Vtx2, per unit of protein, 
was less cytotoxic than Vtx1.  Moreover, research by Karmali’s group (Head et al., 
1988) found that “on a weight basis, Vtx2 was 1,000-fold less active on Vero cells 
than Vtx1” (Karmali, 1989); although the Vtx2 prepared in this instance was 
probably not pure, but instead consisted of the two comparable but not identical 
toxins, Vtx2 and Vtx2c (Schmitt et al., 1991).  However, the Vero cell cytotoxicity 
assay is the conventional technique used to detect the production of Vtx by VTEC 
and has been used routinely to confirm the presence of both Vtx1 and Vtx2 in culture 
and faecal filtrates (Bielaszewska et al., 2007; Karmali et al., 1999; Mellmann et al., 
2005).  Previous research has yielded positive Vero cell cytotoxicity assay results for 
Vtx2 in faecal filtrates (Mellmann et al., 2005) and culture filtrates (Bielaszewska et 
al., 2006; Bielaszewska et al., 2007; Mellmann et al., 2008).  Moreover, a study 
comparing the performance of a commercial latex agglutination assay with that of 
the Vero cell cytotoxicity assay for the detection of Vtx1 and Vtx2 in E. coli culture 
filtrates found that all Vtx2-producing strains analysed gave a positive result in the 
Vero cell assay and made no mention of any observation that Vtx2 was less active 
than Vtx1 on Vero cells (Karmali et al., 1999).  Differences in the cytotoxicity of 
Vtx2-producing strains to Vero cells observed among laboratories could be due to 
variations in expression of the vtx2 gene under different experimental growth 
conditions and/or variations in the sensitivities of different Vero cell lines.   
 
Secondly, the culture filtrates from isolates harbouring vtx2 alone may have had a 
much lower cytotoxic activity on Vero cells than those from isolates containing vtx1 
because they contained lesser amounts of Vtx.  Perhaps the non-induced vtx2-positive 
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isolates produced Vtx2 in quantities that were below the level of detection by the 
Vero cell assay.  It is possible that only low levels of Vtx2 are produced because 
Vtx2 is trafficked to target organs more efficiently than Vtx1 and, once there, Vtx2 
may elicit a more severe cytotoxic response.  Previous research has shown that Vtx1 
binds to the surface of intestinal epithelial cells in vitro with a higher affinity than 
Vtx2 (Hurley et al., 1999) and may, therefore, be ‘held up’ in the intestine in vivo.  
Although more Vtx1 than Vtx2 translocates across intestinal epithelial cells in vitro 
(Hurley et al., 1999), the intestinal capillary network is believed to be the first 
endothelial cell target to be encountered following Vtx translocation across the 
intestinal epithelial cell layer (Jacewicz et al., 1999), and the binding affinity of Vtx1 
to human intestinal microvascular endothelial cells was much greater than that of 
Vtx2 in vitro (Jacewicz et al., 1999).  In addition, it has been reported that Vtx2 was 
more toxic to human intestinal microvascular endothelial cells than Vtx1 (Jacewicz 
et al., 1999).  The decreased binding affinity and increased toxicity for intestinal 
endothelial cells of Vtx2 compared to Vtx1 may facilitate the access of Vtx2 to the 
systemic circulation to reach the kidney.  Here, Vtx will act on renal endothelial cells 
and Vtx2 has been demonstrated to be 1,000 times more toxic for human renal 
microvascular endothelial cells than is Vtx1 (Louise & Obrig, 1995).   
 
To gain further information about whether the lower cytotoxic activity on Vero cells 
of the culture filtrates from isolates harbouring vtx2 alone compared to those from 
isolates carrying vtx1 could be due to (1) reduced sensitivity of the Vero cells to Vtx2 
or (2) lower levels of Vtx2 production, it would be necessary to perform additional 
experiments to characterise Vtx production.  This may include: confirming Vtx1 
and/or Vtx2 production and release using a commercial latex agglutination assay 
(Karmali et al., 1999) or an immuno-PCR assay (Zhang et al., 2008); determining 
Vtx concentrations in the culture filtrates by ELISA (Ritchie et al., 2003); or 
analysing levels of vtx gene expression by quantitative PCR (Q-PCR) (Zhang et al., 
2005). 
 
Thirdly, it is also possible that the reduced cytotoxicity to Vero cells of culture 
filtrates from isolates carrying vtx2 alone was a consequence of production of a Vtx2 
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variant which has low cytotoxic activity on Vero cells.  Previous research has shown 
Vtx2c is less active than Vtx2 on Vero cells (Lindgren et al., 1994).  Therefore, it is 
necessary to determine the vtx2 subgroup harboured by the isolates positive for vtx2 
alone to ascertain whether a Vtx2 variant may be responsible for the reduced 
cytotoxic activity on Vero cells.    
 
Interestingly, the ability of mitomycin C to increase the Vtx titres in the culture 
filtrates from five of six of the isolates positive for vtx2 alone indicates that, in these 
isolates, the vtx2 gene is functional.  However, since Vtx titres by ZAP1128_G20 
were not increased in response to mitomycin C it is possible that the vtx2 gene of this 
strain is not intact, not phage borne or is located on a defective phage.  It would be 
necessary to perform sequence analysis of the vtx2 gene from ZAP1128_G20 to 
investigate whether a mutation or truncation of vtx2 may account for the lack of 
verocytotoxicity of the culture filtrate from this isolate.    
 
The Vero cell cytotoxicity assay also demonstrated that the culture filtrate from the 
non-induced vtx1-positive isolate ZAP1146_I29 had a higher Vtx titre than the 
culture filtrates from the other isolates harbouring vtx1.  Notably, the greater 
cytotoxicity of this isolate to Vero cells correlated with the progression to HUS.  
Although the production of Vtx1 alone is not generally associated with HUS, this 
increased cytotoxicity may contribute to the enhanced pathogenicity of this isolate.  
It is possible that the greater cytotoxicity to Vero cells is due to the production of 
greater quantities of Vtx1.  This could be the consequence of either, increased 
expression of a single vtx1 gene or the presence and expression of multiple copies of 
vtx1 genes.  Although multiple copies of vtx2 genes have been reported in VTEC 
strains (Bielaszewska et al., 2006; Schmitt et al., 1991), Schmitt et al. (1991) did not 
identify multiple copies of the vtx1 gene in any of the E. coli isolates examined.  To 
investigate these possibilities further it would be necessary to determine levels of Vtx 
production more precisely using the techniques mentioned previously, and ascertain 
the number of copies of vtx1 harboured by the VTEC O26 isolates by restriction 
enzyme digestion of genomic DNA and subsequent Southern blotting using a vtx1 
probe (Bielaszewska et al., 2006; Schmitt et al., 1991).   
135 
 
An alternative explanation for the greater cytotoxicity of isolate ZAP1146_I29 to 
Vero cells is the production of a more active toxin variant.  Indeed, Vtx2 variants 
have exhibited different toxicities to Vero cells (Lindgren et al., 1994).  However, 
this is unlikely since Vtx1 is generally more conserved than Vtx2 and isolates 
harbouring the vtx1 variant, vtx1c, had comparable Vero cell cytotoxicity titres to 
isolates carrying vtx1 (Zhang et al., 2002).  In addition, only vtx1 has been detected in 
VTEC O26 isolates previously (Jenkins et al., 2003; Zhang et al., 2002).  However, 
to investigate the possibility that the high Vtx titre of ZAP1146_I29 is due to a more 
cytotoxic variant, the vtx1 gene(s) carried by the VTEC O26 isolates should be 
sequenced. 
 
Overall, there was no evidence of an association between Vtx titre and the risk of 
serious complications following infection with E. coli O26 strains.  With the 
exception of isolate ZAP1146_I29, which was recovered from a case of HUS, there 
were no major differences in Vtx titres between non-induced isolates, which 
harboured vtx1 alone, from cases of diarrhoea and HUS.  In addition, there did not 
appear to be a correlation between the level of increase in Vtx titres by the vtx1-
positive isolates following mitomycin C treatment and the severity of disease.  
Furthermore, the Vtx titres of non-induced isolates, carrying both vtx1 and vtx2, from 
diarrhoea, bloody diarrhoea and HUS infections were similar.  The lack of 
association between levels of Vtx production and clinical outcomes of infection is in 
accordance with two previous studies (Cornick et al., 2002; Zhang et al., 2005) but 
does not agree with other research, which demonstrated that Vtx quantities produced 
by infecting VTEC strains correlated with the clinical outcomes of infection (Eklund 
et al., 2002; Muniesa et al., 2003).  However, it is appreciated that the conditions 
exposed to in vivo may result in expression differences not observed in vitro. 
 
While increased Vtx production may not account for the greater pathogenicity of 
certain VTEC O26 isolates, it is possible that these isolates may colonise the human 
intestine in higher numbers, resulting in increased exposure to toxin and progression 
to more serious disease.  The ability of E. coli strains to form A/E lesions promotes 
colonisation of the intestinal mucosa and the production and secretion of LEE-
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encoded proteins is necessary for the formation of A/E lesions.  Therefore, the ability 
of VTEC O26 to secrete LEE-encoded proteins was investigated.  The VTEC O26 
isolates analysed harboured the LEE pathogenicity island and carried the genes for 
both Vtx1 and Vtx2.  LEE-secreted protein production by each isolate was 
investigated by analysing the supernatant proteins following culture in DMEM 
medium, which has been shown to be permissive for LEE-protein secretion (Ebel et 
al., 1996; Kenny & Finlay, 1995).  Supernatant proteins were TCA precipitated, 
separated by SDS-PAGE and visualised by Colloidal blue staining and EspA 
Western blotting.  Clear differences were detected in the level of secretion of LEE-
encoded proteins between VTEC O26 isolates when cultured in DMEM.  Such 
apparent variation in LEE-protein secretion levels has been observed previously 
among E. coli O157:H7 strains cultured in MEM (Roe et al., 2003; unpublished 
results).  The study by Roe et al. (2003) demonstrated that the level of LEE-protein 
secretion by E. coli O157:H7 strains was associated with the proportion of the 
bacterial population expressing EspA filaments.  Consequently, the presence of EspA 
filaments on the surface of the VTEC O26 isolates following culture in DMEM was 
determined by immunofluorescent staining with an EspA antibody, and the 
percentage of bacteria expressing filaments was calculated.   
 
The results from this analysis indicated that EspA secretion by VTEC O26 is 
heterogeneous.  Only a proportion of the bacterial population from each isolate 
investigated had EspA filaments and were secreting proteins; the remaining bacteria 
lacked filaments and presumably were not secreting.  The extent of EspA 
filamentation in the bacterial population varied both between isolates and when the 
same isolate was cultured on different occasions.  The proportion of the bacterial 
population expressing filaments correlated with the observed differences in levels of 
LEE-encoded protein secretion – high-secreting strains expressed filaments on a 
greater proportion of the population than did low-secreting strains.  Heterogeneous or 
limited, tightly controlled expression of EspA may reduce the likelihood of an 




The molecular basis of the heterogeneity in LEE-protein secretion levels between 
VTEC O26 isolates was considered.  The region upstream of LEE1, which is likely 
to contain the LEE1 promoter, was sequenced to supplement the MLST analysis of 
E. coli O26 isolates (section 3.2.2), and there appeared to be an association between 
the nucleotide sequence at this locus and the level of LEE-protein secretion by VTEC 
O26 isolates harbouring both vtx1 and vtx2 genes.  Those isolates which possessed 
allele 1 for the region upstream of LEE1 were typically low-secreting strains whereas 
those which possessed allele 2 were generally medium- to high-secreting strains.  In 
the 644 bp of sequence data determined, alleles 1 and 2 differ by a single nucleotide 
and this base pair difference lies in an area where regulators are known to act in E. 
coli O157:H7 [between base pairs -218 and -123 to the P2 LEE1 promoter (Figure 
3.3; see Appendix 3)] and is in the region where IHF is known to bind in E. coli 
O157:H7 (Figure 3.3).  Thus, it is possible that such sequence variation may result in 
differences in the potential of regulators to bind in this region.  The effect of 
sequence differences in the LEE1 promoter on protein secretion by E. coli O26 
merits further investigation.  Since analysis of secreted protein levels was only 
performed on a limited number of isolates, all of which had the same vtx genotype, it 
would be necessary to examine a larger collection of isolates harbouring these 
different nucleotide sequences to see if this relationship holds true.  In the limited 
number of isolates examined there did not appear to be an association between the 
level of LEE-protein secretion and the ability to cause more serious clinical disease.   
 
In addition to type III secretion-based intimate attachment, intestinal colonisation 
may be facilitated by adherence mediated by surface-expressed appendages such as 
fimbriae.  Therefore, the capacity of VTEC O26 isolates to adhere to a human 
intestinal epithelial cell line within 2 h was tested.  Culture of the isolates on CFA 
agar at 37ºC resulted in significant variation in the number of bacteria adhering to 
Caco-2 cells.  However, there was no apparent association between the level of 
adherence and severity of disease.  It is interesting to note that the VTEC O26 
isolates which generally secreted low levels of LEE-encoded proteins adhered to 
Caco-2 cells at higher levels than those isolates which consistently secreted high 
levels of LEE-encoded proteins.  It is possible that the expression of factors on the 
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bacterial cell surface is coordinated to reduce the likelihood of redundant adherence 
mechanisms being simultaneously produced.  Those isolates which exhibit low levels 
of LEE-protein secretion have a lower proportion of bacterial cells secreting the 
translocon proteins and this may allow other adhesins to function without 
interference from EspA filaments.  It is possible that these adhesins drive the initial 
adherence of VTEC O26 to human intestinal epithelium which in turn leads to the 
production of the translocon apparatus. 
 
Two of the VTEC O26 isolates that adhered to Caco-2 cells at high levels bound 
congo red when cultured on CFA plates at 37ºC.  This indicates that these isolates 
express curli under such conditions, although further analysis, such as 
immunostaining with a curli antibody, is required for confirmation.  Curli are an 
established adhesin and possibly contribute to the increased adherence observed for 
these two VTEC O26 isolates.  To establish the contribution of curli in their 
adherence it would be necessary to create a curli mutant in each of the isolates and 
then evaluate the adherence of the mutant compared to the parent strain.  
 
Since one of the VTEC O26 isolates that adhered to Caco-2 cells at high levels and 
all four of the isolates that adhered at moderate levels did not bind congo red when 
cultured on CFA agar at 37ºC indicates that these isolates do not express curli under 
these conditions.  It is likely that adherence by these isolates is mediated by 
alternative surface factor(s).  Indeed, at least sixteen putative fimbrial operons have 
been identified in E. coli O157:H7 (Hayashi et al., 2001; Low et al., 2006; Perna et 
al., 2001).  Microarray analysis of gene expression by VTEC O26 isolates following 
culture on CFA agar at 37ºC may indicate adhesins which are potentially 
contributing to adherence under these conditions. 
 
There did not appear to be an association between (1) Vtx titre, (2) level of LEE-
protein secretion, or (3) level of adherence to Caco-2 cells and the ability to cause 
more serious human disease.  However, it should be remembered that host factors, 
including age, clinical history, or treatment issues such as the administration of 
antibiotics and/or anti-motility agents may also be important in determining the 
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clinical outcome of infection.  VTEC O26 isolates recovered from patients in 
continental Europe appeared to produce higher levels of Vtx than their Scottish 
counterparts, although further work is needed to confirm this.  Although there were 
no clear differences in the levels of LEE-protein secretion between VTEC O26 
isolates recovered from patients in Scotland and continental Europe, only a limited 
number of isolates (those which carried the genes for both Vtx1 and Vtx2) were 
examined.  If the LEE1 promoter sequence proves to be indicative of LEE-protein 
secretion levels, then the fact that the majority of VTEC O26 isolates recovered in 
continental Europe carried allele 1 whereas all of the VTEC O26 isolates recovered 
from patients in Scotland possessed allele 2 (Table 3.10) suggests that the majority of 
VTEC O26 from continental Europe should be lower secretors than those from 
Scotland.  The contribution this phenotype may have on the capacity to cause more 
serious human disease is unknown.  Perhaps these low-secreting isolates have a more 
tightly regulated T3SS, which limits potential immune exposure, but can be induced 
at their desired site of colonisation once permissive environmental factors are 
encountered.  However, recent work has demonstrated that O-islands carry effector 
proteins, regulators and surface adhesins that can alter the regulation of the T3SS 
(Tobe et al., 2006; ZAP group unpublished results).  Therefore, the level of LEE-
encoded protein secretion may be a marker of the O-island-phage repertoire of the 
strain and the low-secretion phenotype is simply a marker of the presence or absence 
of DNA which is necessary to allow these strains to cause more serious disease.    
        
Analysis of VTEC O26 isolates recovered from Scottish cattle in Vero cell 
cytotoxicity assays found that the culture filtrates from non-induced isolates carrying 
either vtx1 alone or vtx1 and vtx2 in combination had comparable Vtx titres to those 
from non-induced VTEC O26 isolates recovered from patients in Scotland, but lower 
Vtx titres to those from non-induced VTEC O26 isolates recovered from clinical 
cases in continental Europe, with the same vtx genotype.  This is in agreement with 
the findings of Ritchie et al. (2003), who demonstrated that basal levels of Vtx1 or 
Vtx2 production by HUS-associated isolates was significantly greater than that by 
bovine isolates.  However, further analysis of the vtx1-positive isolates in my study 
found that mitomycin C treatment generally increased Vtx titres more in the cattle 
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isolates than in the human isolates and, as a result, there was no significant difference 
in the Vtx titres between the cattle and human isolates following mitomycin C 
induction.  Since the human body contains other prophage-inducing agents, such as 
H2O2 released by neutrophils (Wagner & Waldor, 2002), cattle isolates might 
produce comparable quantities of Vtx to disease-associated isolates in the human 
host if they successfully colonise human beings.  
 
In the small number of VTEC O26 isolates investigated, it appeared that those 
recovered from Scottish cattle generally secreted higher levels of LEE-encoded 
proteins and adhered to Caco-2 cells at lower levels than the majority of isolates 
from cases of human infection.  On the basis of these phenotypic results it appears 
that the majority of Scottish cattle isolates have different characteristics to those 
causing human disease, and this could explain the low incidence of E. coli O26 
infections in Scotland.  However, the Scottish cattle isolate which, for the genotypic 
characteristics investigated, was indistinguishable from the isolate recovered from a 
patient with HUS remains a serious concern.  This isolate consistently secreted low 
levels of LEE-encoded proteins and adhered to Caco-2 cells at moderate levels and 
was thus comparable to many of the human isolates associated with severe disease.  
Moreover, a further isolate recovered from a case of HUS in continental Europe 
carried vtx1, vtx2, LEE, hlyA and allele 2 for the region upstream of LEE1, and 
consistently secreted high levels of LEE-encoded proteins and adhered to Caco-2 
cells at low levels.  With the exception of the carriage of tccP2, this isolate was 
comparable to a number of VTEC O26 strains residing in Scottish cattle. 
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4.5 Section I discussion 
VTEC O26 strains have emerged as significant human pathogens in continental 
Europe, often causing severe diarrhoea that can progress to life-threatening HUS.  In 
contrast, human infections associated with E. coli O26 are uncommon in Scotland 
and are generally associated with simple diarrhoea.  One of the aims of this study 
was to characterise E. coli O26 isolates from these different locations to identify 
bacterial factors which allow these pathogens to cause more serious disease.   
 
Nucleotide sequencing of housekeeping genes found very little genetic variation in 
the genomic ‘backbone’ among E. coli O26 isolates recovered from patients in 
Scotland and continental Europe.  E. coli O26 has considerable genomic variation 
which is presumed, therefore, to occur as a result of the insertion and deletion of 
horizontally acquired genomic O-islands and bacteriophages.  Thus, it is probable 
that the difference in human pathogenic potential between these two groups of 
isolates is due to horizontally acquired DNA.  Indeed, differences between these two 
groups emerged following investigation of virulence gene carriage.  A number of 
VTEC O26 isolates recovered in continental Europe harboured the vtx2 gene alone 
and the majority of European VTEC O26 carried allele 1 for the region upstream of 
LEE1 and were positive for tccP2.  In contrast, the majority of Scottish human 
isolates were vtx-negative and, among those which were vtx-positive, no isolate 
carried the vtx2 gene alone.  Furthermore, all VTEC O26 recovered from patients in 
Scotland carried allele 2 for the region upstream of LEE1 and were negative for 
tccP2.  Whether any of these factors are directly responsible for the increased 
pathogenesis observed for European O26 isolates is unknown.  It is possible that the 
carriage of any of these factors is an indicator of a certain clonal type, which may 
harbour some yet-undiscovered virulence factor.   
 
The development of an understanding of the gene repertoire of the strains studied has 
provided important knowledge about their virulence potential.  However, virulence 
factor expression levels may also be essential in predicting the human pathogenic 
potential of an isolate.  It is possible that increased production of Vtx by isolates 
recovered from patients in continental Europe may account for why human infections 
142 
 
in Europe are more severe, and perhaps low levels of LEE-protein secretion are a 
marker for enhanced pathogenesis.  However, perhaps the ability of VTEC O26 
bacteria to produce Vtx or LEE-encoded proteins is not sufficient for an organism to 
cause human disease without suitable additional virulence factors.  It is possible that, 
despite the characterisation of the bacterial isolates in this study, there could be some 
additional, and perhaps unknown, virulence factors associated with pathogenesis.  To 
investigate this possibility, it would be interesting to perform DNA-DNA 
hybridisations or high-throughput sequencing for a more thorough examination of 
the virulence genes and genomic islands harboured by E. coli O26 isolates. 
  
In addition to the virulence factors considered in this study there are many other 
pathogen-related factors which may contribute to the potential to cause serious 
human disease and would be interesting to investigate.  These include the capacity of 
strains to survive the harsh conditions in the gastrointestinal tract and resist the 
immune system and their ability to compete with other organisms in the colonic 
flora.  It should also be remembered that the clinical outcome of infection is the end 
result of host, pathogen and environmental interactions.  Therefore factors, other than 
bacterial characteristics, are also likely to contribute to disease patterns seen.  These 
include exposure and infective doses and host susceptibility. 
   
The second aim of this study was to investigate the potential of E. coli O26 strains 
from Scottish cattle to cause human infection.  Characterisation of bovine isolates 
found that they were generally comparable to the Scottish human isolates.  They 
possessed similar virulence gene profiles and produced equivalent levels of Vtx.  
From these results it would be feasible to suggest that bovine E. coli O26 are already 
the source of human infection in Scotland.  However, as trace-back studies are 
unlikely, causal proof of this epidemiological link will remain lacking.  The fact that 
no common PFGE profile has been detected between human and cattle O26 isolates 
recovered in Scotland (L. Allison, personal communication) is possibly the 
consequence of strains frequently changing their genomic ‘make-up’, for example by 
the loss and gain of vtx-converting bacteriophages as has been observed previously 
(Bielaszewska et al., 2007; Mellmann et al., 2005).  If bovine E. coli O26 are the 
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source of human infection in Scotland, it would appear that they do not cause severe 
disease.  However, it is of concern that one of the Scottish cattle isolates was very 
similar to isolates recovered from patients with HUS in continental Europe.  This 
isolate carried vtx1, vtx2, LEE, hlyA, tccP2 and allele 1 for the region upstream of 
LEE1, secreted low levels of LEE-encoded proteins and adhered to Caco-2 cells at 
moderate levels.  It would be interesting to investigate a wider set of cattle isolates 
for these characteristics and surveillance for VTEC O26 isolates of this genotype is 
recommended.  In addition, there are a number of aEPEC O26 isolates in Scottish 
cattle which harbour tccP2 and allele 1.  Although, in the absence of vtx genes, these 
strains are less of a threat to human health they only need to acquire the Vtx2-
encoding bacteriophage and they could prove to be highly pathogenic.  This event is 
feasible since E. coli O26 are a highly dynamic group of organisms that have been 
shown to convert from aEPEC to VTEC via the gain of Vtx-encoding phages 
(Bielaszewska et al., 2007).             
 
It was observed that there were differences in the level of LEE-protein secretion 
between cattle and human isolates, with the cattle isolates generally secreting higher 
levels of protein than the human isolates in vitro.  This indicates that there are 
differences in the regulation of a key colonisation factor between these two groups of 
isolates.  The impact these differences may have in vivo is not clear, but if they are 
important in the potential of a strain to transmit to the human host, there may be a 
reduction in the proportion of cattle isolates which could be transmitted.  However, 
some cattle isolates were comparable to the human isolates and secreted low levels of 
LEE-encoded proteins.  It is possible that these isolates may be able to transmit to 
humans and the genotypic and phenotypic characterisations suggest that E. coli O26 
bovine isolates may then represent a threat to human health.   
 
Although this is an important finding, there are many other variables that must exist 
in determining the potential of a strain to be transmitted from a bovine to a human 
host and then cause disease.  One issue is the environmental exposure dose, with 
greater human exposure possibly resulting in an increased risk of infection.  
Elements which contribute to exposure dose are the carriage rate in cattle, bacterial 
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shedding levels by cattle, the ability to survive in the environment and undefined 
differences in animal management, husbandry or human lifestyle that could influence 
exposure.  A comparison of the situation of E. coli O26 in Scottish cattle to that of E. 
coli O157:H7, where cattle isolates are known to cause human disease, is 
summarised in Figure 4.6.  The percentage of farms on which shedding was detected 
was comparable for both organisms – 22.8% for E. coli O157:H7 (Gunn et al., 2007) 
and 23% for E. coli O26 (Pearce et al., 2006).  However, of the faecal pats tested, 7.9% 
were positive for E. coli O157:H7 (Gunn et al., 2007) whereas only 4.6% were 
positive for E. coli O26 (Pearce et al., 2006).  These data indicate that the carriage rate 
of E. coli O26 in Scottish cattle is lower than that of E. coli O157:H7 so there is 
presumably a reduced exposure to E. coli O26.  It appears important to compare 
cattle and human E. coli O26 isolates in animal studies to investigate their ability to 
colonise the bovine host and the subsequent shedding levels and duration of 
colonisation.  Previous studies with E. coli O157:H7 have indicated that cattle which 
are colonised at the terminal rectum are associated with high levels of faecal 
excretion and a longer duration of faecal shedding (Cobbold et al., 2007; Lim et al., 
2007; Low et al., 2005).  It is possible that Scottish cattle are not shedding high 
levels of E. coli O26 or are only shedding for a short term, thus reducing the risk of 
human infection.  In addition, E. coli O26 can be a pathogen for cattle (Pearson et al., 
1999; Wieler et al., 1996) and this could affect shedding levels and patterns. 
 
In addition to possible differences in the environmental load of these two pathogens, 
while the vast majority (99.8%) of E. coli O157:H7 isolates excreted by Scottish 
cattle harbour the virulence genes vtx2 and eae (Gunn et al., 2007), only a limited 
number (10%) of bovine E. coli O26 isolates from Scotland possess both of these 
genes (Pearce et al., 2006) (Figure 4.6).  Furthermore, a further reduced number of 
VTEC O26 isolates from Scottish cattle carry tccP2 and allele 1 for the region 
upstream of LEE1, which are markers for increased potential to cause serious human 
disease (this study).  The limited exposure of individuals in Scotland to more virulent 
E. coli O26 isolates may explain the differences in the incidence of human infection 






Figure 4.6.  Comparison of the chain of ‘filters’ that may influence the potential of E. 
coli O157 and E. coli O26 from Scottish cattle to cause human disease.  The green 
background corresponds to the environmental load of the two pathogens and the yellow 
background highlights the carriage of important virulence factors by these pathogens.  The 
thickness of the blocks and arrows is indicative of the potential exposure dose to human 
beings of these two pathogens harbouring the said virulence determinants.  See text for 
further explanation.  Data obtained from this thesis, Gunn et al. (2007) and Pearce et al. 
(2006).   
 
 
In conclusion, while the study is insufficient to form a complete risk analysis, the 
genotypic and phenotypic characterisations indicate that E. coli O26 bovine isolates 
from Scotland may represent a threat to human health.  This should be borne in mind 
when seeking to manage the risk to human health in Scotland and continued 













   




VTEC strains of serogroup O157 are associated with human disease including 
diarrhoea, haemorrhagic colitis and HUS.  While non-sorbitol-fermenting (NSF) 
VTEC O157:H7 strains are significant human pathogens world-wide (Mead & 
Griffin, 1998), sorbitol-fermenting (SF) VTEC O157:NM strains have emerged as 
important pathogens in continental Europe (Karch & Bielaszewska, 2001).  Although 
SF VTEC O157:NM strains were first isolated in 1988 in Germany (Karch & 
Bielaszewska, 2001), the earliest report of infection with this pathogen in the United 
Kingdom occurred in Scotland in 2002, when it was isolated from a five year old 
child with HUS (Allison, 2002).  There were subsequent reports of single cases of 
infection with SF VTEC O157:NM in Scotland and England in 2003 and 2004, 
respectively (HPA, 2006; Locking et al., 2004).  However, between April and May 
2006, eighteen cases of SF VTEC O157:NM were identified in Scotland, thirteen of 
which were associated with a nursery (Editorial Team, 2006).  A further two cases of 
SF VTEC O157:NM were identified in August 2006. 
 
There is some evidence to suggest that SF VTEC O157:NM strains are more 
frequently associated with HUS than NSF VTEC O157:H7 strains.  For example, in 
Germany the probability of development of HUS after infection with SF VTEC 
O157:NM is 1:2, whereas after infection with NSF VTEC O157:H7 this ratio is 1:6 
(M. Bielaszewska and H. Karch, personal communication).  A similar situation 
appears to be the case in Scotland, where ten out of twenty cases of SF VTEC 
O157:NM infection identified between April and August 2006 progressed to HUS.  
Whilst host susceptibility may differ between outbreaks, it is also possible that SF 
VTEC O157:NM strains are more virulent than NSF VTEC O157:H7 strains. 
 
The objective of this study was to compare both genotypic and phenotypic 
characteristics of SF VTEC O157:NM and NSF VTEC O157:H7 isolates recovered 
from cases of infection in Scotland to identify bacterial factors which may contribute 













Genotypic and phenotypic characterisation of sorbitol-fermenting 





The observation that SF VTEC O157:NM strains are more frequently associated with 
HUS than NSF VTEC O157:H7 strains prompted an investigation of bacterial 
characteristics that may contribute to this.  Since verocytotoxins are responsible for 
the serious consequences of VTEC O157 infection including HUS, it is possible that 
any increased pathogenicity of SF VTEC O157:NM strains could be accounted for 
by: (1) a more potent toxin variant; (2) increased toxin expression; (3) colonisation of 
the human intestine at higher levels leading to a greater exposure to toxin.  This 
chapter describes the genotypic and phenotypic characterisation of SF VTEC 
O157:NM and NSF VTEC O157:H7 isolates, with a particular focus on whether SF 
VTEC O157:NM strains could be considered more virulent as a result of increased 
toxin expression or enhanced colonisation potential.    
 
5.1 E. coli O157 isolates 
Ten E. coli O157 isolates recovered from cases of human infection were collected for 
this study.  A full description of these isolates is detailed in section 2.1.3 and Table 
2.1(C).  Briefly, six of these isolates were SF VTEC O157:NM recovered in 
Scotland; five were isolated during the 2006 Scottish outbreak cluster and one was 
isolated from a single case in 2003 (Locking et al., 2004).  The remaining four E. 
coli O157 isolates were NSF VTEC O157:H7, which were included for comparison.  
Three NSF VTEC O157:H7 isolates were recovered from separate Scottish outbreaks 
and the remaining isolate was the sequenced strain EDL933.  Two representative SF 
VTEC O157:NM isolates (H2687 and H8824) and two NSF VTEC O157:H7 isolates 
(EDL933 and 1477/AI) were analysed in the phenotypic assays.    
 
5.2 Confirmation of basic characteristics of E. coli O157 isolates 
All isolates included in this research were confirmed to be E. coli serogroup O157 by 
immunostaining with O157 antisera.  To confirm their phenotypic traits, isolates 
were plated on sorbitol MacConkey agar to test for sorbitol fermentation and 
inoculated into soft-agar (0.3% agar) to assess motility.  The six SF VTEC O157:NM 
isolates fermented sorbitol within 24 h of incubation at 37°C on sorbitol MacConkey 
agar and were verified as non-motile.  The NSF VTEC O157:H7 isolates did not 
ferment sorbitol and were confirmed to be motile.  Although the SF VTEC 
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O157:NM isolates were non-motile, their gene encoding the flagellin subunit (fliC) 
was detected and characterised using a fliC PCR-restriction fragment length 
polymorphism (RFLP) method (Fields et al., 1997).  The six SF VTEC O157:NM 
isolates shared a fliC-RFLP pattern that was identical to the four NSF VTEC 
O157:H7 isolates (Figure 5.1).  This demonstrated that the SF VTEC O157:NM 
isolates recovered from infections in Scotland possess the fliC gene encoding the H7 





Figure 5.1.  PCR-restriction fragment length polymorphism of the fliC gene from 
VTEC O157 isolates.  Agarose gel electrophoresis of fliC PCR products after restriction 
with RsaI from NSF VTEC O157:H7 isolates EDL933 (lane 1), H77 (lane 2), H511 (lane 3) 
and 1477/AI (lane 4) and SF VTEC O157:NM isolates H2687 (lane 5), H8824 (lane 6), 
H8432 (lane 7), H8489 (lane 8), H8757 (lane 9) and H8478 (lane 10).  Lane M, 100 bp 
molecular size marker. 
 
 
Multiplex PCR for the detection of genes encoding verocytotoxin 1 (vtx1), 
verocytotoxin 2 (vtx2), intimin (eae) and enterohaemolysin (hlyA) demonstrated that 
the SF VTEC O157:NM isolates were positive for vtx2, eae and hlyA and negative for 
vtx1.  The three NSF VTEC O157:H7 isolates from Scottish outbreaks were also 
positive for vtx2, eae and hlyA and negative for vtx1.  VTEC O157:H7 EDL933 was 
confirmed to be positive for vtx1, vtx2, eae and hlyA.   
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5.3 Nucleotide sequencing of vtx2 
To investigate whether the SF VTEC O157:NM isolates produce a different, possibly 
more potent, Vtx2 variant to NSF VTEC O157:H7, the nucleotide sequences of vtx2 
were determined for the six Scottish SF VTEC O157:NM isolates.  The sequences 
from the five isolates obtained from the 2006 Scottish cluster (GenBank accession 
numbers are detailed in Table 2.3) were identical and the same as those published for 
three previously characterised SF VTEC O157:NM strains (Bielaszewska et al., 
2006).  Their A and B subunit genes differed from the published E. coli EDL933 
sequence by seven nucleotides and one nucleotide, respectively, and encode a Vtx2 
protein which differed from Vtx2 from EDL933 by a single amino acid residue in 
each of the subunits.  The vtx2 sequence from SF VTEC O157:NM isolate H2687 
(GenBank accession number EU526759) differed from EDL933 by a single 
nucleotide in the A subunit.  The B subunits were identical.  This SF VTEC 
O157:NM isolate had a predicted protein sequence for Vtx2 identical to that of 
EDL933. 
 
5.4 Vero cell cytotoxicity assays 
To determine whether SF VTEC O157:NM isolates produced greater quantities of 
Vtx2 than NSF VTEC O157:H7 isolates, the production of Vtx by the two VTEC 
O157 groups was investigated using the Vero cell cytotoxicity assay.  A single SF 
VTEC O157:NM isolate from the 2006 Scottish outbreak cluster (H8824) was 
analysed along with SF VTEC O157:NM isolate H2687 recovered from a single case 
in 2003 and compared with NSF VTEC O157:H7 isolates EDL933 and 1477/AI.  E. 
coli O157:H7 TUV93-0, a toxin-negative derivative of EDL933, was included as a 
negative control.  The levels of Vtx production by each isolate was assessed 
following their culture in MEM without and after induction with mitomycin C and 
the results are shown in Figure 5.2. 
 
One-way analysis of variance analysis of Vero cell survival following exposure to 
basal levels of toxin in cultures filtrates from the four VTEC O157 uninduced 
cultures demonstrated significant variation (P < 0.001).  The source of this variation 
is almost entirely due to EDL933, which has a different verocytotoxin background 
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(Vtx1 and Vtx2) to the other three VTEC O157 isolates (Vtx2 alone).  Induction with 
mitomycin C reduced Vero cell survival for all toxin-positive isolates tested, but 
there was no significant difference in Vero cell survival between the four VTEC 
O157 isolates examined following induction (P = 0.723).  Therefore, under the in 
vitro conditions tested there was no evidence of increased toxin expression and 
activity from the SF VTEC O157:NM isolates in comparison with the NSF VTEC 






Figure 5.2.  Vero cell cytotoxicity of culture filtrates from VTEC O157 isolates.  NSF 
VTEC O157:H7 isolates (EDL933 and 1477/AI) and SF VTEC O157:NM isolates (H2687 
and H8824) were cultured in MEM-HEPES with (unshaded bars) and without (shaded bars) 
mitomycin C (0.5 µg/ml).  TUV93-0, a Vtx-negative derivative of EDL933, serves as a 
negative control.  Viable Vero cells, following 72 h of exposure to culture filtrates, were 
quantified by crystal violet staining and subsequent absorbance measurement of crystal 
violet in solution.  Vero cell survival is expressed relative to untreated controls not exposed 




5.5 LEE protein secretion 
Type III secretion-based intimate attachment is likely to be important for intestinal 
colonisation and both SF VTEC O157:NM and NSF VTEC O157:H7 isolates 
possess a type III secretion system.  To investigate if there are differences in the level 
of secretion of LEE-encoded proteins between the two VTEC O157 groups, the 
proteins present in the supernatants of three NSF VTEC O157:H7 and six SF VTEC 
O157:NM isolates cultured in MEM-HEPES were analysed.  It is known that MEM-
HEPES is permissive for LEE-protein secretion by E. coli O157:H7 (Roe et al., 
2003) and E. coli O157:H7 Walla-3, a Vtx-negative strain which secretes high levels 
of LEE-encoded proteins, was included as a positive control.  The isolates were 
cultured in MEM-HEPES to an OD600 of 0.8 and supernatant proteins were TCA 
precipitated, separated by SDS-PAGE and visualised by Colloidal blue staining.  The 
isolates were cultured on three separate occasions and representative secreted protein 
profiles are shown in Figure 5.3. 
 
None of the VTEC O157 isolates secreted LEE-encoded proteins at levels which 
could be detected by Colloidal blue staining.  Therefore, there was no evidence of 
differences in the level of LEE-encoded protein secretion from the SF VTEC 





















Figure 5.3.  LEE-encoded protein secretion by VTEC O157 isolates.  Secreted protein 
profiles from NSF VTEC O157:H7 isolates H77 (lane 1), H511 (lane 2) and 1477/AI (lane 
3) and SF VTEC O157:NM isolates H2687 (lane 4), H8824 (lane 5), H8432 (lane 6), H8489 
(lane 7), H8757 (lane 8) and H8478 (lane 9).  E. coli O157:H7 Walla-3 was included as a 
high secretor positive control (lane 10).  Bacteria were cultured in MEM-HEPES to an OD600 
of 0.8 and supernatant proteins were TCA precipitated, separated by SDS-PAGE and 
visualised by staining with Colloidal blue.  The positions of the co-precipitant BSA (66 kDa) 







5.6 Adherence assays 
In addition to type III secretion-based intimate attachment, adherence mediated by 
surface-expressed factors such as fimbriae may also be important for intestinal 
colonisation. 
 
5.6.1 Adherence to Caco-2 cells 
To investigate if there are differences in the capacities of the two VTEC O157 
groups to adhere to human intestinal epithelial cells, NSF VTEC O157:H7 isolates 
EDL933 and 1477/AI and SF VTEC O157:NM isolates H2687 and H8824 were 
tested for their capacity to bind to Caco-2 cells within 2 h.  Bacteria were cultured at 
37ºC under two different conditions; namely, on CFA agar plates and in CDMT 
broth, which have both been used previously to promote fimbrial expression 
(Brunder et al., 2001; Evans et al., 1977).  The adherence of the VTEC O157 isolates 
to Caco-2 cells is shown in Figure 5.4A.  Significantly higher levels of adherence 
(fifty-fold) were observed for the SF VTEC O157:NM isolates compared with the 
NSF VTEC O157:H7 isolates when cultured on CFA agar, whereas little difference 
was observed between the two groups when cultured in CDMT broth (Figure 5.4A). 
 
Microscopy revealed that the SF VTEC O157:NM isolates cultured on CFA agar at 
37ºC adhered to Caco-2 cells in aggregates whereas the NSF VTEC O157:H7 
isolates cultured in this way did not.  Images showing the adherence of the VTEC 

























Figure 5.4.  Adherence of VTEC O157 isolates to Caco-2 cells.  (A) NSF VTEC O157:H7 
isolates (EDL933 and 1477/AI) and SF VTEC O157:NM isolates (H2687 and H8824) were 
cultured on CFA agar (shaded bars) and in CDMT broth (unshaded bars) at 37°C and 
adherence assays were performed at 37°C for 2 h.  Microscopy was used to determine the 
number of bacteria per field for at least 20 fields.  Adherence assays for each isolate were 
performed on at least three separate occasions.  Data were log10 transformed and analysed 
within mixed models using the REML directive.  The bars represent back-transformed 
predicted means and error bars define 95% confidence interval values.  (B) Visualisation of 
adherence to Caco-2 cells by immunofluorescence microscopy.  The indicated isolates were 
cultured on CFA agar at 37°C and the micrographs show bacteria (stained red) adherent to 
Caco-2 cells after 2 h of incubation at 37°C.  Slides were examined using an x100 objective 
and images were captured with Leica software.   
157 
 
5.6.2 Biofilm assays 
The observed difference in the level of adherence to an intestinal epithelial cell line 
between SF VTEC O157:NM isolates and NSF VTEC O157:H7 isolates following 
culture on CFA agar and the fact that the SF VTEC O157:NM isolates, but not the 
NSF VTEC O157:H7 isolates, autoaggregated following CFA culture prompted an 
investigation of the ability of the two VTEC O157 groups to adhere to an abiotic 
surface.  Isolates were cultured in polystyrene microtitre plates in LB, CFA and 
CDMT broths and adherence assays were performed at 28ºC or 37ºC for 24 h or 48 
h.  The extent of bacterial adherence to microtitre well surfaces was determined by 
crystal violet staining and the results are shown in Figure 5.5. 
 
The SF VTEC O157:NM isolates demonstrated increased adherence to polystyrene 
microtitre plates in comparison with the NSF VTEC O157:H7 isolates under the 
different conditions tested (Figure 5.5A and B).  It was evident that culturing the two 
SF VTEC O157:NM isolates in CDMT broth promoted biofilm formation but did not 
increase adherence to Caco-2 cells.  This indicates that the same combination of 
factors is not required for the two different adherence phenotypes. 
 
5.7 Analysis of fimbriae expression 
The observation that the SF VTEC O157:NM isolates adhered to Caco-2 cells at 
significantly higher levels than NSF VTEC O157:H7 isolates following culture on 
CFA agar prompted an investigation of the factor(s) responsible for this.  At least 
sixteen putative fimbrial operons have been identified in NSF VTEC O157:H7 
(Hayashi et al., 2001; Low et al., 2006; Perna et al., 2001), including the well-
characterised adhesins type 1 fimbriae and curli.  While the capacity to express many 
of these fimbrial adhesins appears to have been lost by NSF VTEC O157:H7 strains 
(Low et al., 2006), SF VTEC O157:NM strains may be different.  In addition, SF 
VTEC O157:NM uniquely possess the sfp gene cluster which encodes novel Sfp 



























Figure 5.5.  Adherence of VTEC O157 isolates to polystyrene microtitre plates.  NSF 
VTEC O157:H7 isolates (EDL933 and 1477/AI) and SF VTEC O157:NM isolates (H2687 
and H8824) were cultured in LB, CFA and CDMT broths and adherence assays were 
performed for 24 h and 48 h at (A) 28°C and (B) 37°C.  Bacterial adherence was quantified 
by crystal violet staining of bacteria and subsequent absorbance measurement (590 nm) of 
released crystal violet.  Background levels were determined for sterile media and were 
subtracted from the other values.  Assays were performed on three separate occasions.  The 
bars represent the average absorbance of released crystal violet for each isolate and error 
bars indicate standard errors of the means. 
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5.7.1 Analysis of type 1 fimbriae expression by NSF VTEC O157:H7 and SF 
VTEC O157:NM   
NSF E. coli O157:H7 strains have been shown to contain a 16 bp deletion in the fim 
switch that controls type 1 fimbriae expression (Li et al., 1997; Roe et al., 2001), 
thus preventing inversion of the fim switch to the on orientation and the expression of 
type 1 fimbriae.  A PCR designed to detect the presence of this deletion (Li et al., 
1997) was used to analyse the two groups of VTEC O157 strains and the results are 
shown in Figure 5.6A.  The SF VTEC O157:NM isolates did not contain the deletion 
(Figure 5.6A, lanes 5 to 10), whereas the deletion was present in the NSF VTEC 
O157:H7 isolates tested (Figure 5.6A, lanes 1 to 4).   
 
The status of type 1 fimbriae expression was then examined using the fim switch 
orientation assay and yeast cell agglutination.  The two groups of VTEC O157 
isolates were initially cultured under conditions optimal for expression of type 1 
fimbriae (3 day subculture in LB broth, statically at 37°C).  PCR and restriction 
digestion analysis of the fim switch found that the SF VTEC O157:NM isolates had 
the fim switch in both the on and off orientations whereas the NSF VTEC O157:H7 
isolates only had the fim switch in the off orientation (Figure 5.6B).  The presence of 
functional type 1 fimbriae was assessed by yeast cell agglutination and only the SF 
VTEC O157:NM isolates exhibited agglutination of yeast cells (Figure 5.6B), which 
was found to be mannose-sensitive (data not shown).  Taken together, these results 
demonstrate that, in contrast to NSF VTEC O157:H7, SF VTEC O157:NM strains 
can express functional type 1 fimbriae.  However, when SF VTEC O157:NM isolates 
were cultured on CFA agar at 37°C, as for the adherence assays, the majority of the 
bacterial population had the fim switch in the off orientation (Figure 5.6C, lanes 3 
and 4). 





















Figure 5.6.  Analysis of type 1 fimbriae expression by VTEC O157 isolates.  (A) PCR 
analysis of the fim switch deletion using VTEC O157:H7-specific primers.  NSF VTEC 
O157:H7 isolates EDL933 (lane 1), H77 (lane 2), H511 (lane 3) and 1477/AI (lane 4) 
generate a 943 bp product indicating the presence of the deletion that is absent in the SF 
VTEC O157:NM isolates H2687 (lane 5), H8824 (lane 6), H8432 (lane 7), H8489 (lane 8), 
H8757 (lane 9) and H8478 (lane 10).  Lane 11, DNA negative (PCR control); lane M, 100 bp 
molecular size marker.  (B and C) PCR and restriction digestion of the fim switch from 
isolates indicating the expression status within the bacterial population.  (B) The isolates 
were cultured under conditions optimal for type 1 fimbriae expression (3 day subculture in 
LB broth, statically at 37°C).  The results of the yeast cell agglutination assay are 
summarised below the gel image.  The fim switch was detected in both the on and off 
orientations for the two SF VTEC O157:NM isolates examined [H2687 (lane 3) and H8824 
(lane 4)] but only in the off orientation for the two NSF VTEC O157:H7 isolates analysed 
[EDL933 (lane 1) and 1477/AI (lane 2)].  (C) The isolates were cultured on CFA agar plates.  
The fim switch in the on orientation was only detected in one SF VTEC O157:NM isolate 
(H2687, lane 3) but not in the other (H8824, lane 4) nor in the two NSF VTEC O157:H7 
isolates [EDL933 (lane 1) and 1477/AI (lane 2)].  Lane M, 100 bp molecular size marker. 
Agglutination 





5.7.1.1  Type 1 fimbriae inhibition adherence assays 
To evaluate the contribution of type 1 fimbriae in the adherence of SF VTEC 
O157:NM isolates to Caco-2 cells following culture on CFA agar, inhibition assays 
were carried out in the presence of 3% (w/v) α-D-mannose.  The addition of mannose 
reduced adherence of the two SF VTEC O157:NM isolates tested (Figure 5.7) but 






Figure 5.7.  Contribution of type 1 fimbriae to Caco-2 cell adherence.  SF VTEC 
O157:NM isolates H2687 and H8824 were cultured on CFA agar at 37°C and Caco-2 
adherence assays were performed in the absence (shaded bars) and presence (unshaded bars) 
of 3% (w/v) α-D-mannose, which will inhibit type 1 fimbrial adherence.  Microscopy (using 
an x100 objective) was used to determine the number of bacteria per field for at least 20 
fields.  Adherence assays for each isolate were performed on three separate occasions.  Data 
were log10 transformed and analysed within mixed models using the REML directive.  The 
bars represent back-transformed predicted means and error bars define 95% confidence 




5.7.2 Analysis of Sfp fimbriae expression by NSF VTEC O157:H7 and SF 
VTEC O157:NM   
SF VTEC O157:NM strains possess a unique fimbrial gene cluster on their large 
plasmid, pSFO157, which encodes novel Sfp fimbriae (Brunder et al., 2001).  The 
expression of Sfp fimbriae on the surface of bacteria cultured on CFA agar and in 
CDMT broth at 37°C was investigated by immunostaining with serum raised to the 
main subunit of these fimbriae, SfpA (Brunder et al., 2001), kindly provided by Prof 
H. Karch.  When the isolates were cultured on CFA agar at 37°C, a proportion of the 
SF VTEC O157:NM bacteria exhibited fluorescent surface staining whereas there 
was no antibody recognition of NSF VTEC O157:H7 bacteria (Figure 5.8A).  There 
was no surface staining of either VTEC O157 group when the bacteria were cultured 
in CDMT broth (data not shown). 
 
Further investigation of Sfp fimbriae expression was achieved by analysing sfpA 
promoter activity.  The promoter region for sfpA from SF VTEC O157:NM isolate 
H8824 was fused to gfp, creating a translational fusion.  The fusion was transformed 
into the appropriate VTEC O157 background and transformants were cultured on 
CFA agar and in CDMT broth, both containing chloramphenicol (CAM), at 37°C.  
Total GFP produced by the population was determined and the results are shown in 
Figure 5.8B.  There were no significant differences in sfpA promoter activity 
between the NSF VTEC O157:H7 isolate 1477/AI and the SF VTEC O157:NM 
isolate H8824 when they were cultured on CFA agar or in CDMT broth.  However, 
sfpA promoter activity in SF VTEC O157:NM isolate H8824 was found to be 
significantly higher (P = 0.0015) following culture on CFA agar compared to in 
CDMT broth (Figure 5.8B).  Taken together, these results indicate that the SF VTEC 



























Figure 5.8.  Analysis of Sfp fimbriae expression by VTEC O157 isolates.  (A) Detection 
of SfpA by immunofluorescence microscopy.  Phase-contrast (left panel) and fluorescence 
(right panel) micrographs are shown for the indicated VTEC O157 isolates stained for SfpA, 
using anti-SfpA serum, following culture on CFA agar at 37°C.  (B) sfpA promoter activity 
in VTEC O157 isolates.  The indicated isolates were transformed with a plasmid-based 
promoter-GFP fusion and expression from the sfpA promoter was determined following the 
culture of transformed isolates on CFA-CAM agar (shaded bars) and in CDMT-CAM broth 
(unshaded bars) at 37°C.  Background fluorescence levels were determined for the promoter-
less plasmid pAJR70 and subtracted.  The data are expressed as relative fluorescence units 
(RFU).  Error bars indicate standard errors of the means. 
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5.7.2.1  Sfp fimbriae inhibition adherence assays 
To evaluate the contribution of Sfp fimbriae in the adherence of SF VTEC O157:NM 
isolates to Caco-2 cells following culture on CFA agar at 37°C, inhibition assays were 
attempted using anti-SfpA serum at a 1:400 dilution.  There was a slight reduction in 
adherence to Caco-2 cells by the two SF VTEC O157:NM isolates tested in the 






Figure 5.9.  Contribution of Sfp fimbriae to Caco-2 cell adherence.  SF VTEC O157:NM 
isolates H2687 and H8824 were cultured on CFA agar at 37°C and incubated in the absence 
(shaded bars) and presence (unshaded bars) of anti-SfpA serum.  Microscopy was used to 
determine the number of bacteria per field for at least 20 fields.  Adherence assays for each 
isolate were performed on three separate occasions.  Data were log10 transformed and 
analysed within mixed models using the REML directive.  The bars represent back-




5.7.3 Analysis of curli expression by NSF VTEC O157:H7 and SF VTEC 
O157:NM   
The observation that the SF VTEC O157:NM isolates, but not the NSF VTEC 
O157:H7 isolates, autoaggregated following CFA culture prompted an investigation 
of curli expression by the two VTEC O157 groups.  Curli are thin aggregative 
fimbriae and are an established adhesin (Barnhart & Chapman, 2006).  However, 
while curli are expressed by many strains of E. coli (Barnhart & Chapman, 2006), the 
majority of NSF VTEC O157:H7 strains are considered not to express this adhesin 
under in vitro conditions (Cookson et al., 2002; Uhlich et al., 2001). 
 
Congo red (CR) binding is a well established method to demonstrate surface curli 
expression by bacteria (Barnhart & Chapman, 2006; Hammar et al., 1995; Uhlich et 
al., 2001).  The VTEC O157 isolates were cultured on CFA-CR indicator plates at 
37°C and while the NSF VTEC O157:H7 isolates EDL933 and 1477/AI were 
negative, the SF VTEC O157:NM isolates H2687 and H8824 were positive (data not 
shown).  Additional evidence for curli expression was provided by immunostaining 
with an anti-SEF17 monoclonal antibody which recognises curli, kindly provided by 
Dr R. La Ragione.  For ease, this anti-SEF17 antibody will be referred to as “anti-
curli” throughout the remainder of this thesis.  When the isolates were cultured on 
CFA agar or in CFA broth at 37°C, the majority of aggregated SF VTEC O157:NM 
bacteria exhibited fluorescent surface staining, while the NSF VTEC O157:H7 
bacteria were negative (Figure 5.10A).  When the bacteria were cultured in CDMT 
broth, there was no surface staining of either VTEC O157 group (data not shown).  
Furthermore, analysis of curli main subunit (csgBAC) promoter activity, using a 
promoter-GFP translational fusion, revealed that the SF VTEC O157:NM isolates 
had significantly higher (P < 0.001) levels of expression from the csgBAC curli 
promoter compared with the NSF VTEC O157:H7 isolates when cultured on CFA 
agar at 37°C (Figure 5.10B).  Taken together, these data indicate that the SF VTEC 

























Figure 5.10.  Analysis of curli expression by VTEC O157 isolates.  (A) Detection of curli 
by immunofluorescence microscopy.  Phase-contrast (left panel) and fluorescence (right 
panel) micrographs are shown for the indicated VTEC O157 isolates stained for curli using 
an anti-curli monoclonal antibody following culture on CFA medium at 37°C.  (B) csgBAC 
curli promoter activity in VTEC O157 isolates.  NSF VTEC O157:H7 isolates (EDL933 and 
1477/AI) and SF VTEC O157:NM isolates (H2687 and H8824) were transformed with a 
plasmid-based promoter-GFP fusion and expression from the csgBAC promoter was 
determined following the culture of transformed isolates on CFA-CAM agar (shaded bars) 
and in CDMT-CAM broth (unshaded bars).  Background fluorescence levels were 
determined for the promoter-less plasmid pAJR70 and subtracted.  The data are expressed as 
relative fluorescence units (RFU).  Error bars indicate standard errors of the means. 
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5.7.3.1  The contribution of curli to SF VTEC O157:NM adherence 
To evaluate the contribution of curli in the adherence of SF VTEC O157:NM isolates 
to Caco-2 cells, inhibition assays were carried out using an anti-curli monoclonal 
antibody at a 1:100 dilution.  The SF VTEC O157:NM isolates cultured on CFA agar 
at 37°C demonstrated a significant inhibition of adherence to Caco-2 cells in the 
presence of the antibody (Figure 5.11A).  This indicated that, under these conditions, 
curli were an important factor in the increased adherence of SF VTEC O157:NM 
isolates to Caco-2 cells.  To further substantiate the role of curli in the adherence, 
adherence assays comparing a curli deletion mutant with its wild-type parent were 
performed.  The curli mutant was created by Ms T. Dransfield (University of 
Edinburgh) by deleting csgBA from SF VTEC O157:NM isolate H8824 by allelic 
exchange.  The csgBA deletion strain did not bind CR and was negative for curli 
expression as determined by immunostaining (data not shown).  This deletion strain 
could be complemented for CR binding and curli expression using a plasmid created 
by Ms T. Dransfield, in which the csgBAC genes were cloned into pWSK29, 
allowing csgBAC induction.  The adherence of the csgBA deletion strain to Caco-2 
cells was significantly reduced (P < 0.001) compared to the parent strain and was 

























Figure 5.11.  Contribution of curli to Caco-2 cell adherence.  (A) Inhibition of adherence 
using anti-curli antibody.  SF VTEC O157:NM isolates H2687 and H8824 were cultured on 
CFA agar at 37°C and incubated in the absence (shaded bars) and presence (unshaded bars) 
of anti-curli monoclonal antibody.  Microscopy was used to determine the number of 
bacteria per field for 30 fields.  Data were log10 transformed and analysed within mixed 
models using the REML directive.  The bars represent back-transformed predicted means 
and error bars define 95% confidence interval values.  (B) Comparative adherence studies of 
a curli deletion mutant and wild-type isolates.  SF VTEC O157:NM isolate H8824 was 
deleted for csgBA and was demonstrated not to bind CR or express curli.  The adherence of 
this strain to Caco-2 cells was compared with its parent and NSF VTEC O157:H7 EDL933.  
Microscopy was used to determine the number of bacteria per field for 30 fields.  The bars 




SF VTEC O157:NM strains have emerged as significant human pathogens in 
continental Europe, causing diarrheal disease often resulting in life-threatening HUS.  
Of particular concern is that 10 out of 20 Scottish patients infected with SF VTEC 
O157:NM in 2006 progressed to HUS.  This is consistent with findings in Germany, 
where humans infected by these strains are more likely to progress to HUS.  This 
compares to NSF VTEC O157:H7 infections that are typically associated with HUS 
at lower frequencies (5 to 10%) (Griffin & Tauxe, 1991; Mead & Griffin, 1998).  As 
clinical cases with SF VTEC O157:NM are uncommon, host factors in these cases 
may be responsible for a bias toward HUS.  These include age, clinical history or 
treatment issues such as the administration of antibiotics and/or anti-motility agents.  
However, the aim of this research was to investigate the hypothesis that bacterial 
factors are the cause of the increased association of SF VTEC O157:NM with HUS.  
This chapter described the genotypic and phenotypic characterisation of NSF VTEC 
O157:H7 and SF VTEC O157:NM isolates to identify bacterial traits which may be 
responsible for the increased virulence of SF VTEC O157:NM strains. 
 
Basic characterisation of six Scottish SF VTEC O157:NM isolates confirmed that 
they were nonmotile in soft agar but carried the fliC gene encoding the H7 antigen.  
This is in agreement with previous characterisation of the fliC gene in European SF 
VTEC O157:NM strains (Bielaszewska et al., 2000; Monday et al., 2004).  Analysis 
of SF E. coli O157:NM strains recovered in Germany found that a 12 bp in-frame 
deletion in the flhC gene of the flhDC master regulator operon, which controls 
flagellum biosynthesis, was responsible for their nonmotility (Monday et al., 2004).  
The Scottish SF VTEC O157:NM isolates examined in this study possessed the 
genes encoding verocytotoxin 2, intimin and enterohaemolysin.  This is in accord 
with all previous studies on SF VTEC O157:NM strains (Bettelheim et al., 2002; 
Bielaszewska et al., 1998; Bielaszewska et al., 2000; Eklund et al., 2006; Gunzer et 
al., 1992; Keskimaki et al., 1998).  The NSF VTEC O157:H7 isolates recovered 
from Scottish outbreaks, which were included in this research for comparison, were 




Previous research has shown that SF VTEC O157:NM strains possess a specific 
combination of virulence determinants, including vtx2 as the sole vtx gene, eae 
encoding γ-intimin, and a large plasmid that carries the hlyA, etp and sfp genes but 
not espP and katP (Karch & Bielaszewska, 2001).  There are notable differences in 
the virulence characteristics of SF VTEC O157:NM and NSF VTEC O157:H7 
strains.  While SF VTEC O157:NM strains harbour vtx2 as the sole vtx gene, NSF 
VTEC O157:H7 strains can possess vtx1, vtx2 and vtx2c genes, either alone or in 
combination (Karch & Bielaszewska, 2001).  In contrast to NSF VTEC O157:H7, SF 
VTEC O157:NM strains contain a complete EHEC factor for adherence (efa1) gene, 
which is only rudimentarily present in NSF VTEC O157:H7 (Janka et al., 2002) and 
the majority of SF VTEC O157:NM strains possess the cytolethal distending toxin-V 
(cdt-V) gene cluster, which is absent in most NSF VTEC O157:H7 strains (Janka et 
al., 2003).  Differences also exist between the large plasmids harboured by these two 
pathogens.  The large plasmid of SF VTEC O157:NM strains lacks espP and katP, 
which encode a serine protease and a catalase-peroxidase, respectively, and carries 
the sfp fimbriae gene cluster instead (Brunder et al., 2006).  In addition, although 
both large plasmids contain the gene for enterohaemolysin (hlyA), there are 
differences in its expression.  The hlyA gene is regularly expressed in NSF VTEC 
O157:H7 strains whereas the majority of SF VTEC O157:NM strains do not express 
this gene and are thus nonhaemolytic on enterohaemolysin agar (Ammon et al., 
1999; Bielaszewska et al., 1998; Bielaszewska et al., 2000; Eklund et al., 2006; 
Keskimaki et al., 1998; Orth et al., 2006). 
 
It is possible that a higher HUS rate following SF VTEC O157:NM infection 
compared to NSF VTEC O157:H7 infection could be accounted for by a more active 
toxin or the release of more toxin during infection.  In the present study, the 
predicted protein sequence for Vtx2 produced by the SF VTEC O157:NM isolates 
was either identical to or differed by a single amino acid in the A and B subunits 
from Vtx2 from NSF VTEC O157:H7 EDL933.  The levels of toxin released by 
isolates under induced and uninduced in vitro conditions were examined, and there 
was no evidence of increased toxin expression from the SF VTEC O157:NM 
isolates.  These results support the findings of others as published work has indicated 
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that there are no significant differences in the Vtx2 proteins encoded by SF VTEC 
O157:NM and NSF VTEC O157:H7 strains (Bielaszewska et al., 2006), and a report 
suggests that their toxicity levels may be similar (Gunzer et al., 1992).  Thus, toxin 
sequence variation and increased toxin release are unlikely to account for any 
differences in virulence between SF VTEC O157:NM and NSF VTEC O157:H7 
strains.  However, it is appreciated that in vivo conditions may result in expression 
differences not observed in vitro. 
 
Alternatively, SF VTEC O157:NM strains may colonise the human intestine in 
higher numbers, resulting in increased exposure to toxin.  To test this, the potential of 
SF VTEC O157:NM and NSF VTEC O157:H7 strains to adhere to a human colon 
carcinoma cell line were compared.  Culture of the isolates on CFA agar plates at 
37°C resulted in up to 50 times more SF VTEC O157:NM bacteria than NSF VTEC 
O157:H7 bacteria adhering to Caco-2 cells within 2 hours.  While type III secretion-
based intimate attachment is likely to be important for intestinal colonisation 
(Donnenberg et al., 1993; Tacket et al., 2000), type III secretion profiles and levels 
were similar for the isolates analysed in this study.  Consequently, initial adherence 
is more likely to involve surface-expressed factors such as fimbriae and so the 
expression and importance of established adhesins was investigated. 
 
Type 1 fimbriae are the most common fimbrial adhesin produced by E. coli (Leathart 
& Gally, 1998).  However, NSF VTEC O157:H7 are unable to express type 1 
fimbriae due to a 16 bp deletion in the fim switch that controls type 1 fimbriae 
expression (Li et al., 1997; Roe et al., 2001).  This study demonstrated that SF 
VTEC O157:NM strains do not contain the 16 bp deletion in the fim switch and, 
when cultured under conditions optimal for the expression of type 1 fimbriae, they 
exhibited mannose-sensitive agglutination of yeast cells and the bacterial population 
had the fim switch in both the on and off orientations.  Thus, in contrast to NSF 
VTEC O157:H7, SF VTEC O157:NM are able to express functional type 1 fimbriae.  
These results corroborate the recent findings of Shaikh et al. (2007).  However, when 
SF VTEC O157:NM were cultured on CFA agar, as for the adherence assays, the 
majority of the bacterial population had the fim switch in the off orientation, 
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indicating that type 1 fimbriae were unlikely to be the main factor responsible for the 
increased adherence to Caco-2 cells under these conditions.  This was substantiated 
in inhibition adherence assays performed in the presence of mannose. 
 
SF E. coli O157:NM strains have been shown to possess a unique fimbrial cluster 
encoded on their large plasmid which mediates the expression of Sfp fimbriae 
(Brunder et al., 2001).  In this study, immunostaining with serum raised to SfpA 
showed surface staining of a proportion of SF VTEC O157:NM bacteria cultured on 
CFA agar at 37°C and promoter fusion analysis agreed with this result.  However, 
inhibition adherence assays performed in the presence of anti-SfpA serum did not 
significantly reduce the adherence of SF VTEC O157:NM isolates to Caco-2 cells, 
implying Sfp fimbriae were not the main factor responsible for the increased 
adherence of SF VTEC O157:NM isolates following culture on CFA agar.  It should 
be noted that inhibition assays were only performed using anti-SfpA serum at a 1:400 
dilution because there was not enough serum available to test inhibition at higher 
concentrations.  Recently published work demonstrates that Sfp fimbriae are 
expressed by SF VTEC O157:NM strains cultured under anaerobic conditions on 
solid media simulating the colonic environment and that the induction of Sfp 
fimbriae on wild-type SF VTEC O157:NM strains correlated with increased 
adherence to Caco-2 and HCT-8 cells (Musken et al., 2008). 
 
Many strains of E. coli express thin aggregative fimbriae called curli (Barnhart & 
Chapman, 2006).  In this study, an initial investigation of curli expression by the SF 
VTEC O157:NM isolates demonstrated that they could bind CR when cultured on 
CFA agar at 37°C.  This assay is commonly applied at 28°C to detect surface curli 
expression (Barnhart & Chapman, 2006; Uhlich et al., 2001).  The expression of 
curli by the SF VTEC O157:NM isolates cultured on CFA medium at 37°C was 
substantiated by immunostaining with an anti-curli monoclonal antibody and csgBAC 
promoter fusion analysis.  In contrast, the majority of NSF E. coli O157:H7 strains 
are considered not to express curli under in vitro conditions (Cookson et al., 2002; 
Uhlich et al., 2001) and the results of this study support this.  Curli are an established 
adhesin, and so their contribution to the increased adherence of SF VTEC O157:NM 
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isolates compared to NSF VTEC O157:H7 isolates was examined.  Inhibition 
adherence assays demonstrated that there was a significant inhibition of adherence of 
SF VTEC O157:NM isolates to Caco-2 cells in the presence of anti-curli monoclonal 
antibody.  Furthermore, the absence of curli expression in a csgBA deletion strain 
reduced the binding capacity of this strain to a level comparable to that of the NSF 
VTEC O157:H7 isolates tested.  These data indicate that, following culture on CFA 
agar at 37°C, curli expression was the principal factor responsible for the adherence 
of SF VTEC O157:NM isolates to Caco-2 cells.    
















Investigation of curli expression by sorbitol-fermenting  





The observation that SF VTEC O157:NM isolates recovered from patients in 
Scotland expressed curli at 37ºC following culture on CFA agar prompted an 
investigation of the ability of a larger number of SF VTEC O157:NM isolates to 
express curli.  This chapter describes the investigation of curli expression by 
European SF VTEC O157:NM isolates. 
 
6.1 Analysis of curli expression by European SF VTEC O157:NM isolates 
To determine whether curli expression at 37°C is a common attribute of SF VTEC 
O157:NM strains, a collection of 66 isolates, collected by Prof. H. Karch’s group 
(Műnster University, Germany), were analysed for their potential to bind CR on 
CFA-CR indicator plates at 37°C.  This initial analysis was performed by Ms T. 
Dransfield (University of Edinburgh) and Dr R. La Ragione (VLA Weybridge) and a 
total of 52/66 (79%) SF VTEC O157:NM isolates were assessed as positive for CR 
binding.  My research confirmed that CR binding by these isolates was associated 
with surface curli expression by immunostaining with the anti-curli monoclonal 
antibody.  Two CR-positive isolates (E02/879 and E06/486) and two CR-negative 
isolates (340/97 and 080/01) were analysed and while both CR-positive isolates 
exhibited fluorescent surface staining, the two CR-negative isolates did not (Figure 

































Figure 6.1.  Detection of curli by immunofluorescence microscopy.  Phase-contrast (left 
panel) and fluorescence (right panel) micrographs are shown for the indicated European SF 
VTEC O157:NM isolates stained for curli using an anti-curli monoclonal antibody following 
culture on CFA medium at 37°C.  The potential of the isolate to bind CR on CFA-CR 
indicator plates at 37°C is indicated in parenthesis.  Slides were examined using an x100 




6.2 Contribution of curli expression to Caco-2 cell adherence 
To further examine the association of curli expression with Caco-2 cell adherence, 
two CR-positive isolates and two CR-negative isolates were tested in Caco-2 
adherence assays.  Following culture on CFA agar at 37ºC, both CR-positive curli-
expressing isolates (E02/879 and E06/486) adhered to Caco-2 cells at significantly 
higher levels (P < 0.01) than the CR-negative isolates that did not express curli 






Figure 6.2.  Adherence of selected European SF VTEC O157:NM isolates to Caco-2 
cells.  The indicated isolates were cultured on CFA agar at 37°C and adherence assays were 
performed at 37°C for 2 h.  SF VTEC O157:NM isolate H8824 was included as a positive 
control.  Microscopy was used to determine the number of bacteria per field for 30 fields.  
Adherence assays for each isolate were performed on at least three separate occasions.  The 
bars represent the average number of bacteria per field and error bars define standard 
deviations.  The potential of the isolate to bind CR on CFA-CR indicator plates at 37°C, 
which correlates with curli expression, is indicated below the graph.    
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6.3 Investigation of the differential curli expression in SF VTEC O157:NM 
isolates 
The fact that there are differences in curli expression between SF VTEC O157:NM 
strains prompted an investigation to identify the source of this variation. 
 
6.3.1 Nucleotide sequencing of curli operons 
To establish if sequence variation in curli loci could account for the differences in 
curli expression between SF VTEC O157:NM isolates, the nucleotide sequences of 
the relevant regions (csgBAC and csgDEFG operons and the csgB-to-csgD intergenic 
region) were determined for CR-negative isolates 340/97 and 080/01 and CR-
positive isolates E06/486 and H8824.  GenBank accession numbers are detailed in 
Table 2.3.  The sequences of the entire region from isolates 080/01, E06/486 and 
H8824 were identical, and isolate 340/97 only differed from them by a single 
nucleotide in the csgD gene.  The putative CsgG, CsgF, CsgE, CsgD, CsgB, CsgA 
and CsgC proteins encoded by the four SF VTEC O157:NM isolates should be 
identical. 
 
6.3.2 Measurement of csgBAC and csgD promoter activity in SF VTEC 
O157:NM isolates 
Given that the curli expression differences are not accounted for by mutations or 
changes in the curli operons themselves, it is likely that the regulation acting on the 
csgBAC promoter must differ between these isolates.  This could be on the csgBAC 
promoter via differences in CsgD activator levels or on the csgBAC promoter 
independent of the CsgD level (Barnhart & Chapman, 2006; Uhlich et al., 2001).  To 
investigate the expression of csgBAC and csgD in wild-type SF VTEC O157:NM 
isolates, promoter-GFP fusion constructs were transformed into different SF VTEC 
O157:NM backgrounds.  Following the culture of transformed strains on CFA-CAM 
agar plates at 37°C, expression from the csgBAC promoter was found to be 
significantly higher (P < 0.02) in isolates E02/879, E06/486 and H8824 than in 
isolates 340/97 and 080/01 (Figure 6.3).  These results correlate with CR binding 
data and curli expression.  In contrast, while expression from the csgD promoter was 
significantly higher (P < 0.001) in one isolate (H8824), which could account for the 
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increase in csgBAC expression and curli production, it was equivalent in the four 
other isolates tested, only two of which express curli on CFA medium at 37°C 
(Figure 6.3).  This indicates that curli expression in these isolates may be driven by 






Figure 6.3.  csgBAC and csgD promoter activity in selected European SF VTEC 
O157:NM isolates.  The indicated isolates were transformed with plasmid-based promoter-
GFP fusion constructs, and expression from the csgBAC promoter (shaded bars) and the 
csgD promoter (unshaded bars) was determined following the culture of transformed isolates 
on CFA-CAM agar at 37°C.  Background fluorescence levels were determined for the 
promoter-less plasmid pAJR70 and subtracted.  The data are expressed as relative 
fluorescence units (RFU).  Error bars indicate standard errors of the means.  The potential of 
the isolate to bind CR on CFA-CR indicator plates at 37°C, which correlates with curli 




SF VTEC O157:NM isolates recovered from clinical cases in Scotland were shown 
to express curli at 37°C following culture on CFA agar and this curli expression was 
found to be the main factor responsible for the increased adherence of SF VTEC 
O157:NM isolates to Caco-2 cells compared to NSF VTEC O157:H7 isolates.  
However, it is important to determine whether curli expression at 37°C is a common 
characteristic of SF VTEC O157:NM strains.  This chapter described the 
investigation of curli expression by European SF VTEC O157:NM isolates. 
 
Analysis, performed by Ms T. Dransfield and Dr R. La Ragione, of 66 SF VTEC 
O157:NM isolates recovered in Europe indicated that 79% could bind CR when 
cultured on CFA agar at 37°C.  For the subset tested, this phenotype again correlated 
with curli expression, as determined by immunostaining with an anti-curli 
monoclonal antibody and csgBAC promoter fusion analysis.  An interesting 
observation to come out of this analysis is that SF VTEC O157:NM isolates 
recovered most recently (from 2001 to present) were generally able to express curli 
under the conditions investigated whereas those recovered prior to 2001 generally 
were not.  Therefore, curli expression at 37°C is a common attribute of recent SF 
VTEC O157:NM isolates following culture on CFA agar.  Analysis of these isolates 
in Caco-2 adherence assays provided further evidence of the association of curli 
expression with Caco-2 cell adherence.  Both CR-positive curli-expressing isolates 
adhered to Caco-2 cells at significantly higher levels than the CR-negative isolates 
that did not express curli. 
 
The observation that many of the early SF VTEC O157:NM isolates did not express 
curli following culture on CFA agar at 37°C prompted an investigation of the 
differences in curli expression between SF VTEC O157:NM isolates.  In E. coli, two 
divergently transcribed operons, csgBAC and csgDEFG, are required for curli 
formation (Hammar et al., 1995).  The csgBAC operon encodes: CsgA, the main 
subunit protein; CsgB, the nucleator protein; and CsgC, which has no reported role in 
curli formation (Barnhart & Chapman, 2006).  The csgDEFG operon encodes four 
accessory proteins required for curli assembly, where CsgD is the positive 
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transcriptional regulator of the csgBAC operon (Barnhart & Chapman, 2006).  The 
curli loci from four SF VTEC O157:NM isolates (two curli-expressing isolates and 
two that did not express curli under the conditions tested) were sequenced, and there 
were no changes detected that could account for the differences in curli expression.  
In particular, there were no sequence differences in the csgB-to-csgD intergenic 
region.  This is significant as nucleotide changes in the csgD promoter region have 
been associated with variation in curli expression in E. coli O157:H7 (Uhlich et al., 
2001).  Transcription from the csgBAC promoter requires expression of the CsgD 
positive regulator (Hammar et al., 1995).  In the present study, csgBAC expression 
was higher in isolates expressing curli.  In one case, this increased level coincided 
with a higher level of csgD expression, but in the other isolates, levels of csgD 
expression were equivalent irrespective of curli expression phenotype.  Therefore, it 
appears that curli expression in SF VTEC O157:NM isolates can be controlled either 
by increased csgD expression or by regulators acting directly on the csgBAC 
promoter together with CsgD.  Curli expression is controlled by osmolarity and 
various stress responses, in particular those that affect membrane integrity (Barnhart 
& Chapman, 2006).  Regulators controlled by these responses can act directly on the 
csgBAC promoter; for example, RcsB and CpxR, which are modified by 
phosphorylation (Barnhart & Chapman, 2006).  It would be interesting to investigate 
differences in signaling pathways that control curli expression in SF VTEC 
O157:NM strains.      
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6.5 Section II discussion 
The emergence of SF VTEC O157:NM strains in Europe is of particular concern 
since these pathogens appear to be associated with a higher incidence of HUS 
compared to the more common NSF VTEC O157:H7.  The aim of this research was 
to investigate potential bacterial factors which could account for increased virulence 
of SF VTEC O157:NM strains.  While no evidence of verocytotoxin or 
verocytotoxin expression differences between the two VTEC O157 groups were 
found, SF VTEC O157:NM isolates adhered at significantly higher levels to a human 
colonic cell line than NSF VTEC O157:H7 isolates.  It was demonstrated that curli 
were the main factor responsible for this increased adherence observed in vitro.  
However, the ability of SF VTEC O157:NM bacteria to express functional type 1 
fimbriae and Sfp fimbriae on their surface (this study; Musken et al., 2008; Shaikh et 
al., 2007) suggests that these adhesins are also likely to contribute to the adherence 
of these pathogens in vivo.   
 
Although previous studies have shown that in E. coli curli are generally expressed 
optimally at temperatures below 30°C (Olsen et al., 1989), this study demonstrated 
that SF VTEC O157:NM strains can express curli at 37°C.  There is clear evidence 
that curli are an important virulence factor.  For example, CR-binding variants of E. 
coli O157:H7 were more virulent in a mouse model (Uhlich et al., 2002) and 
expression of curli at 37°C has been reported for a significant number of human E. 
coli sepsis isolates (Bian et al., 2000).  Curli expression may contribute to the 
virulence of the pathogen in several ways.  Firstly, curli can contribute to increased 
colonisation through adherence to host cells (this study; Kikuchi et al., 2005; Kim & 
Kim, 2004) and extracellular matrix proteins (Barnhart & Chapman, 2006; Olsen et 
al., 1989) and through bacterial aggregation.  Secondly, the interaction of curliated 
bacteria with certain host proteins may facilitate the spread of the bacteria through 
the host (Barnhart & Chapman, 2006) and as bacteria expressing curli can bind to 
human contact-phase proteins, including fibrinogen, the clotting cascade may be 
inhibited (Barnhart & Chapman, 2006).  Thirdly, curli can activate the innate 
immune system and have been shown to be a pathogen-associated molecular pattern 
recognised by TLR2 (Tukel et al., 2005).  This is in agreement with an earlier study 
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which demonstrated that curli induce the proinflammatory cytokines TNF-α, IL-6 
and IL-8 (Bian et al., 2000).  This final point may be critical in terms of toxin 
translocation during SF VTEC O157:NM infections as there is evidence that toxin 
circulates on the surface of neutrophils (te Loo et al., 2000).  Therefore, the more 
inflammation that is induced by bacteria in the gastrointestinal tract, the more 
neutrophils are recruited that could traffic toxin into the bloodstream via the lymph 
system.   
 
It is noteworthy that curli expression at 37°C is characteristic of SF VTEC O157:NM 
isolates recovered most recently (from 2001 to present).  Those isolates recovered 
prior to 2001 generally do not express curli under the conditions investigated.  This is 
interesting since there were only two registered HUS outbreaks caused by SF VTEC 
O157:NM before 2001 in Germany (the first in 1988 and the other in 1996) whereas 
there were four HUS outbreaks caused by this pathogen during 2002 to 2006 (H. 
Karch, personal communication).  It is possible that SF VTEC O157:NM have 
evolved the ability to express curli and this has provided strains with an increased 
virulence potential directly.  Furthermore, perhaps the development of curli 
expression is a reflection of changes in the regulation and expression of other 
virulence genes by SF VTEC O157:NM and these also contribute to the 
pathogenicity of this organism.  Changes in the regulation of virulence factors, 
including curli, may be a consequence of the acquisition or loss of DNA which 
carries effector proteins or regulators.    
 
To support the role of curli in the disease process following infection with SF VTEC 
O157:NM, it would be interesting to analyse serum samples from infected patients to 
look for anti-curli antibodies. 
   
The ability of SF VTEC O157:NM to express fimbrial adhesins and colonise the 
human intestine at higher levels could have serious implications for human health 
where the presence of greater bacterial numbers, and perhaps more persistent 
colonisation, in the intestine leads to increased toxin exposure and an increased 




In attempting to understand differences in the pathogenic potential of bacterial 
strains, in a bid to minimise the risk of human infections, we are often in the situation 
of trying to develop an understanding of a complex set of interactions between the 
bacteria, their host and environment.  In this situation, I have deliberately chosen to 
investigate the bacterial factors that are of importance to the emergence of two 
bacterial pathogens, although this work is informed by some host and environmental 
information.  It remains a key requirement to place my work into the context of 
human health in Scotland.   
 
This research illuminated key bacterial differences which may potentially contribute 
directly to the increased pathogenicity of a strain, or which simply serve as indicators 
of other differences.  However, even when focusing on solely bacterial factors, we 
find ourselves in a complex situation since a single E. coli serotype is a complex 
mixture of strains with different combinations of virulence-associated determinants 
that have evolved together to make a successful pathogen.  Developing an 
understanding of the synergism among different factors is essential. 
 
However, in spite of this complexity, curli expression has been identified as a key 
virulence factor for SF VTEC O157:NM.  This research demonstrated that SF VTEC 
O157:NM can express curli at 37°C following culture on CFA agar whereas NSF 
VTEC O157:H7 do not.  Since Congo red (CR) binding is a well established method 
to demonstrate surface curli expression and CFA-CR indicator plates were able to 
distinguish the majority of SF VTEC O157:NM isolates from NSF VTEC O157:H7  
at 37°C, it is possible that CFA-CR indicator plates could be used as a basis for the 
detection and identification of SF VTEC O157:NM in a diagnostic laboratory and 
this merits further investigation. 
 
This study demonstrated that curli are expressed by the vast majority of recently 
isolated SF VTEC O157:NM strains.  Therefore, it is recommended that an 
examination of European strain repositories of SF VTEC O157:NM isolates should 
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be conducted to identify if the evolution of isolates capable of expressing curli at 
37°C is a relatively recent event. 
 
Since curli is a proven virulence factor that may promote increased pathogenicity in a 
strain in a number of ways (see section 6.5 for details), it would be useful to develop 
a good animal model that could be used to analyse strains that do and do not express 
curli at 37°C to get a better understanding of the role of curli in pathogenesis. 
 
In the study of E. coli O26 strains it is apparent that the genetic backbone of strains is 
relatively similar.  However, the work did reveal fundamental attributes that may be 
considered important for strains to be more likely to cause serious human infection.  
These attributes include the carriage of the gene encoding verocytotoxin 2, allele 1 
for the region upstream of LEE1 and also possession of tccP2.  Thus, I consider that 
it would be beneficial for there to be greater screening of E. coli O26 isolates from 
cattle, and other potential reservoirs, for strains carrying the above mentioned 
virulence determinants, and that the Reference Laboratory should include these 
characterisations in its routine screening of HUS cases.   
 
Finally, because of the complexity of bacterial pathogenesis it is not possible to be 
certain about the threat to human health of a particular pathogen.  However, I have 
shown that E. coli strains which may represent a threat are present in Scotland and, 
since bacteria are continually evolving, there will no doubt be the emergence of new 
pathogenic clones in the future.  Continued surveillance and further research will be 
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Appendix 1: Preparation of media and reagents 
All chemicals used were from Sigma-Aldrich unless otherwise stated. 
 
CDMT broth 
A concentrated stock of each component was prepared and autoclaved.  The working 
medium contained 13 mM K2HPO4, 6 mM KH2PO4, 8 mM (NH4)2SO4, 2 mM 
sodium citrate, 0.4 mM MgSO4 (Fisher), 0.2% (w/v) casamino acids (Oxoid), 0.2% 
(w/v) glucose, 5 µM CaCl2 and 0.01% (w/v) tryptone (BD Biosciences). 
 
CFA agar  
Medium consisting of 1% (w/v) casamino acids (Oxoid), 0.15% (w/v) yeast extract 
(Oxoid) and 1.5% (w/v) agar (Melford) was autoclaved and cooled to 55°C before 
the following sterile components were added: 0.005% (w/v) MgSO4 (Fisher) and 
0.0005% (w/v) MnCl2. 
 
CFA broth 
As for CFA agar without the agar. 
 
Crystal violet solution 
Crystal violet stock: 0.5% (w/v) crystal violet prepared in dH2O was filtered through 
Whatman filter paper and phenol [0.25% (w/v), BDH] added. 
 
Crystal violet solution: 0.13% crystal violet, 0.065% phenol, 5% (v/v) ethanol, 2% 
(v/v) formaldehyde in PBS.  [To prepare 200 ml: 52 ml crystal violet stock, 10 ml 
ethanol, 10.8 ml 37% formaldehyde in 127.2 ml PBS]. 
 
ECL solution 
ECL solution was made by mixing equal volumes of ECL reagent 1 and ECL reagent 
2.  
ECL reagent 1: 100 mM Tris-HCl (pH 8.5), 2.5 mM Luminol (Fluka), 0.4 mM p-
coumaric acid.  




1% trypticase peptone (BD Biosciences), 0.5% NaCl, 0.3% agar (Melford). 
 
TFB I 
The final 1 L solution contained 30 mM potassium acetate (KC2H3O2), 10 mM 
CaCl2.2H2O, 100 mM KCl, 15% (v/v) glycerol and 50 mM MnCl2.  The potassium 
acetate, CaCl2.2H2O, KCl and glycerol were prepared in a volume of 900 ml and 
autoclaved before 100 ml sterile MnCl2 was added.   
 
TFB II 





Appendix 2: Genotypic characterisation of E. coli O26 isolates. 
 





STc ST cplxc espAd upstream 
of LEE1d 
vtxf LEEg hlyA tccP tccP2h 
ZAP1077_B1  29 29 1 3  – + – – + (1050bp) 
ZAP1078_B2   21 29 1 1  1, 2 + + – – 
ZAP1079_B3   21 29 1 2  1 + + – – 
ZAP1080_B4   21 29 1 2  1 + + – + (750bp) 
ZAP1081_B5  21 29 1 2  1 + + – + (750bp) 
ZAP1082_B6  29 29 1 1  – + + – + (1050bp)  
ZAP1083_B7   21 29 1 2  1 + + – – 
ZAP1084_B8   21 29 1 2  1 + + – – 
ZAP1085_B9   21 29 1 2  1 + + – – 
ZAP1086_B10   21 29 1 2  1, 2 + + – – 
ZAP1087_B11   986 10 ND ND  1 – – – – 
ZAP1088_B12  21 29 1 2  1 + + – – 
ZAP1089_B13   29 29 1 4  – + + – + (750bp) 
ZAP1090_B14  29 29 1 1  – + – – + (1050bp)  
ZAP1091_B15  21 29 1 2  1 + + – + (750bp) 
ZAP1092_B16   29 29 1 4  – + + – + (900bp) 
ZAP1093_B17  21 29 1 2  1 + + – – 
ZAP1094_B18   21 29 1 2  1, 2 + + – – 
ZAP1095_B19  21 29 1 2  1 + + – + (750bp) 
ZAP1096_B20  29 29 1 1  – + + – + (1050bp) 
ZAP1097_B21  21 29 1 2  1 + + – – 
ZAP1098_B22  29 29 1 4  – + + – + (750bp) 
ZAP1099_B23  29 29 1 1  – + – – + (1050bp) 
ZAP1100_B24  21 29 1 2  1, 2 + + – – 
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STc ST cplxc espAd upstream 
of LEE1d 
vtxf LEEg hlyA tccP tccP2h 
ZAP1101_B25  21 29 1 2  1 + + – + (750bp) 
ZAP1102_B26  29 29 1 1  – + – – + (1050bp) 
ZAP1103_B27  21 29 1 2  1 + + – + (750bp) 
ZAP1104_B28  10 10 ND ND  – – – – – 
ZAP1105_B29   21 29 1 1  1, 2 + + – + (750bp) 
ZAP1106_B30  21 29 1 2  1, 2 + + – – 
ZAP1107_B31   21 29 1 2  1 + + – – 
ZAP1108_B32   21 29 1 2  1 + + – + (750bp) 
ZAP1109_B33   21 29 1 2  1, 2 + + – – 
ZAP1111_S2  No info 574 29 1 2  1 + + – – 
ZAP1112_S3  D 29 29 1 4  – + + – + (900bp) 
ZAP1114_S6  D 21 29 1 2  1 + + – – 
ZAP1115_S7  D 21 29 1 2  1 + + – – 
ZAP1116_S8  BD 29 29 1 1  – + – – + (1050bp) 
ZAP1117_S9  D 10 10 ND ND  – – – – – 
ZAP1118_S10  D 29 29 2 5  – + + – + (950bp) 
ZAP1119_S11  D 575 29 1 1  – + + – + (1250bp) 
ZAP1120_S12  D 29 29 1 6  – + – – + (1400bp) 
ZAP1152_S35 D 21 29 1 2  1, 2 + + – – 
ZAP1153_S36 BD 21 29 1 2  1, 2 + + – – 
ZAP1121_G13 D 29 29 1 1  – + – – + (900bp) 
ZAP1122_G14  HUS 21 29 1 2  1, 2 + + – + (750bp) 
ZAP1124_G16 HUS 21 29 1 2  1 + – – + (750bp) 
ZAP1125_G17 D 29 29 1 1  – + + – + (900bp, 
    750bp) 
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STc ST cplxc espAd upstream 
of LEE1d 
vtxf LEEg hlyA tccP tccP2h 
ZAP1126_G18 HUS 21 29 1 1  1, 2 + – – + (750bp) 
ZAP1127_G19 D 21 29 1 2  1 + + – + (750bp) 
ZAP1128_G20  HUS 29 29 1 1  2 + + – + (850bp) 
ZAP1129_G21  HUS 21 29 1 2  1, 2 + – – + (750bp) 
ZAP1130_G22 HUS 21 29 1 1  1, 2 + + – + (750bp) 
ZAP1131_G23  D 21 29 1 1  1 + – – + (750bp) 
ZAP1132_G24  HUS 21 29 1 2  2 + – – – 
ZAP1133_G25 D 21 29 1 1  – + – – + (900bp) 
ZAP1134_G26  HUS 29 29 1 1  2 + + – + (900bp) 
ZAP1135_G27  D 29 29 1 1  – + + – + (900bp) 
ZAP1146_I29 HUS 21 29 1 1  1 + + – – 
ZAP1147_I30 HC 21 29 1 1  2 + + – + (900bp) 
ZAP1149_I32 HUS 21 29 1 1  2 + + – + (900bp) 
ZAP1150_I33 HUS 21 29 1 1  2 + + – + (900bp) 
ZAP1151_I34 HUS 21 29 1 1  1 + + – + (750bp) 
a The suffix indicates the origin of the isolate: B, bovine; S, human (Scotland); G, human (Germany); I, human (Italy). 
b Information provided by the supplier of the isolate.  BD, bloody diarrhoea; D, diarrhoea; HC, haemorrhagic colitis; HUS, haemolytic uraemic 
syndrome. 
c The sequence type (ST) and ST complex were assigned in accordance with the E. coli MLST website (http://mlst.ucc.ie/mlst/dbs/Ecoli) 
following sequencing of housekeeping genes. 
d The allele numbers for espA and the region upstream of LEE1 were assigned in the order in which they were discovered; ND, not determined. 
e  +, gene present; –, gene absent. 
f vtx types: 1, vtx1; 2, vtx2; 1, 2, vtx1 and vtx2; –, vtx negative. 
g The possession of the LEE was determined by PCR screening for eae (intimin) and sepL (SepL). 










Appendix 3.  Schematic diagram detailing factors involved in the regulation of the LEE in 
E. coli O157:H7.  The numbering of the bases (-393 to +323) is in relation to the P2 LEE1 
promoter transcriptional start site.  Image reproduced from Sharp and Sperandio (2007). 
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